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Abstract
In this dissertation, three successful applications of Type II Anion Relay Chemistry (ARC), a versatile multi-
component union tactic, are described.
Part 1: An effective, general protocol for the Diversity-Oriented Synthesis (DOS) of 2,4,6-trisubstituted
piperidine congeners has been designed and validated. The successful strategy entails a modular approach to
all possible stereoisomers of a selected piperidine scaffold, exploiting Type II Anion Relay Chemistry (ARC),
followed in turn by intramolecular SN2 cyclization, chemoselective removal of the dithiane moieties and
carbonyl reductions.
Part 2: A highly convergent synthesis of (-)-secu'amamine A has been achieved by exploiting a highly efficient
Type II Anion Relay Chemistry (ARC) tactic to provide the full carbon and nitrogen skeleton with requisite
functionalities in a single-flask.
Part 3: One-step access to diverse carbobicycles utilizing Type II ARC envolving Aldol-Brook
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Part 1: Diversity-Oriented Synthesis of Polysubstituted 
Piperidine Analogues via Type II  Anion Relay Chemistry 
(ARC) 
“Adapted with permission from Amos B. Smith, III, Heeoon Han, and Won-Suk Kim Org. Lett. 2011, 13, 
3328. Copyright 2011 American Chemical Society." 
1-1: Introduction of Anion Relay Chemistry (ARC) 
   Nature’s   biosynthesis   of   architecturally   complex  molecules   often   comprises   iterative  
reaction sequences utilizing complex molecular machines, such as polyketide synthases, 
to unite activated, stereochemically pure building blocks.1 In an attempt to mimic 
Nature’s   iterative   biosynthesis   of   complex   molecules,   the Smith Laboratory has 
developed and validated Type I and Type II Anion Relay Chemistry (ARC) (Scheme 1-
1),2  two closely related synthetic methods comprising multi-component union protocols.  
 
   Type I Anion Relay Chemistry (Scheme 1-1, Eq 1), a multi-component coupling 
protocol, that involves addition of an anion, derived from a nucleophilic bi-functional 
linchpin 1.1 to an electrophile (1.2) capable of generating an alkoxide that, with the aid of 
2 
 
a silyl transfer agent (Brook rearrangement), relays the negative charge back to the 
originating nucleophilic locus on the linchpin (1.31.4).  Addition of the resultant anion 
1.4 to a second electrophile furnishes three-component adduct 1.5.  
   Type II Anion Relay Chemistry (Scheme 1-1, Eq 2), also a multi-component reaction, 
involves the addition of an external nucleophile 1.6 to a bi-functional electrophilic 
linchpin 1.7 to generate an alkoxide 1.8 that again, with the aid of a transfer agent, also 
relays  the  negative  charge,  but  now  differs  by  “across  space”  negative  charge  migration  
to a new (i.e., different) locus on the linchpin 1.9.  Termination with an electrophile at the 
new distal site also results in a three-component adduct 1.10.  The Type II ARC tactic in 
particular holds   the   potential   for   multiple   “iterations”   by   employing   the   sequential  
addition of bi- and trifunctional linchpins.  
   In addition to providing access to specific architectures, the ARC tactic also holds 
considerable potential for Diversity Oriented Synthesis (DOS).3 The Smith laboratory has 
designed and validated various novel bifunctional linchpins (linchpins in Scheme 1-2),2 
thereby opening the ARC tactic to much greater structural diversity. Fundamentally, 
Anion Relay Chemistry differs from the traditional multi-component reactions (cf. the 
Noyori three-component4 or Ugi four-component unions5), wherein the scope is limited 
to the construction of  specific defined scaffolds, with assigned functional groups. On the 
other hand, the ARC tactic has the clear advantage to access a wide variety of scaffolds 






1-2: General Strategy to Access Diverse Piperidine Analogues via Type 
II ARC 
   To illustrate the utility of the Type II ARC tactic in the area of DOS, we developed a 
general strategy to access all possible stereoisomers of a family of 2,4,6-trisubstituted 
piperidines, utilizing this union tactic, followed in turn by an intramolecular SN2 
cyclization, with further elaboration (Scheme 1-3). From the medicinal perspective, the 
piperidine scaffold has attracted considerable interest in the synthetic6 and biological7 
communities. However, notwithstanding the availability of numerous methods to access 
individual members of the 2,4,6-trisubstituted piperidine family in a stereocontrolled 
fashion, there are few general methods that can provide access to all stereoisomers.8 
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   The Type II ARC tactic, as illustrated in Scheme 1-3, not only would provide a 
convergent route to 2,4,6-trisubstituted piperidines, but also would enable chemical and 
stereochemical diversification at the C(2) and C(6) stereogenic centers, depending on the 
components 1.11-1.13 employed.  
 
   In addition, the two dithiane groups in 1.15 provide synthetic handles for further 
chemoselective diversification. Here, we focused on delivering full stereoisomers of diols 
(1.16) via stereoselective reduction of the ketones generated from oxidative removal of 
dithiane moieties in 1.15. To initiate this program, the three requisite components for the 
ARC Type II reaction were prepared, including initiating nucleophiles (dithianes 1.11a-
d), bifunctional linchpins [(+)-1.12, ()-1.12], and aziridines [(+)-1.13a, (+)-1.13b, (–)-
1.13a, (–)-1.13c)], the latter readily accessible from enantiomerically pure amino acids.9  
 
1-3: Multi-component Reaction 
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   With these components in hand, reaction conditions for the Type II ARC protocol were 
optimized based on earlier studies in the Smith Laboratory. Conditions employing the 
modified Schlosser base10 proved highly effective, without the use of co-solvents such as 
HMPA or DMPU to enhance the nucleophilicity of dithiane anion.11 The TBS group of 
multi-component adducts was then removed with TBAF or by employing acidic 
conditions (Table 1-1).  
 





1 1.11a (+)-1.12 (+)-1.13a (S,S)-1.18 74 
2 1.11a (+)-1.12 ()-1.13a (S,R)-1.18 69 
3 1.11a ()-1.12 (+)-1.13a (R,S)-1.18 69 
4 1.11a ()-1.12 ()-1.13a (R,R)-1.18 74 
5 1.11a (+)-1.12 (+)-1.13b (S,S)-1.19 61 
6 1.11a (+)-1.12 ()-1.13c (S,S)-1.20 41 
7 1.11b (+)-1.12 (+)-1.13a (S,S)-1.21 65 
8 1.11b ()-1.12 (+)-1.13a (R,S)-1.21 59 
9 1.11b (+)-1.12 (+)-1.13b (S,S)-1.22 55 
10 1.11c (+)-1.12 (+)-1.13a (R,S)-1.23 56 
11 1.11d (+)-1.12 (+)-1.13a (R,S)-1.24 52 
12 1.11d ()-1.12 (+)-1.13a (S,S)-1.24 55 
a Absolute configuration of the corresponding stereocenters. b Isolated yield for ARC. 
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1-4: Intramolecular SN2 Cyclization 
   Mesylation of the hydroxy group in 1.17 next furnished the substrates for the 
subsequent intramolecular SN2 cyclization. Examination of a variety of conditions, 
including solvents, bases, and leaving groups to suppress potential elimination reactions, 
revealed that treatment of the mesylates in dilute THF solution with NaH effectively 










1 (S,S)-1.18 Me/Bn (R,S)-1.25 cis 87 
2 (R,R)-1.18 Me/Bn (S,R)-1.25 cis 85 
3 (S,R)-1.18 Me/Bn (R,R)-1.25 trans 55 
4 (R,S)-1.18 Me/Bn (S,S)-1.25 trans 58 
5 (S,S)-1.19 Me/nPr (R,S)-1.26 cis 89 
6 (R,S)-1.24 Ph/Bn (S,S)-1.27 cis 81 
      a Absolute configuration of the corresponding stereocenters. b Isolated yield for ARC. 
   In the case of the preparation of 2, 6-trans piperidines, the TBS ether moieties of the 
syn multi-component products (S,R)-1.18 and (R,S)-1.18 are stable to TBAF in THF.  
Acidic cleavage of the TBS group was satisfactory (cat. HCl or CSA/MeOH/rt).  It was 
found however that the yield leading to 2,6-trans piperidine ring was low; the major side 
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reaction was elimination to furnish olefin isomers of 1.28 (Table 1-3).  When polar 
solvents such as methanol or DMF were used in order to increase the nucleophilicity of 
the sulfonamide moiety, the elimination product was isolated predominantly. I next 
observed that polar solvents increase the rates of E1/E2 reaction rather than the rate of 
SN2 reaction, which implies that the rate of this cyclization reaction is controlled by steric 
hindrance more than nucleophilicity.  
 




MsCl, TEA, THF, 0 oC; 
K2CO3, MeOH, rt, 12h 1.28 only 77 
2 tBuOK, DMF, 0 oC - rt, 5h 1:10 77 
3 tBuOK, THF, rt, 5h 1:10 74 
4 tBuOK, Toluene, 0 oC - rt, 5h 1:7.4 84 
5 NaH, THF/HMPA (1:4), rt, 5h 1:5.6 66 
6 DBU, DMF, rt, 12h 1:10 84 
7 DBU, THF, 12h 1:10 85 
8 DBU, CHCl3, 12h 1:10 85 
9 DBU, Toluene, 12h 1:7 81 
10 NaH, THF, rt, 5h 2:1 82 
11 NaH, Toluene, 12h 1:3.5 79 
12 Tf2O, pyr, DCM, 0 oC; NaHMDS, THF, 0 oC - rt, 5h (R,S)-1.18 recovered >90 
13 Tf2O, pyr, DCM, 0 oC; NaH, THF, 0 oC - rt, 5h (R,S)-1.18 recovered >90 
14 Tf2O, pyr, DCM, 0 oC; DBU, CHCl3, 0 oC - rt, 5h (R,S)-1.18 recovered >90 
15 DIAD, PPh3, THF 1:10 77 
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1-5: Diversification of 2,6-cis-Disubstituted Piperidine 
   Next, the utility of the two dithiane groups was explored (Scheme 1-4). Treatment of 
(R,S)-1.25 with Hg(ClO4)2 and 2,6-lutidine in wet THF led to regioselective removal of 
the more accessible side chain dithiane moiety to furnish ketone (R,S)-1.29, which in turn 
was subjected to various reduction conditions (Table 1-4A; Entry 1-5). Use of the Corey 
(R)-CBS12 (Table 1-4A; Entry 4) and Al(OiPr)3 reagents (Table 1-4A; Entry 5) proved 
optimal. The resultant diastereomeric alcohols (S,R,S)-1.30 and (R,R,S)-1.30, readily 
separable by column chromatography, were then subjected to removal of the remaining 





   Ketones 1.31 were also subjected to various reduction conditions. Regardless of steric 
encumberance of the hydride reducing agent, (S,R,S)-1.31 led to -hydroxy isomer  
(S,R,S,R)-1.32 as the major diastereomer (Table 1-4B; Entry 1-3). 
Table 1-4 Screening Conditions for Reduction of Ketones 
A. Reduction of (R,S)-1.29 
entry condition product ratio
a 
(S,R,S)-1.30 : (R,R,S)-1.30 
yieldb 
(%) 
1 A 1:2 93 
2 B 1:3 97 
3 C 1:4 92 
4 D 20:1 93 
5 E 1:5 88 
    
B. Reduction of (S,R,S)-1.31 (entry 1-4) and (R,R,S)-1.31 (entry 5) 
entry condition product ratio
a 
(S,R,S,R)-1.32 : (S,R,S,S)-1.32 
yieldb 
(%) 
1 A 5:1 93 
2 B 20:1 97 
3 F 2:1 95 
4 G 1:1.5 89 
5 G 1:1.3c 91 
a Ratio of diastereomers was determined by 1H NMR. b Combined yield of diastereomers. c The ratio of 
(R,R,S,R)-1.32: (R,R,S,S)-1.32, conditions: (A) NaBH4, MeOH, 0 oC; (B) L-Selectride, THF, -78 ~ 0 oC; 
(C) (R)-CBS reagent, BH3, THF, THF, 0 oC; (D) (S)-CBS reagent, BH3, THF, THF, 0 oC; (E) Al(OiPr)3, 
iPrOH, reflux; (F) BH3, THF, -78 ~ 0 oC; (G) SmI2, H2O, THF, , -78 ~ 0 oC. 
   Molecular mechanics calculations (MMFF94) revealed that the 2,6-diaxial chair-like 
conformer A possesses a lower energy, by ca. 16 kcal/mol than the 2,6-diequatorial chair-
like conformer B, due to pseudo A1,3-strain14 between the substituents at the 2- and 6-
10 
 
positions and the tosyl group,  thus leading to hydride attack from the more accessible -
face of A (Figure 1-1). In accordance with this reasoning, an increase in the bulkiness of 
the hydride reagent (L-Selectride) led to excellent selectivity (ca. 20:1) to provide 
(S,R,S,R)-32 (Table 1-3B; Entry 4). Stereochemical assignments were based on NOE 
analysis and confirmed by X-ray crystallographic analysis. 
 
   At this juncture, we presumed that the diastereoselectivity could be reversed under 
dissolving metal conditions15 to obtain diastereomer (S,R,S,S)-1.32. Treatment of (S,R,S)-
1.31 with SmI2 (4.0 equiv) and H2O (6.0 equiv) in THF furnished the desired -hydroxy 
isomer as the major product, albeit with modest selectivity (Table 1-3B; Entry 4). The 
lack of diastereoselectivity in the dissolving metal reductions presumably arises from 
competition of the two possible chelated intermediates (Figure 1; C and D). The 
structures and the relative configurations of (S,R,S,R)-1.32 and (R,R,S,R)-1.32 were 
confirmed by X-ray crystallographic analysis. Under the same reduction conditions, 
(R,R,S,R)-1.32 and (R,R,S,S)-1.32 were obtained from (R,R,S)-1.31 (Table 1-3B; Entry 5).  
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1-6: Diversification of the 2,6-trans-Disubstituted Piperidine Scaffold 
   Based on the successful elaboration of the 2,6-cis-piperidine congeners from (R,S)-1.25, 
the 2,6-trans congener (R,R)-1.25 was subjected to the same procedure. Following 
selective removal of the less-hindered dithiane moiety of (R,R)-1.25, all attempts to 
provide a single diastereomeric alcohol employing a wide variety of reducing agents 
proved unsuccessful.16 Equally disappointing, separations of the two diastereomeric 
alcohols (S,R,R)-1.30/(R,R,R)-1.30, as well as the hydroxy ketones (S,R,R)-1.31/(R,R,R)-
1.31 could not be readily achieved (Scheme 1-5). 
 
   To solve this issue, we explored the regioselective reduction of dione (R,R)-1.33 
(Scheme 1-6), which was generated by removal of the both dithiane moieties in (R,R)-
1.24 employing the Corey-Erickson protocol.17 Pleasingly, the internal ketone of (R,R)-
1.33 was reduced chemoselectively upon treatment with one equivalent of the bulky 
reducing agent [LiAlH(OCEt3)3] to provide a mixture of (S,R,R)-1.34 and (S,R,S)-1.34, 
readily separable by flash column chromatography. Reduction of the remaining side 
chain ketone employing BH3•THF   furnished  mixtures   (ca.   1:1)   of   diastereomeric   diols  
[(S,R,R,R)- 1.32/(R,R,R,R)-1.32 and (S,R,R,S)-1.32/(R,R,R,S)-1.32], which were separated 
12 
 




1-9: Completion of the Library Synthesis 
   Identical synthetic steps were followed with congeners (S,R)-1.24 and (S,S)-1.24 to 
prepare the enantiomeric library. In summary, an effective DOS strategy has been 
designed and validated to access all possible stereoisomers of the targeted 2,4,6-
trisubstituted piperidine scaffold, exploiting the modular Type II ARC protocol, followed 
inturn by intramolecular SN2 cyclization. Chemoselective dithiane removal and reduction 
conditions were examined and optimized. Importantly, this DOS venture identified a 
number of shortcomings in our synthetic arsenal that had to be overcome to arrive at the 
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1-11: Experimental Section 
1-11-1: Materials and Methods 
   Reactions were carried out in oven or flame-dried glassware under an argon atmosphere, 
unless otherwise noted. All solvents were reagent grade. Diethyl ether and THF were 
obtained from a Pure Solve TM PS-400. Reactions were magnetically stirred and 
monitored by thin layer chromatography (TLC) with 0.25 mm E. Merck precoated silica 
gel plates. In aqueous work-up, all organic solutions were dried over sodium sulfate or 
magnesium sulfate, and filtered prior to rotary evaporation at water aspirator pressure. 
Flash chromatography was performed with silica gel 60 (particle size 0.040 – 0.062 mm) 
supplied by Silicycle and Sorbent Technologies. Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated.  t-BuLi (1.7 M in hexane), t-
BuOK (1.0 M in THF) were purchased from Aldrich.  Infrared spectra were recorded on 
a Perkin-Elmer Model 283B spectrophotometer or a Jasco Model FT/IR-480 Plus 
spectrometer. 1H and 13C NMR spectra were recorded on a Bruker AMX-500 
spectrometer. Chemical  shifts  are  reported  as  δ  values  relative  to  the  internal  chloroform  
(δ  7.27  ppm  for  1H  and  δ  77.16  ppm  for  13C). Optical rotations were measured on a Jasco 
Perkin-Elmer model 241 polarimeter. High resolution mass spectra were measured at the 
University of Pennsylvania Mass Spectrometry Service Center on either a VG Micromass 
70/70 H or VG ZAB-E spectrometer. Jasco SFC was used for separation of some of the 
diastereomers using 4.6 mm ϕ × 250 mm CHIRALPAK® IC 5 µm (Eluent: Isocratic 
CO2:i-PrOH = 67:33, Flow rate: 4 mL/min). 





           1.11       1.12         1.13 
 
1.14 
1-11-2-1: General procedure for multi-component reaction (Type II ARC): 
Reactions were carried out on the following scale, unless otherwise noted. 
 
Compound 1.14: A solution of dithiane 1.11 (0.050 mL, 0.74 mmol, 1.2 equiv) in THF 
(2.0 mL) was cooled to –78 C and treated with a 1.0 M solution of  t-BuOK (0.78 mmol, 
1.25 equiv) in THF and a 1.7 M solution of  t-BuLi (0.78 mmol, 1.3 equiv) in hexane 
dropwise via syringe, successively. The resulting solution was stirred for 0.5 h. A 
solution of linchpin 1.12 (0.62 mmol, 1.0 equiv) in THF (2.0 mL) was added dropwise to 
the reaction mixture at –78 C via cannula. The resulting solution was stirred for 0.5 h. A 
solution of aziridine 1.13 (0.81 mmol, 1.3 equiv) in THF (2.0 mL) was added dropwise to 
the reaction mixture at –78 C via cannula. Then the reaction was warmed to 0 C for 2 h 
with stirring. The resulting mixture was poured into saturated aqueous NH4Cl (5.0 mL) 
and extracted with EtOAc (3 X 10 mL). The combined organic layers were washed with 
brine (5.0 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography on silica gel (hexane/EtOAc = 20/1 to 3/1) provided 1.14 as a pale 






1-11-2-2: General procedure for TBS group removal. 
Method A - A solution of 1.14 in THF was treated with a 1.0 M solution of TBAF in 
THF (1.5 equiv), and stirred at room temperature for 12 h. The reaction mixture was 
concentrated in vacuo and flash chromatography on silica gel (hexane/EtOAc = 5/1 to 1/1) 
provided alcohol 1.17. 
Method B - A solution of 1.14 in MeOH was treated with a catalytic amount of 
concentrated HCl, and stirred at room temperature for 12 h. The reaction mixture was 
concentrated in vacuo and flash chromatography on silica gel (hexane/EtOAc = 5/1 to 1/1) 






(S,S)-1.18: Following the general Type II ARC procedure, 2-methyl-1,3-dithiane 1.11a 
(0.54 mL, 4.5 mmol, 1.2 equiv), linchpin (+)-1.12 (1.1 g, 3.8 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (1.4 g, 4.9 mmol, 1.3 equiv) affored (S,S)-1.14 (2.0 g, 2.8 mmol, 74% 
yield) as a pale yellow oil. Following the general procedure Method A, TBS group 
removal of (S,S)-1.14  (1.9 g, 2.6 mmol) afforded (S,S)-1.18 (1.4 g, 2.3 mmol, 90% yield) 
as a pale yellow oil: Rf 0.55 (hexane/EtOAc = 2:1); []25D   2.78 (c 1.00, CHCl3);  IR  
(film) 3179 (m, br), 3025 (w), 2923 (s), 1599 (w), 1494 (w), 1420 (m), 1326 (m), 1157 
(s), 1090 (s), 908 (w), 754 (m), 703 (s) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.87  (d,  J = 
8.3 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 7.5 Hz, 2H), 7.22 (d, J = 6.9 Hz, 2H), 
7.19 (t, J = 7.2 Hz, 1H), 4.38 (t, J = 10.0 Hz, 1H), 3.92 – 3.86 (m, 1H), 3.17 (dd, J = 6.5, 
3.0 Hz, 1H), 3.16 – 3.14 (m, 2H), 3.14 – 3.11 (m, 1H), 3.07 (ddd, J = 14.3, 11.4, 2.6 
Hz,1H), 2.77 (ddd, J = 14.6, 5.4, 3.1 Hz, 2H), 2.62 – 2.51 (m, 2H), 2.48 (dd, J = 13.3, 
10.7 Hz, 1H), 2.41 (s, 3H), 2.29 (d, J = 15.3 Hz, 1H), 2.23 (dd, J = 15.6, 9.3 Hz, 1H), 
2.16 – 2.09 (m, 1H), 2.07 – 2.02 (m, 1H), 1.90 – 1.85 (m, 1H), 1.85 (dd, J = 14.8, 10.5 
Hz, 1H), 1.72 – 1.66 (m, 1H), 1.63 – 1.50 (m, 4H), 1.58 (s, 3H), 1.43 (d, J = 15.1 Hz, 1H); 
13C NMR (125 MHz, CDCl3)  δ  143.09,  139.44,  138.57,  130.05,  129.64,  128.59,  127.37,  
126.61, 65.62, 53.35, 51.21, 47.34, 47.13, 44.28, 44.20, 38.26, 28.35, 26.93, 26.73, 25.96, 






(S,R)-1.18: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(0.54 mL, 4.5 mmol, 1.2 equiv), linchpin (+)-1.12 (1.1 g, 3.8 mmol, 1.0 equiv) and 
aziridine (–)-1.13a (1.27g, 4.9 mmol, 1.3 equiv) afforded (S,R)-1.14 (1.9 g, 2.7 mmol, 69% 
yield) as a pale yellow oil. Following the general procedure for TBS group removal 
(Method A), (S,R)-1.14  (1.7 g, 2.3 mmol) afforded (S,R)-1.18 (1.2 g, 2.0 mmol, 85% 
yield) as a pale  yellow oil: Rf 0.45 (hexane/EtOAc = 2:1); []25D 31.21   (c 0.79, 
CHCl3);  );  IR  (film) 3277 (m, br), 3027 (w), 2923 (s), 1599 (w), 1495 (w), 1420 (m), 
1327 (m), 1158 (s), 1091 (s), 908 (w), 737 (m), 666 (s) cm-1; 1H NMR (500 MHz, CDCl3) 
δ  7.78 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.23 (dd, J = 8.0, 6.5 Hz, 2H), 7.19 (t, 
J = 8.0 Hz, 1H), 7.13 (d, J = 6.5 Hz, 2H), 5.44 (d, J = 5.0 Hz, 1H), 4.21-4.18 (m, 1H), 
3.90 – 3.82 (m, 1H), 3.28 (brs, 1H), 2.97-2.89 (m, 3H), 2.86 – 2.76 (m, 3H), 2.73 – 2.67 
(m, 2H),  2.59 (ddd, J = 14.0, 7.0, 3.5 Hz,1H), 2.47 (ddd, J = 14.0, 8.0, 3.5 Hz, 2H), 2.43 
(s, 3H), 2.25 (dd, J = 15.5, 4.0 Hz, 1H), 2.17 (dd, J = 15.5, 8.5 Hz, 1H), 2.15 (dd, J = 15.5, 
9.5 Hz, 1H), 2.07 – 2.00 (m, 1H), 1.91 ((dddd, J = 105, 10.5, 3.5, 3.5 Hz, 1H), 1.88 – 
1.76 (m, 1H), 1.71 (dd, J = 15.5, 1.5 Hz, 1H), 1.71 – 1.64 (m, 2H), 1.60 (s, 3H); 13C 
NMR (125 MHz, CDCl3)   δ   143.42, 137.65, 137.47, 130.02, 129.76, 128.54, 127.74, 
126.70, 66.07, 57.94, 51.22, 48.42, 47.93, 46.27, 42.79, 42.06, 28.70, 26.92, 26.77, 26.50, 
26.08, 24.84, 24.68, 21.74; HRMS (ES) m/z 620.1445  [(M+Na)+; calcd for 





(R,S)-1.18: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(0.56 mL, 4.8 mmol, 1.2 equiv), linchpin (–)-1.12 (1.17 g, 4.0 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (1.5 g, 5.2 mmol, 1.3 equiv) afforded (S,R)-1.14 (2.0g, 2.8 mmol, 69% 
yield) as a pale yellow oil. Following the general procedure for TBS group removal 
(Method B), (R,S)-1.14  (2.0 g, 2.8 mmol) afforded (R,S)-1.18 (1.5 g, 2.4 mmol, 88% 
yield) as a pale  yellow oil: Rf 0.45 (hexane/EtOAc = 2:1); []24D   +25.75 (c 0.79, 
CHCl3);  IR, 1H and 13C NMR are identical to those of (S,R)-1.14; HRMS (ES) m/z 




(R,R)-1.18: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(0.578mL, 4.82mmol, 1.10 equiv), linchpin (–)-1.12 (1.2 g, 4.0 mmol, 1.0 equiv) and 
aziridine (–)-1.13a (1.5 g, 5.2 mmol, 1.3 equiv) afforded (S,R)-1.14 (2.1 g, 3.0 mmol, 74% 
yield) as a pale yellow oil. Following the general procedure for TBS group removal 
(Method A), (R,R)-1.14  (2.0 g, 2.7 mmol) afforded (R,R)-1.18 (1.5 g, 2.5 mmol, 92% 
yield) as a pale  yellow oil: Rf 0.55 (hexane/EtOAc = 2:1); []28D 3.01 (c 1.00, CHCl3); 
22 
 
IR, 1H and 13C NMR are identical to those of (S,S)-1.18; HRMS (ES) m/z 618.1051  
[(M+Cl); calcd for C27H37ClNO3NS5:  618.1066]. 
 
 
                               TBS-(S,S)-1.19                                   (S,S)-1.19 
(S,S)-1.19: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.12a 
(0.050 mL, 0.42 mmol, 1.5 equiv), linchpin (+)-1.12 (81 mg, 0.28 mmol, 1.0 equiv) and 
aziridine (+)-1.13b (130 mg, 0.56 mmol, 2.0 equiv) afforded TBS-(S,S)-1.19 (110 mg, 
0.17 mmol, 61% yield) as a pale yellow oil. Following the general procedure for TBS 
group removal (Method A), TBS-(S,S)-1.19  (110 mg, 0.16 mmol) afforded (S,S)-1.19 
(80 mg, 0.15 mmol, 92% yield) as a pale yellow oil: Rf 0.33 (hexane/EtOAc = 2:1); 
[]28D 8.83 (c 0.80, CHCl3);  IR  (film) 3180 (m, br), 2924 (s), 1599 (w), 1421 (m), 
1325 (m), 1157 (s) 1092 (s), 814 (m), 755 (m), 665 (m) cm-1; 1H NMR (500 MHz, CDCl3) 
δ  7.78  (d,  J = 8.3 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 4.38 (t, J = 10.0 Hz, 1H), 3.76 (td, J 
= 9.6, 4.6 Hz, 1H), 3.18 (ddd, J = 14.3, 11.6, 2.6 Hz, 1H), 3.10 (ddd, J = 14.2, 8.9, 2.6 Hz, 
1H), 2.82 -2.68 (m, 6H), 2.65 (dd, J = 15.0, 10.0 Hz, 1H), 2.41 (s, 3H), 2.34 (dd, J = 15.4, 
9.8 Hz, 1H), 2.15 – 2.06 (m, 3H), 1.96 – 1.90 (m, 2H), 1.89 – 1.80 (m, 1H), 1.71 (d, J = 
15.3 Hz, 1H), 1.63 (dd, J = 14.9, 0.9 Hz, 1H), 1.61 (s, 3H), 1.43 – 1.36 (m, 2H), 1.33 – 
1.16 (m, 4H), 0.77 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  142.87,  139.53,  
129.48, 127.30, 66.76, 51.62, 50.41, 47.22, 47.18, 42.85, 41.43, 39.27, 28.31, 26.89, 
26.70, 26.19, 26.17, 25.44, 24.50, 21.66, 17.76, 14.11; HRMS (ES) m/z 572.1418  




TBS-(S,S)-1.20                   (S,S)-1.20 
(S,S)-1.20: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(0.050 mL, 0.42 mmol, 1.5 equiv), linchpin (+)-1.12 (81 mg, 0.28 mmol, 1.0 equiv) and 
aziridine (+)-1.13c (190 mg, 0.56 mmol, 2.0 equiv) afforded TBS-(S,S)-1.20 (80 mg, 0.12 
mmol, 41% yield) as a pale yellow oil. Following the general procedure for TBS group 
removal (Method B), TBS-(S,S)-1.20  (75 mg, 0.11 mmol) afforded (S,S)-1.20 (54 mg, 
0.093 mmol, 87% yield) as a pale  yellow oil: Rf 0.30 (hexane/EtOAc = 2:1); []24D –
50.1 (c 2.00, CHCl3);  IR  (film) 3274 (m, br), 3028 (w), 2920 (m), 1598 (w), 1493 (m), 
1420 (m), 1326 (m), 1159 (s), 1091 (m), 813 (w), 756 (m), 701 (m) cm-1; 1H NMR (500 
MHz, CDCl3)  δ  7.59  (d,  J = 8.2 Hz, 2H), 7.22 – 7.14 (m, 7H), 6.35 (d, J = 3.5 Hz, 1H), 
4.76 (ddd, J = 4.10, 4.10, 9.06 Hz 1H), 4.38-4.32 (m, 1H), 3.04 – 2.96 (m, 1H), 2.96 – 
2.86 (m, 2H), 2.86 – 2.74 (m, 4H), 2.68 (ddd, J = 14.7, 6.4, 3.1 Hz, 1H), 2.62 (dd, J = 
15.3, 9.1 Hz, 1H), 2.41 (dd, J = 15.0, 10.7 Hz, 1H), 2.38 (s, 3H), 2.15 (dd, J = 14.9, 9.3 
Hz, 1H), 2.09 – 1.96 (m, 2H), 1.93 – 1.80 (m, 2H), 1.70 – 1.64 (m, 3H) 1.63 (s, 3H); 13C 
NMR (125 MHz, CDCl3)   δ   143.08,   142.34,   137.21,   129.38,   128.44,   127.72,   127.36,  
126.90, 65.91, 56.02, 51.20, 48.40, 47.82, 45.84, 45.54, 28.76, 26.86, 26.75, 26.46, 26.21, 





        TBS-(S,S)-1.21                                   (S,S)-1.21 
(S,S)-1.21: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(38 mg, 0.26 mmol, 1.5 equiv), linchpin (+)-1.12 (50 mg, 0.17 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (99 mg, 0.34 mmol, 2.0 equiv) afforded TBS-(S,S)-1.21 (81 mg, 0.11 
mmol, 65% yield) as a pale yellow oil. Following the general procedure for removal of 
TBS group (Method A), TBS-(S,S)-1.21  (81 mg, 0.11 mmol) afforded (S,S)-1.21 (64 mg, 
0.11 mmol, 94% yield) as a pale yellow oil: Rf 0.33 (hexane/EtOAc = 2:1); []25D 4.67 
(c 0.28, CHCl3);  IR  (film) 3179 (m, br), 2926 (s), 1419 (m), 1327 (m), 1157 (s), 1091 (s), 
813 (m), 754 (m), 667 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.87  (d,  J = 8.2 Hz, 2H), 
7.30 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.4 Hz, 2H), 7.23 (d, J = 6.8 Hz, 2H), 7.22 – 7.17 
(m, 1H), 4.68 (s, 1H), 4.36 (t, J = 9.8 Hz, 1H), 3.88 (app t, J = 9.4 Hz, 1H), 3.20 (dd, J = 
13.2, 3.2 Hz, 1H), 3.13 (ddd, J = 13.9, 10.9, 2.7 Hz, 1H), 2.98 (ddd, J = 13.9, 10.9, 2.7 
Hz, 1H), 2.78 (ddd, J = 14.6, 7.5, 4.5 Hz, 1H), 2.57 (ddd, J = 13.8, 10.9, 2.7 Hz, 1H), 
2.53 – 2.45 (m, 2H), 2.41 (s, 3H), 2.39 ((dd, J = 15.0, 10.0 Hz, 1H), 2.29 (d, J = 15.4 Hz, 
1H), 2.21 (dd, J = 15.6, 9.5 Hz, 1H), 2.15 – 2.06 (m, 1H), 2.06 – 1.95 (m, 2H), 1.93 – 
1.83 (m, 2H), 1.77 (dd, J = 15.1, 10.0 Hz, 1H), 1.71 – 1.65 (m, 2H), 1.61 – 1.53 (m, 1H), 
1.53 – 1.45 (m, 1H), 1.40 (d, J = 15.0 Hz, 1H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR (125 
MHz, CDCl3)  δ  143.05,  139.40,  138.62,  130.04,  129.61,  128.57,  127.37,  126.58,  65.10,  
53.40, 52.00, 51.14, 44.46, 44.34, 43.85, 37.96, 32.86, 26.55, 25.98, 25.95, 25.18, 24.92, 





   TBS-(R,S)-1.21                          (R,S)-1.21 
(R,S)-1.21: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(61 mg, 0.41 mmol, 1.5 equiv), linchpin (–)-1.12 (80 mg, 0.28 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (160 mg, 0.55 mmol, 2.0 equiv) afforded TBS-(R,S)-1.21 (120 mg, 
0.16 mmol, 59% yield) as a pale yellow oil. Following the general procedure for removal 
of TBS group (Method B), TBS-(R,S)-1.21  (86 mg, 0.11 mmol) afforded (R,S)-1.21 (70 
mg, 0.11 mmol, 97% yield) as a pale  yellow oil: Rf 0.31 (hexane/EtOAc = 2:1); []28D 
+23.64 (c 2.00, CHCl3);  IR  (film) 3290 (m, br), 2926 (s), 1598 (w), 1419 (m), 1325 (m), 
1157 (s), 1087 (s), 1043 (s), 812 (m), 702 (m) cm-1; 1H NMR (500 MHz, CDCl3) δ  7.78 
(d, J = 8.5 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 7.0 Hz, 2H), 7.19 (dddd, J = 8.0, 
8.0, 1.0, 1.0 Hz, 1H), 7.14 (d, J = 7.0 Hz, 2H ), 5.57 (d, J = 5.5 Hz, 1H ), 4.18 (dddd, J = 
5.5, 5.5, 3.5, 3.5 Hz, 1H), 3.30 (brs, 1H), 2.95 (dd, J = 14.0, 4.5 Hz, 1H), 2.96 – 2.74 (m, 
5H),  2.75 – 2.63 (m, 2H), 2.56 (ddd, J = 14.5, 7.4, 3.5 Hz, 1H), 2.46 (ddd, J = 14.5, 9.0, 
3.0 Hz, 1H), 2.42 (s, 3H), 2.24 ((dd, J = 15.5, 3.5 Hz, 1H), 2.17 (dd, J = 15.0, 8.5 Hz, 1H), 
2.08 (dd, J = 15.5, 9.5 Hz, 1H), 2.23 – 1.95 (m, 2H), 1.94– 1.85 (m, 2H), 1.85 – 1.73 (m, 
2H), 1.66 (dd, J = 15.1, 2.0 Hz, 1H), 1.63 (d, J = 5.5 Hz, 2H), 0.99 (t, J = 7.0 Hz, 3H). 
13C NMR (125 MHz, CDCl3)  δ  143.31, 137.60, 137.49, 130.02, 129.68, 128.42, 127.70, 
126.57, 65.62, 52.90, 52.83, 51.17, 46.31, 44.95, 42.72, 41.83, 32.54, 26.44, 26.36, 26.10, 
26.02, 25.06, 24.64, 21.68, 8.88; HRMS (ES) m/z 612.1782  [(M+H)+; calcd for 




     TBS-(S,S)-1.22              (S,S)-1.22 
(S,S)-1.22: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11a 
(60 mg, 0.41 mmol, 1.5 equiv), linchpin (–)-1.12 (80 mg, 0.27 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (130 mg, 0.54 mmol, 2.0 equiv) afforded TBS-(S,S)-1.22 (100 mg, 
0.15 mmol, 55% yield) as a pale yellow oil. Following the general procedure for TBS 
group removal (Method B), TBS-(S,S)-1.22  (27 mg, 0.040 mmol) afforded (S,S)-1.22 (20 
mg, 0.036 mmol, 89% yield) as a pale  yellow oil: Rf 0.40 (hexane/EtOAc = 2:1); []26D 
4.69 (c 1.00, CHCl3);  IR  (film) 33184 (m, br), 2928 (s), 1598 (w), 1420 (m), 1326 (m), 
1158 (s), 1092 (s), 813 (m), 755 (m), 667 (s) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.79 (d, 
J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 7.09 (d, J = 3.9 Hz, 1H), 4.65 (s, 1H), 4.37 (t, J 
= 9.9 Hz, 1H), 3.78 (sextet, J = 4.7 Hz, 1H), 3.19 (ddd, J = 14.0, 11.1, 2.6 Hz, 1H), 3.1 
(ddd, J = 14.0, 11.1, 2.6 Hz, 1H), 2.82 – 2.74 (m, 3H), 2.74 – 2.65 (m, 3H), 2.54 (dd, J = 
15.2, 10.0 Hz, 1H), 2.41 (s, 3H), 2.34 (dd, J = 15.4, 9.9 Hz, 1H), 2.14 – 2.06 (m, 1H), 
2.10 (d, 2.03 J = 14.4 Hz, 1H), 2.03 (m, 2H), 1.97 – 1.82 (m, 4H), 1.71 (app t, J = 13.7 
Hz, 2H), 1.45 – 1.39 (m, 2H), 1.36 – 1.26 (m, 1H), 1.26 – 1.16 (m, 1H), 1.03 (t, J = 7.4 
Hz, 1H), 0.78 (t, J = 7.3 Hz, 1H); 13C NMR (125 MHz, CDCl3)  δ  142.82,  139.55,  129.46,  
127.31, 66.31, 52.08, 51.61, 50.42, 43.77, 43.02, 41.22, 39.41, 32.87, 26.55, 26.20, 26.14, 
25.97, 25.44, 24.98, 21.66, 17.77, 14.12, 8.52; HRMS (ES) m/z 586.1584  [(M+Na)+; 





   TBS-(R,S)-1.23               (R,S)-1.23 
(R,S)-1.23: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11c 
(46 mg, 0.28 mmol, 1.5 equiv), linchpin (+)-1.12 (55 mg, 0.19 mmol, 1.0 equiv) and 
aziridine (+)-1.13b (110 mg, 0.38 mmol, 2.0 equiv) afforded TBS-(R,S)-1.23 (78 mg, 
0.11 mmol, 56% yield) as a pale yellow oil. Following the general procedure for TBS 
group removal (Method A), TBS-(R,S)-1.23  (78 mg, 0.110 mmol) afforded (R,S)-1.23 
(60 mg, 0.096 mmol, 91% yield) as a pale  yellow oil: Rf 0.45 (hexane/EtOAc = 2:1); 
[]25D 56.38 (c 1.00, CHCl3);  IR  (film) 3178 (m, br), 3026 (w), 2926 (s), 1599 (w), 
1419 (m), 1328 (m), 1158 (s), 1090 (s), 979 (w), 906 (w), 813 (w), 755 (m), 703 (w) cm-1; 
1H NMR (500 MHz, CDCl3)  δ  7.88  (d,  J = 8.2 Hz, 2H), 7.46 (d, J = 3.8 Hz, 1H), 7.31 (d, 
J = 7.9 Hz, 2H), 7.28 (d, J = 7.3 Hz, 2H), 7.24 (d, J = 6.8 Hz, 2H), 7.19 (t, J = 7.2 Hz, 
1H), 4.84 (s, 1H), 4.44 (app t, J = 9.9 Hz, 1H), 3.89 (app t, J = 9.5 Hz, 1H), 3.21 (dd, J = 
13.2, 3.3 Hz, 1H), 3.14 (ddd, J = 13.9, 8.4, 2.9 Hz, 1H), 2.96 (ddd, J = 13.6, 10.4, 2.9 Hz, 
1H), 2.84 – 2.76 (m, 2H), 2.57 (ddd, J = 14.0, 11.0, 2.7 Hz, 1H), 2.52 – 2.45 (m, 2H), 
2.41 (s, 3H), 2.45 – 2.35 (m, 1H), 2.32 – 2.25 (m, 2H), 2.22 (dd, J = 15.5, 9.4 Hz, 1H), 
2.12-2.06 (m, 1H), 2.02 (m, 1H), 1.92 – 1.83 (m, 1H), 1.78 – 1.71 (m, 2H), 1.71 – 1.64 
(m, 1H), 1.59 – 1.52 (m, 1H), 1.51-1.44 (m, 1H), 1.40 (d, J = 15.0 Hz, 1H), 1.23 (d, J = 
6.8 Hz, 2H), 1.00 (d, J = 6.8 Hz, 2H); 13C NMR (125 MHz, CDCl3)  δ  143.03,  139.50,  
138.71, 130.08, 129.62, 128.59, 127.40, 126.60, 64.77, 56.88, 53.48, 51.20, 44.62, 44.45, 
42.14, 37.86, 34.82, 26.41, 25.98, 25.55, 25.24, 25.01, 24.71, 21.68, 18.65, 17.09; HRMS 




    TBS-(R,S)-1.24             (R,S)-1.24 
(R,S)-1.24:Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11d 
(51 mg, 0.26 mmol, 1.5 equiv), linchpin (+)-1.12 (50 mg, 0.17 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (99 mg, 0.34 mmol, 2.0 equiv) afforded TBS-(R,S)-1.24 (69 mg, 
0.089  mmol, 52% yield) as a pale yellow oil. Following the general procedure for TBS 
group removal (Method A), TBS-(R,S)-1.24 (69 mg, 0.089 mmol) afforded (R,S)-1.24 (55 
mg, 0.083 mmol, 93% yield) as a pale  yellow oil: Rf 0.35 (hexane/EtOAc = 2:1); []30D 
+66.04 (c 1.00, CHCl3);  IR  (film) 3190 (m, br), 2923 (s), 1597 (w), 1442 (m), 1328 (m), 
1158 (s), 1090 (s), 813 (w), 754 (m), 702 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.86  (d,  
J = 8.3 Hz, 2H), 7.83 (d, J = 7.5 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 7.32 –7.22 (m, 7H), 
7.18 (t, J = 7.1 Hz, 1H), 4.29 (t, J = 9.6 Hz, 1H), 3.83 – 3.77 (m, 1H), 3.24 (dd, J = 13.2, 
3.2 Hz, 1H), 2.87 (dddd, J = 14.0, 14.0, 6.5, 3.0 Hz, 2H), 2.81 – 2.70 (m, 2H), 2.53 (dd, J 
= 13.5, 10.5 Hz, 1H), 2.48 (dd, J = 10.6, 3.0 Hz, 1H), 2.44 – 2.38 (m, 1H), 2.39 (s, 2H), 
2.27 (dd, J = 15.1, 9.3 Hz, 1H), 2.20 (d, J = 15.4 Hz, 1H), 2.09 (dd, J = 15.6, 9.6 Hz, 1H), 
2.07 – 1.97 (m, 2H), 1.99 – 1.90 (m, 1H), 1.87 (d, J = 14.9 Hz, 1H), 1.67 – 1.58 (m, 1H), 
1.58 – 1.47 (m, 3H), 1.30 (d, J = 15.1 Hz, 1H); 13C NMR (125 MHz, CDCl3)  δ  143.06,  
141.63, 139.13, 138.59, 130.11, 129.68, 129.13, 128.55, 127.95, 127.89, 127.44, 126.57, 
65.55, 56.80, 53.28, 51.11, 44.57, 43.93, 38.16, 28.06, 27.43, 25.92, 25.10, 24.76, 24.63, 





TBS-(S,S)-1.24   (S,S)-1.24 
(S,S)-1.24: Following the Type II ARC general procedure, 2-methyl-1,3-dithiane 1.11d 
(51 mg, 0.26 mmol, 1.5 equiv), linchpin (–)-1.12 (50 mg, 0.17 mmol, 1.0 equiv) and 
aziridine (+)-1.13a (99 mg, 0.34 mmol, 2.0 equiv) afforded TBS-(S,S)-1.24 (73 mg, 0.094 
mmol, 55% yield) as a pale yellow oil. Following the general procedure for TBS group 
removal (Method A), TBS-(S,S)-1.24  (73 mg, 0.094 mmol) afforded (S,S)-1.24 (56 mg, 
0.085 mmol, 90% yield) as a pale yellow oil: Rf 0.35 (hexane/EtOAc = 2:1); []26D 
+14.80 (c 1.00, CHCl3);  IR  (film) 3282 (m, br), 3025 (w), 2910 (s), 1598 (w), 1422 (m), 
1327 (m), 1158 (s), 1089 (s), 814 (w), 753 (m), 702 (s), 665 (m) cm-1; 1H NMR (500 
MHz, CDCl3)  δ  7.90  (dd,  J = 8.4, 1.0 Hz, 2H), 7.77 (d, J = 8.3 Hz, 2H), 7.40 (t, J = 8.3Hz, 
2H), 7.30 – 7.24 (m, 3H), 7.22 (d, J = 7.43 Hz, 2H), 7.20 – 7.16 (m, 1H), 7.13 (d, J = 
7.43 Hz, 2H), 5.29 (d, J = 5.4 Hz, 1H), 4.08 – 4.02 (m, 1H), 3.84 – 3.76 (m, 1H), 2.93 (dd, 
J = 13.5, 4.1 Hz, 1H), 2.80 (dd, J = 13.5, 7.8 Hz, 1H), 2.74 – 2.68 (m, 4H), 2.62 (d, J = 
5.7 Hz , 2H), 2.48 (ddd, J = 14.5, 6.6, 4.1 Hz, 1H), 2.43 – 2.34 (m, 2H), 2.37 (s, 3H), 2.10 
(dd, J = 15.4, 3.2 Hz, 1H), 2.08 – 2.03 (m, 1H), 1.99 – 1.91 (m, 3H), 1.80 – 1.76 (m, 1H), 
1.78 – 1.69 (m, 2H), 1.42 – 1.39 (m, 2H); 13C NMR (125 MHz, CDCl3)  δ  143.41,  141.95,  
137.51, 137.41, 130.08, 129.73, 128.97, 128.58, 128.41, 127.72, 127.49, 126.57, 65.56, 
57.74, 52.90, 52.69, 51.04, 45.48, 42.90, 41.61, 27.91, 27.55, 26.36, 25.92, 24.84, 24.59, 






1-11-2-3: General procedure for intramolecular SN2 cyclization. 
1.15: To a solution of alcohol 1.17 (0.10 mmol, 1.0 equiv) in THF (5.0 mL) were added 
triethylamine (0.30 mmol, 3.0 equiv) and methanesulfonyl chloride (0.15 mmol, 1.5 
equiv) at 0 C. After being stirred for 5 h, a saturated aqueous NH4Cl solution (5.0 mL) 
was added, and the resulting mixture filtered through a short silica gel and rinsed with dry 
THF (5 x 20mL). The combined organic layers were diluted with THF (100 mL) 
affording a ~0.5mM solution of the mesylate. This solution was treated with NaH (0.50 
mmol, 5.0 equiv) at room temperature, and stirred for 5-12 h. The reaction mixture was 
quenched with MeOH (5.0 mL) and concentrated in vacuo. Flash chromatography 




(R,S)-1.25: Following the general procedure for intramolecular SN2 cyclization, (S,S)-
1.18 (1.4 g, 2.3 mmol) afforded (R,S)-1.25 (1.2 mg, 2.1 mmol, 87 % yield) as a pale 
yellow oil: []28D +21.65 (c 1.00 , CHCl3);  IR  (film) 2923 (s), 1599 (w), 1493 (w), 1449 
(m), 1333 (m), 1159 (s), 1100 (m), 911 (w), 813 (w), 753 (m), 704 (m) cm-1; 1H NMR 
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(500 MHz, CDCl3)  δ  7.79  (d,  J = 8.3 Hz, 2H), 7.36 – 7.24 (m, 7H), 4.18 – 4.13 (m, 1H), 
4.12 – 4.07 (m, 1H), 3.36 (dd, J = 13.2, 3.3 Hz, 1H), 3.22 (dd, J = 13.2, 10.2 Hz, 1H), 
3.02 (ddd, J = 13.8, 10.8, 2.6 Hz, 1H), 2.90 (ddd, J = 13.8, 10.8, 2.7 Hz, 1H), 2.84 – 2.67 
(m, 5H), 2.61 – 2.52 (m, 2H), 2.41 (s, 3H), 2.23 (dd, J = 14.5, 1.6 Hz, 1H), 2.12 (dd, J = 
15.2, 2.8 Hz, 1H), 2.08 (t, J = 7.0 Hz, 2H), 2.06 – 2.01 (m, 1H), 1.92 – 1.78 (m, 2H), 1.71 
(dd, J = 15.2, 6.3 Hz, 1H), 1.65 (s, 1H); 13C NMR (125 MHz, CDCl3)  δ  143.64,  138.34,  
136.81, 129.90, 129.84, 128.68, 127.89, 126.79, 54.47, 50.80, 48.49, 48.31, 44.40, 44.37, 
41.38, 37.13, 29.83, 28.52, 27.31, 27.19, 27.05, 26.85, 24.92, 24.74, 21.69; HRMS (ES) 




(S,R)-1.25: Following the general procedure for intramolecular SN2 cyclization, (R,R)-
1.18 (1.5 g, 2.5 mmol) afforded (S,R)-1.25 (1.4 g, 2.3  mmol, 85% yield) as a pale yellow 
oil: []26D 24.30 (c 1.00 , CHCl3);  IR, 1H and 13C NMR are identical to those of (R,S)-





(S,S)-1.25: Following the general procedure for intramolecular SN2 cyclization, (R,S)-
1.18 (0.64 g, 1.1 mmol) affored (S,S)-1.25 (0.36 g, 0.62  mmol, 58% yield) as a pale 
yellow oil: []25D +24.64 (c 0.67 , CHCl3; IR  (film) 3026 (w), 2918 (s), 1597 (w), 1495 
(w), 1432 (w), 1316 (m), 1150 (s), 1094 (m), 860 (s), 750 (m), 694 (m) cm-1;  1H NMR 
(500 MHz, CDCl3)  δ  7.32  – 7.24 (m, 5H), 7.20 – 7.10 (m, 2H), 7.05 (d, J = 8.0 Hz, 2H), 
4.60 (app brs, 1H), 4.26 – 4.16 (m, 1H), 3.48 (dd, J = 13.9, 9.3 Hz, 1H), 3.06 (dd, J = 
14.0, 6.4 Hz, 1H), 2.92 – 2.83 (m, 2H), 2.83 – 2.75 (m, 1H), 2.70 – 2.63 (m, 1H), 2.60 (d, 
J = 5.4 Hz, 2H), 2.55 (d, J = 15.1 Hz, 1H), 2.53 - 2.45 (m, 3H), 2.40 - 2.34 (m, 1H), 2.33 
(s, 3H), 2.30 (d, J = 4.8 Hz, 2H), 2.26 – 2.23 (m, 1H), 2.02 – 1.88 (m, 2H), 1.80 – 1.69 
(m, 2H), 1.50 (s, 3H); 13C NMR (125 MHz,  CDCl3)  δ  142.67,  141.13,  139.67,  129.65,  
129.47, 128.71, 127.11, 126.50, 58.57, 51.60, 49.04, 48.92, 43.72, 43.29, 40.47, 39.90, 
27.88, 26.85, 26.47, 26.42, 26.32, 25.24, 24.71, 21.47; HRMS (ES) m/z 580.1155  




(R,R)-1.25: Following the general procedure for intramolecular SN2 cyclization, (S,R)-
1.18 (0.30g, 0.502 mmol) affored (R,R)-1.25 (0.16 g, 0.276  mmol, 55% yield) as a pale 
yellow oil: []27D 27.54 (c 0.75 , CHCl3); IR, 1H and 13C NMR are identical to those of 





(R,S)-1.26: Following the general procedure for intramolecular SN2 cyclization, (S,S)-
1.19 (80 mg, 0.15 mmol) affored (R,S)-1.26 (69 mg, 0.13 mmol, 89% yield) as a pale 
yellow oil: []31D 31.40 (c 0.51, CHCl3); IR  (film) 2956 (s), 2927 (s), 2869 (s), 1597 
(w), 1438 (m), 1326 (s), 1161 (s), 1094 (s), 909 (m), 813 (m), 735 (m), 662 (s) cm-1; 1H 
NMR (500 MHz, CDCl3)  δ  7.74  (d,  J = 8.3 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 4.16 (ddd, 
J = 8.7, 6.4, 3.3 Hz, 1H), 3.89 (dq, J = 8.2, 6.0 Hz, 1H), 3.07 (ddd, J = 14.0, 10.5, 3.0 Hz, 
1H), 2.95 (J = 14.0, 10.5, 3.0 Hz, 1H), 2.88 – 2.80 (m, 2H), 2.79 – 2.74 (m, 2H), 2.74 – 
2.68 (m, 3H), 2.52 (dd, J = 14.5, 2.0 Hz, 1H), 2.40 (s, 3H), 2.17 (dd, J = 15.1, 4.6 Hz, 
1H), 2.08 – 1.96 (m, 5H), 1.93 – 1.85 (m, 3H), 1.80 – 1.71 (m, 1H), 1.69 (s, 3H), 1.46 – 
1.36 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  143.42,  137.24,  
129.75, 127.79, 52.85, 50.80, 48.64, 48.38, 44.59, 40.50, 40.45, 38.82, 28.89, 27.24, 
27.09, 27.09, 26.92, 24.99, 24.82, 21.68, 19.99, 14.06; HRMS (ES) m/z 554.1320  






(S,S)-1.27: Following the general procedure for intramolecular SN2 cyclization, (R,S)-
1.24 (0.65 mg, 0.099 mmol) affored (S,S)-1.27 (0.51 mg, 0.080  mmol, 81% yield) as a 
pale yellow oil: []31D 16.86 (c 2.00 , CHCl3);  IR  (film) 3025 (w), 2908 (s), 1598 (w), 
1491 (w), 1442 (m), 1336 (s), 1160 (s), 1100 (s), 908 (m), 814 (m), 753 (s), 702 (s) cm-1; 
1H NMR (500 MHz, CDCl3)  δ  7.97  (d,  J = 7.5 Hz, 2H), 7.56 (d, J = 8.3 Hz, 2H), 7.45 (t, 
J = 7.8 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 7.29 (d, J = 7.3 Hz, 2H), 7.25 (d, J = 6.9 Hz, 
1H), 7.23 - 7.17 (m, 3H), 4.14 – 4.05 (m, 1H), 3.96 (dt, J = 9.5, 4.8 Hz, 1H), 3.18 (dd, J = 
13.1, 3.5 Hz, 1H), 3.08 (dd, J = 13.1, 10.8 Hz, 1H), 2.84 - 2.77 (m, 2H), 2.77 - 2.67 (m, 
5H), 2.64 (ddd, J = 14.4, 7.5, 3.5 Hz, 1H), 2.56 (ddd, J = 14.2, 8.5, 3.1 Hz, 1H), 2.46 
(ddd, J = 14.5, 7.5, 3.2 Hz, 1H), 2.37 (s, 3H), 2.03 – 1.92 (m, 1H), 1.90 (dd, J = 15.2, 5.7 
Hz, 1H), 1.86 – 1.71 (m, 4H), 1.66 (dd, J = 15.3, 6.3 Hz, 1H); 13C NMR (125 MHz, 
CDCl3)  δ  143.28,  141.17,  138.43,  137.04,  129.75,  129.57, 129.06, 128.97, 128.65, 127.73, 
127.52, 126.68, 57.59, 54.40, 51.70, 49.68, 44.49, 44.36, 39.77, 36.98, 28.02, 27.75, 
27.09, 27.06, 24.90, 24.64, 21.64; HRMS (ES) m/z 642.1678  [(M+H)+; calcd for 




(R,S)-1.29: To a stirred solution of (R,S)-1.25 (130 mg, 0.22 mmol) in THF-H2O (4:1, 13 
mL) were added 2,6-lutidine (180 L, 1.7 mmol) and Hg(ClO4)2 (240 mg, 0.60 mmol) at 
0 C. After 30 min, the reaction mixture was filtered through celite and rinsed with 
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EtOAc (3 x 10 mL). The combined organic layers were poured into saturated aqueous 
NH4Cl (20 mL) and extracted with EtOAc (3 x 20 mL). The combined organic layers 
were washed with brine (5 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
Flash chromatography on silica gel (hexanes/EtOAc, 100/1 to 2/1) provided (R,S)-1.29 
(72 mg, 0.15 mmol, 68% yield) as a pale yellow oil: Rf 0.35 (hexane/EtOAc = 4:1); 
[]24D +32.27 (c 0.50, CHCl3);  IR  (film) 3027 (w), 2922 (s), 1712 (s), 1598 (s), 1473 
(w), 1421 (m), 1326 (s), 1160 (s), 1098 (s), 1034 (w), 754 (m), 703 (m) cm-1; 1H NMR 
(500 MHz, CDCl3)  δ  7.63  (d,  J = 8.3 Hz, 2H), 7.27 – 7.23 (m, 4H), 7.19 (d, J = 7.4 Hz, 
2H), 7.17 – 7.14 (m, 1H), 4.34 (ddt, J = 13.7, 6.9, 3.8 Hz, 1H), 4.13 (ddt, J = 10.5, 6.9, 
3.4 Hz, 1H), 3.46 (dd, J = 17.9, 10.7 Hz, 1H), 3.29 (dd, J = 13.0, 11.4 Hz, 1H), 3.14 (dd, 
J = 13.0, 3.5 Hz, 1H), 2.96 (dd, J = 17.9, 3.0 Hz, 1H), 2.81 – 2.73 (m, 2H), 2.62 (ddd, J = 
14.4, 6.6, 3.1 Hz, 1H), 2.51 (ddd, J = 14.5, 6.7, 3.0 Hz, 1H), 2.38 (dd, J = 15.0, 3.7 Hz, 
1H), 2.32 (s, 3H), 2.09 (s, 3H), 1.98 (dd, J = 14.9, 2.8 Hz, 1H), 1.86 (dd, J = 14.9, 6.1 Hz, 
2H), 1.79 – 1.68 (m, 1H), 1.49 (dd, J = 15.0, 6.8 Hz, 1H); 13C NMR (125 MHz, CDCl3)  δ  
206.88, 143.60, 138.59, 137.22, 129.88, 129.82, 128.74, 127.22, 126.77, 54.58, 50.30, 
48.14, 44.84, 44.29, 37.83, 36.82, 30.68, 26.94, 26.90, 24.72, 21.63; HRMS (ES) m/z 
512.1351  [(M+Na)+; calcd for C25H31NO3S3Na:  512.1364]. 
 
1-11-2-4: Reduction Conditions of (R,S)-1.29 
 
              (R,S)-1.29                                        (S,R,S)-1.30                        (R,R,S)-1.30 
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Condition A: To a stirred solution of (R,S)-1.29 (8.0 mg, 0.016 mmol) in MeOH (1.0 mL) 
was added NaBH4 (1.0 mg, 0.026 mmol) at 0 oC. After being stirred for 30 min, the 
reaction mixture was concentrated in vacuo to provide (S,R,S)-1.30 and (R,R,S)-1.30 as a 
1:2 mixture as determined by crude 1H NMR spectroscopy which were separated by 
preparatory thin-layer chromatography (hexane/EtOAc = 2/1) affording (S,R,S)-1.30 (2.5 
mg, 31%) and (R,R,S)-1.30 (5.0 mg, 62%) as pale yellow oils. 
Condition B: To a stirred solution of (R,S)-1.29 (45 mg, 0.92 mmol) in THF (5.0 mL) 
was added L-selectride 1.0M in THF (1.3 mL, 1.3 mmol) at  78 C. After being stirred 
for 3 h, the reaction mixture was quenched with MeOH (1.0 mL) and 2N NaOH (5.0 mL). 
After being stirred at room temperature for 1 h, the reaction mixture was extracted with 
Et2O (3 x 10 mL). The combined organic layers were washed with brine and dried over 
MgSO4, filtered, and concentrated in vacuo to provide (S,R,S)-1.30 and (R,R,S)-1.30 as a 
1:3 mixture as determined by crude 1H NMR spectroscopy which were separated by flash 
chromatography (hexanes/EtOAc = 2/1) affording (S,R,S)-1.30 (13 mg, 28%) and 
(R,R,S)-1.30 (31 mg, 69%) as pale yellow oils. 
Condition C: To a stirred solution of (R,S)-1.29 (27 mg, 0.055 mmol) in THF (3.0mL) 
were added (S)-CBS reagent 1.0 M in THF (55 L, 55 mol) and BH3THF 1.0M in THF 
(55 L, 0.055 mmol) at 0 C. After being stirred for 1 h, the reaction mixture was 
quenched with MeOH (1.0 mL) and concentrated in vacuo to provide (S,R,S)-1.30 and 
(R,R,S)-1.30 as a 1:4 mixture as determined by crude 1H NMR spectroscopy which were 
separated by flash chromatography (hexane/EtOAc = 2/1)  affording (S,R,S)-1.30 (4.8 mg, 




Condition D: To a stirred solution of (R,S)-1.29 (6.0 mg, 0.012 mmol) in THF (3.0 mL) 
were added (R)-CBS reagent 1.0 M in THF (1.2 L, 1.2 mol) and BH3THF 1.0 M in 
THF (12 L, 0.012 mmol) at 0 oC. After being stirred for 1h, the reaction mixture was 
quenched with MeOH (1.0 mL) and concentrated in vacuo to provide (S,R,S)-1.30 and 
(R,R,S)-1.30 as a 20:1 mixture as determined by crude 1H NMR spectroscopy, which was 
purified by flash chromatography (hexane/EtOAc = 2/1)  affording (S,R,S)-1.30 (5.8 mg, 
0.11 mmol, 93%) as pale yellow oils. 
Condition E: To a stirred solution of (R,S)-1.29 (6.0 mg, 0. 012 mmol) in iPrOH (3.0mL) 
was treated with Al(OiPr)3 (25 mg, 0.12 mmol). After heating at reflux for 5 h, the 
reaction mixture was cooled to room temperature and diluted with Et2O (10 mL) and 
treated with 1N HCl. The mixture was extracted with Et2O (3 x 10 ml) and the combined 
organic layers were washed with saturated aq. NaHCO3 and brine, and dried over MgSO4. 
The reaction mixture was filtered through a plug of silica gel and concentrated in vacuo 
to provide a 1:5 mixture of (S,R,S)-1.30 and (R,R,S)-1.30 (5.3 mg, 0.011 mmol, 88%)  as 




(S,R,S)-1.30: Rf 0.40 (hexane/EtOAc = 2:1); []29D +101.0  (c 0.67, CHCl3); IR  (film) 
3522 (m, br), 3026 (w), 2922 (s), 1596 (w), 1420 (m), 1327 (s), 1157 (s), 1115 (s), 1043 
(s), 932 (m), 813 (m), 756 (m), 702 (s) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.75  (d,  J = 
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8.3 Hz, 2H), 7.36 – 7.32 (m, 4H), 7.30 (d, J = 8.0 Hz, 2H), 7.27 – 7.24 (m, 1H), 4.28 - 
4.24 (m, 1H), 4.16 – 4.08 (m, 2H), 3.36 (dd, J = 13.0, 10.8 Hz, 1H), 3.30 (dd, J = 13.0, 
3.7 Hz, 1H), 2.82 – 2.72 (m, 2H), 2.66 – 2.57 (m, 2H), 2.41 (s, 3H), 2.32 (t, J = 13.4 Hz, 
1H), 2.16 (dd, J = 14.9, 5.6 Hz, 1H), 2.04 (d, J = 15.1 Hz, 1H), 1.93 – 1.78 (m, 2H), 1.72 
(dd, J = 14.9, 6.3 Hz, 1H), 1.57 (dd, J = 15.0, 7.2 Hz, 1H), 1.45 (ddd, J = 14.2, 10.6, 3.4 
Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  143.96,  138.58, 136.84, 
130.08, 129.76, 128.78, 127.27, 126.84, 63.43, 54.81, 49.81, 46.79, 44.58, 43.95, 40.37, 
35.77, 27.09, 27.03, 24.74, 22.99, 21.72; HRMS (ES) m/z 492.1688 [(M+H)+; calcd for 
C25H33NO3S3:  492.1701]. 
 
(R,R,S)-1.30 
(R,R,S)-1.30: Rf 0.30 (hexane/EtOAc = 2:1); []22D +105.6 (c 0.50, CHCl3); IR  (film) 
3410 (m, br), 3026 (w), 2925 (s), 1599 (w), 1451 (m), 1326 (s), 1159 (s), 1096 (s), 938 
(m), 753 (m), 756 (m), 702 (s) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.75  (d,  J = 8.3 Hz, 
2H), 7.36 – 7.30 (m, 4H), 7.28 (d, J = 8.2 Hz, 2H), 7.26 – 7.22 (m, 1H), 4.25 – 4.14 (m, 
2H), 3.98 – 3.90 (m, 1H), 3.34 (dd, J = 13.29, 15.5 Hz, 1H), 3.32 (s, 1H), 2.78 (dd, J = 
6.21, 4.99 Hz, 2H), 2.69 – 2.57 (m, 2H), 2.41 (s, 3H), 2.17 (ddd, J = 14.9, 10.6, 4.1 Hz, 
2H), 2.12 – 1.99 (m, 2H), 1.91 – 1.83 (m, 2H), 1.80 (dd, J = 15.0, 6.4 Hz, 2H), 1.74 (dd, J 
= 15.0, 6.7 Hz, 2H), 1.26 (d, J = 6.2 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  143.63,  
138.82, 137.20, 129.88, 129.77, 128.73, 127.49, 126.71, 66.42, 54.69, 50.32, 47.17, 44.67, 
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44.11, 39.08, 36.45, 27.16, 27.05, 24.79, 24.33, 21.69; HRMS (ES) m/z 492.1700  




(S,R,S)-1.31: To a stirred solution of (S,R,S)-1.30 (43.0 mg, 0.087 mmol) in CH3CN-H2O 
(9:1, 5.0 mL) was added PhI(O2CCF3)2 (75 mg, 0.18 mmol) at 0 oC. After 5 min, the 
reaction mixture was quenched with saturated aq. NH4Cl (5.0 mL) and extracted with 
EtOAc (3 x 10 mL) and the combined organic layers were dried over Na2SO4, filtered, 
and concentrated in vacuo. Flash chromatography (hexane/EtOAc = 3:1) afforded 
(S,R,S)-1.31 (30 mg, 0.075 mmol, 86%) as a white solid:  Rf 0.45 (hexane/EtOAc = 1:1); 
[]20D +142.0 (c 0.51, CHCl3); IR  (film) 3536 (m, br), 3028 (w), 2967 (m), 1719 (s), 
1598 (w), 1495 (m), 1453 (m), 1329 (s), 1159 (s), 1105 (s), 927 (m), 855 (m), 700 (m) 
cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.80  (d,  J = 8.3 Hz, 2H), 7.35 (d, J = 6.0 Hz, 2H), 
7.33 (d, J = 5.9 Hz, 2H), 7.28 – 7.24 (m, 3H), 4.75 - 4.68 (m, 1H), 4.61 – 4.55 (m, 1H), 
4.11 (dt, J = 12.3, 5.3 Hz, 1H), 3.44 (d, J = 4.2 Hz, 1H), 3.18 (dd, J = 12.8, 3.0 Hz, 1H), 
2.78 (dd, J = 12.8, 11.4 Hz, 1H), 2.44 (s, 3H), 2.23 (ddd, J = 14.4, 3.4, 1.6 Hz, 1H), 2.18 
(dd, J = 14.5, 7.9 Hz, 1H), 2.09 (d, J = 14.5 Hz, 1H), 2.05 (dd, J = 14.4, 7.6 Hz, 1H), 1.77 
(ddd, J = 14.3, 12.5, 1.7 Hz, 1H), 1.48 (ddd, J = 14.4, 10.5, 3.9 Hz, 1H), 1.21 (d, J = 6.3 
Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  206.38,  144.52,  137.38,  137.03, 130.51, 129.72, 
129.01, 127.25, 126.82, 63.73, 58.12, 53.11, 46.18, 44.35, 44.31, 41.22, 22.73, 21.73; 





(R,R,S)-1.31: To a stirred solution of (R,R,S)-1.30 (30 mg, 0.061 mmol) in CH3CN-H2O 
(9:1, 5.0 mL) was added PhI(O2CCF3)2  (53 mg, 0.12 mmol) at 0 oC. After 5 min, the 
reaction mixture was quenched with saturated aq. NH4Cl (5.0 mL) and extracted with 
EtOAc (3 x 10 mL) and the combined organic layers were dried over Na2SO4, filtered, 
and concentrated in vacuo. Flash chromatography (hexane/EtOAc = 3:1) afforded 
(R,R,S)-1.31 (22 mg, 0.054 mmol, 88%) as a white solid: Rf 0.40 (hexane/EtOAc = 1:1); 
[]20D +142.0 (c 0.51, CHCl3); IR  (film) 3504 (m, br), 3028 (w), 2967 (m), 1717 (s), 
1598 (w), 1494 (m), 1453 (m), 1329 (s), 1160 (s), 1097 (s), 935 (m), 816 (m), 702 (m) 
cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.78  (d,  J = 8.2 Hz, 2H), 7.34 - 7.28 (m, 6H), 7.25 - 
7.21 (m, 1H), 4.77 – 4.71 (m, 1H), 4.61 (ddd, J = 10.6, 7.1, 3.4 Hz, 1H), 3.88 – 3.81 (m, 
1H), 3.19 (dd, J = 13.0, 3.2 Hz, 1H), 2.80 (dd, J = 12.8, 11.5 Hz, 1H), 2.42 (s, 4H), 2.33 
(dd, J = 14.6, 7.1 Hz, 1H), 2.30 – 2.24 (m, 2H), 2.18 (dd, J = 14.5, 7.3 Hz, 1H), 1.88 (ddd, 
J = 14.1, 9.1, 5.1 Hz, 1H), 1.78 – 1.69 (m, 2H), 1.26 (d, J = 6.2 Hz, 3H); 13C NMR (125 
MHz, CDCl3)  δ  207.06,  144.10,  137.69,  137.41,  130.23,  129.67,  128.91,  127.12,  127.07,  
65.50, 57.71, 52.75, 46.52, 44.14, 43.54, 41.76, 24.27, 21.68; HRMS (ES) m/z 402.1733  




1-11-2-5: Reduction Conditions of (S,R,S)-1.30 
              
              (S,R,S)-1.31                                 (S,R,S,R)-1.32                     (S,R,S,S)-1.32 
Condition A: To a stirred solution of (S,R,S)-131  (6.0 mg, 0.015 mmol) in MeOH (1.0 
mL) was treated with NaBH4 (1.0 mg, 0.026 mmol) at 0 oC. After being stirred for 30 
min, the reaction mixture was concentrated in vacuo and filtered through a plug of silica 
affording a 1:5 mixture (S,R,S,R)-1.32 and (S,R,S,S)-1.32 (5.6 mg, 0.014 mmol, 93%) as a 
white solid as determined by crude 1H NMR spectroscopy. 
Condition B: To a stirred solution of (S,R,S)-1.31 (30 mg, 0.075 mmol) in THF (5.0 mL) 
was treated with 1.0 M sol of L-Selectride in THF (0.19 mL, 0.19 mmol) at 78 oC. After 
being stirred for 3 h, the reaction mixture was quenched with MeOH (1.0 mL) and 2N 
NaOH (5.0 mL) and stirred at room temperature for 1 h. The reaction mixture was 
extracted with Et2O (3 x 10 m) and combined organic layers were washed with brine and 
dried over MaSO4, filtered, and concentrated in vacuo. The residue was filtered through a 
plug of silica gel affording a 20:1 mixture of (S,R,S,R)-1.32 and (S,R,S,S)-1.32 (29 mg, 
0.072 mmol, 97%) as a white solid, which was dissolved in CH2Cl2 (2.0 mL) and put in a 
20 C refrigerator affording crystals of  (S,R,S,R)-1.32. 
Condition F: To a stirred solution of (S,R,S)-1.31 (6.0 mg, 0.015 mmol) in THF (3.0 mL) 
was treated with BH3THF 1.0M  in THF (15 L, 0.015 mmol) at 0C and stirred for 1h. 
The reaction mixture was quenched with MeOH (1.0 mL) and concentrated in vacuo. The 
residue was filtered through short a plug of silica gel affording a 2:1 mixture (5.6 mg, 
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0.014mmol, 93%) of (S,R,S,R)-1.32 and (S,R,S,S)-1.32 as a white solid as determined by 
crude 1H NMR spectroscopy. 
Condition G: To a stirred solution of (S,R,S)-1.31 (15 mg, 0.037 mmol) in THF (5.0mL) 
was added H2O (40 L, 0.22 mmol). The solution was cooled to78 C and treated with 
a freshly prepared 0.10 M solution of SmI2 in THF (1.5 mL, 0.15 mmol). The reaction 
mixture was slowly warmed to room temperature over 5 h. The reaction mixture was 
quenched with saturated aq. NH4Cl (5.0 mL) and extracted with EtOAc (3x10 mL). The 
combined organic layers were washed with brine and dried over Na2SO4, then filtered 
and concentrated in vacuo to provide as a 2:1 mixture as determined by crude 1H NMR of 
(S,R,S,R)-1.32 and (S,R,S,S)-1.32 which was purified by flash chromatography 
(hexane/EtOAc, 3:1 to 1:1) affording (S,R,S,R)-1.32 (8.1 mg, 0.020 mmol, 53%) and 
(S,R,S,S)-1.32 (5.3 mg, 0.013 mmol, 35%) as white solids. 
 
(S,R,S,R)-1.32 
 (S,R,S,R)-1.32: Rf 0.25 (hexane/EtOAc = 1:1); m.p. 181~ 183 oC; []24D +62.0  (c 1.00, 
CHCl3); IR  (film) 3430 (s, br), 2922 (s), 1601 (w), 1417 (w), 1316 (m), 1152 (s), 916 
(m), 741 (w), 701 (w) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.72  (d,  J = 8.3 Hz, 2H), 7.34 
– 7.29 (m, 4H), 7.27 (d, J = 8.1 Hz, 2H), 7.25 – 7.20 (m, 1H), 4.34 (ddd, J = 10.8, 7.3, 3.2 
Hz, 1H), 4.22 – 4.14 (m, 1H), 4.09 (ddd, J = 14.9, 7.1, 3.5 Hz, 1H), 3.76 – 3.70 (m, 1H), 
3.61 (brs, 1H), 3.31 (t, J = 12.0 Hz, 1H), 3.21 (dd, J = 12.4, 3.7 Hz, 1H), 2.43 – 2.35 (m, 
1H), 2.41 (s, 3H), 1.64 – 1.53 (m, 5H), 1.26 (d, J = 6.3 Hz, 3H), 1.15 (ddd, J = 14.2, 7.2, 
3.3 Hz, 1H); 13C NMR (125 MHz, CDCl3)   δ   143.56,   139.30,   137.91,   130.06,   129.78,  
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128.71, 126.74, 126.65, 64.55, 63.69, 54.19, 48.61, 47.66, 44.63, 35.15, 30.70, 23.04, 
21.66; HRMS (ES) m/z 404.1962  [(M+H)+; calcd for C22H29NO4S:  403.1817]. 
 
(S,R,S,S)-1.32 
 (S,R,S,S)-1.32: Rf 0.20 (hexane/EtOAc = 1:1); []21D +98.14  (c 0.30, CHCl3); IR  (film) 
3409 (s, br), 3027 (w), 2928 (s), 1598 (w), 1494 (w), 1454 (w), 1402 (w), 1324 (m), 1159 
(s), 927 (m), 753 (m), 673 (s) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.72  (d,  J = 8.3 Hz, 
2H), 7.36 - 7.33 (m, 2H), 7.29 (dd, J = 7.9, 5.1 Hz, 2H), 7.27 – 7.24 (m, 3H), 4.50 – 4.43 
(m, 1H), 4.33 – 4.27 (m, 1H), 4.18 – 4.10 (m, 2H), 3.74 (d, J = 4.0 Hz, 1H), 3.11 (dd, J = 
12.8, 3.2 Hz, 1H), 2.81 (app t, J = 12.3 Hz, 1H), 2.41 (s, 3H), 1.96 (ddd, J = 14.2, 12.3, 
1.6 Hz, 1H), 1.81 – 1.72 (m, 2H), 1.48 (ddd, J = 14.2, 10.5, 3.6 Hz, 1H), 1.31 (brs, 1H), 
1.26 (d, J = 6.4 Hz, 3H), 1.12 (ddd, J = 12.2, 12.2, 6.4 Hz, 1H), 0.75 (ddd, J = 12.1, 12.1, 
6.4 Hz, 1H); 13C NMR (125 MHz, CDCl3)   δ   143.80,   138.70,   137.79,   130.19,   129.39,  
128.94, 127.03, 126.66, 63.60, 61.20, 56.25, 51.10, 45.66, 43.32, 38.37, 33.85, 22.82, 
21.68; HRMS (ES) m/z 404.1913  [(M+H)+; calcd for C22H29NO4S:  403.1817]. 
 
1-11-2-6: Reduction Conditions of (R,R,S)-1.31 
                 




Condition B: Following the same reduction conditions B of (S,R,S)-1.31,  (R,R,S)-31 (28 
mg, 0.070 mmol) afforded 20:1 mixture as determined by crude 1H NMR spectroscopy of 
(S,R,S,R)-32 and (S,R,S,S)-32 (27 mg, 0.065 mmol, 93%) as white solids, which was 
dissolved in CH2Cl2 (2.0 mL) and put in a 20 C refrigerator overnight affording 
crystals of  (S,R,S,R)-17. 
Condition G: Following the same reduction conditions G of (S,R,S)-1.31,  (R,R,S)-1.31 
(18 mg, 0.045 mmol) afforded a 1:1.3 mixture of (R,R,S,R)-1.32 and  (R,R,S,S)-1.32 as 
determined by crude 1H NMR spectroscopy which were separated by flash 
chromatography (hexane/EtOAc, 3:1 to 1:1) affording  (R,R,S,R)-1.32 (7.1 mg, 0.018 




 (R,R,S,R)-1.32: Rf 0.40 (hexane/EtOAc = 1:2); m.p. 152~ 154 oC; []29D +40.3 (c 0.50, 
CHCl3); IR  (film) 3420 (s, br), 2924 (s), 1598 (w), 1495 (w), 1454 (w), 1323 (m), 1159 
(s), 934 (m), 814 (w), 751 (m), 668 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.70  (d,  J = 
8.2 Hz, 2H), 7.33 – 7.27 (m, 4H), 7.25 (d, J = 8.0 Hz, 2H), 7.24 – 7.19 (m, 1H), 4.29 (td, 
J = 8.5, 2.6 Hz, 1H), 4.15 (ddd, J = 15.6, 7.7, 4.0 Hz, 1H), 4.00 – 3.92 (m, 1H), 3.73 (qui, 
J = 4.5 Hz, 1H), 3.34 (dd, J = 15.7, 8.4 Hz, 1H), 3.22 (dd, J = 12.6, 3.8 Hz, 1H), 2.39 (s, 
3H), 2.22 (ddd, J = 13.0, 9.0, 3.8 Hz, 1H), 2.09 (ddd, J = 14.2, 8.5, 6.0 Hz, 1H), 1.89 (brs, 
1H), 1.73 (m, 1H), 1.63 (m, 2H), 1.36 – 1.33 (ddd, J = 14.3, 7.5, 3.8 Hz, 1H), 1.29 (d, J = 
6.2 Hz, 3H), 1.28 - 1.24 (m, 1H); 13C NMR (125 MHz, CDCl3)  δ  143.28,  139.45,  138.07,  
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129.88, 129.76, 128.62, 126.90, 126.51, 66.25, 64.71, 53.94, 48.85, 47.58, 44.85, 33.99, 





 (R,R,S,S)-1.32: Rf 0.35 (hexane/EtOAc = 1:2); []26D +32.58 (c 1.00, CHCl3); IR  (film) 
3385 (s, br), 2924 (s), 1599 (w), 1457 (w), 1323 (m), 1160 (s), 929 (m), 755 (m), 671 (s) 
cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.71  (d,  J = 8.1 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 
7.28 – 7.22 (m, 5H), 4.43 (app q, J = 6.2 Hz, 1H), 4.37 – 4.31 (m, 1H), 4.20 – 4.13 (m, 
1H), 3.96 – 3.88 (m, 1H), 3.17 (dd, J = 12.8, 2.2 Hz, 1H), 2.87 (t, J = 12.4 Hz, 1H), 2.40 
(s, 3H), 1.97 (ddd, J = 14.3, 8.7, 5.7 Hz, 1H), 1.93 – 1.88 (m, 1H), 1.88 – 1.83 (m, 1H), 
1.83 – 1.78 (m, 1H), 1.61 (brs, 1H), 1.36 (brs, 1H), 1.30 (d, J = 6.2 Hz,3H), 1.14 (td, J = 
12.1, 6.1 Hz, 1H), 0.91 (td, J = 12.1, 6.4 Hz, 1H); 13C NMR (125 MHz, CDCl3)  δ  143.46,  
138.98, 138.19, 129.98, 129.39, 128.85, 126.86, 126.81, 66.29, 61.17, 56.03, 51.07, 46.13, 
43.35, 37.19, 34.42, 24.34, 21.65; HRMS (ES) m/z 426.1707  [(M+H)+; calcd for 






1.28: HRMS (ES) m/z 580.1497 [(M+H)+; calcd for C28H38NO2S5:  580.1506]. 
 
(R,R)-1.29 
(R,R)-1.29: To a stirred solution of (R,R)-1.25 (60 mg, 0.10 mmol) in THF/H2O (4:1, 13 
mL) were added 2,6-lutidine (66 L, 0.62 mmol) and Hg(ClO4)2 (83 mg, 0.21 mmol) at 0 
C. After 30 min, the reaction mixture was filtered through celite and rinsed with EtOAc 
(3 x 10 mL). The combined organics were poured into saturated aquous NH4Cl (20 mL) 
and extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with 
brine (5.0 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography on silica gel (hexanes/EtOAc, 100/1 to 2/1) provided (R,R)-1.29 (31 mg, 
0.063 mmol, 61% yield) as a pale yellow oil: Rf 0.37 (hexane/EtOAc = 4:1); []21D +4.93 
(c 0.86, CHCl3);  IR  (film) 3027 (w), 2923 (s), 1718 (s), 1305 (s), 1151 (s), 1095 (m), 
815 (w), 750 (m), 659 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.34  (d,  J = 8.3 Hz, 2H), 
7.29 – 7.20 (m, 3H), 7.18 – 7.15 (m, 3H), 7.13 (d, J = 8.0 Hz, 3H), 4.54 – 4.48 (m, 1H), 
4.43 – 4.37 (m, 1H), 3.34 (dd, J = 13.7, 7.4 Hz, 1H), 3.16 (dd, J = 13.8, 8.3 Hz, 1H), 3.10 
(dd, J = 18.2, 6.0 Hz, 1H), 3.05 (dd, J = 18.5, 8.7 Hz, 1H), 2.99 – 2.87 (m, 1H), 2.74 (ddd, 
J = 14.6, 6.5, 3.1 Hz, 1H), 2.64 ((ddd, J = 14.4, 6.9, 3.0 Hz, 1H), 2.38 (s, 3H), 2.35 (dd, J 
= 14.0, 2.7 Hz, 1H), 2.25 (dd, J = 14.1, 9.2 Hz, 1H), 2.16 (d, J = 4.5 Hz, 3H), 2.05 (s, 1H), 
2.02 – 1.95 (m, 1H), 1.93 – 1.85 (m, 1H); 13C NMR (125 MHz, CDCl3)  δ  205.56,  143.21,  
139.65, 139.07, 129.65, 129.58, 128.70, 127.25, 126.56, 57.32, 48.73, 48.14, 46.47, 40.80, 
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39.77, 39.02, 30.46, 26.59, 26.47, 25.15, 21.59; HRMS (ES) m/z 512.1345  [(M+Na)+; 
calcd for C25H31NO3S3Na:  512.1364]. 
1-11-2-7: Screening Conditions for the Reduction of (R,R)-1.25.  
 
(S,R,R)-1.30/(R,R,R)-1.30 
entry conditions Ratio of (S,R,R)-1.30:(R,R,R)-1.30 Yield (%) 
1 NaBH4, MeOH 2:1 77 
2 L-Selectride, THF, -78 C to rt. 3:1 77 
3 Al(OiPr)3, iPrOH, reflux 1.8:1 96 
4 LiHAl(OCEt3)3, THF, -78 C to rt. 4.5:1 84 
5 (S)-CBS, BH3THF, THF, 0 C 1:3 66 
6 (R)-CBS, BH3THF, THF, 0 C 5:1 93 
 
Entry 1: To a stirred solution of (R,R)-1.25 (20 mg, 0.041 mmol) in MeOH (1.0 mL) was 
treated with NaBH4 (2.3 mg, 0.061 mmol) at 0 oC. After being stirred for 30 min, the 
reaction mixture was concentrated in vacuo and filtered through a plug of silica gel 
affording a 1:2 mixture of (S,R,R)-1.30 and (R,R,R)-1.30 (18 mg, 0.037 mmol, 90%) as a 
pale yellow oil. 
1:2 mixture of (S,R,R)-1.30/(R,R,R)-1.30: 1H NMR (500 MHz, CDCl3)  δ  7.55  (d,  J = 7.6 
Hz, 0.65H), 7.39 (d, J = 8.0 Hz, 1.35H), 7.29 (m, 4.30H), 7.18 (d, J = 7.1 Hz, 1.35H), 
7.14 (d, J = 8.2 Hz, 1.35H), 4.43 – 4.33 (m, 1H), 4.28 (dt, J = 11.4, 7.2 Hz, 0.68H), 4.16 
(m, 0.33 H), 3.85 - 3.76 (m, 0.68H), 3.79 – 3.72 (m, 0.33 H), 3.58 (dd, J = 13.8, 6.0 Hz, 
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0.33H), 3.39 (dd, J = 13.7, 7.1 Hz, 0.68H), 3.08 (dd, J = 13.7, 8.9 Hz, 0.68H), 3.05 (dd, J 
= 13.9, 9.9 Hz, 0.33H), 2.81 – 2.68 (m, 1.68 H), 2.68 - 2.63 (s, 0.33H), 2.55– 2.48 (m, 
1H), 2.41 (s, 1H), 2.38 (s, 2H), 2.28 (dt, J = 14.3, 4.8 Hz, 2H), 2.23 – 2.11 (m, 2H), 1.99 
– 1.94 (m, 1.35H), 1.93 - 1.87 (m, 1.35H), 1.87 – 1.74 (m, 1H), 1.47 (ddd, J = 14.3, 10.0, 
3.9 Hz, 0.33H), 1.20 (d, J = 6.1 Hz, 2H), 1.15 (d, J = 6.2 Hz, 1H); HRMS (ES) m/z 




(S,R,R)-1.31/(R,R,R)-1.31:  To a stirred solution of a mixture of (S,R,R)-1.30 and (R,R,R)-
1.30 (18 mg, 0.037 mmol) in CH3CN/H2O (9:1, 5.0 mL) was added PhI(O2CCF3)2  (52 
mg, 0.12 mmol) at 0 oC. After 5 min, the reaction mixture was quenched with saturated 
aquous NH4Cl (5.0 mL) and extracted with EtOAc (3 x 10 mL) and the combined 
organics were dried over Na2SO4, filtered and concentrated in vacuo. Flash 
chromatography (hexane:EtOAc=3:1) afforded a 1:2 mixture of (S,R,R)-1.31 and (R,R,R)-
1.31 (13 mg, 0.031 mmol, 84%): HRMS (ES) m/z 402.1731  [(M+H)+; calcd for 






(R,R)-1.33: To a stirred solution of (R,R)-1.25 (120 mg, 0.21 mmol) in CH3CN/H2O (4:1, 
12 mL) was added the solution of N-chlorosuccinimide (110 mg, 0.83 mmol) and AgNO3 
(160 mg, 0.93 mmol) in CH3CN-H2O (4:1, 5.0 mL) at 0 oC. After 5 min, the reaction was 
treated with saturated aquous Na2SO3 (1.0mL), saturated aq. NaHCO3 (1.0 mL) and brine 
(1.0 mL), successively. The reaction mixture was filtered through celite and extracted 
with Et2O (3 x 10 mL). The combined organic layers were dried over Na2SO4. Flash 
chromatography (hexane:EtOAc, 6:1 to 2:1) afforded (R,R)-1.33 (73 mg, 0.18 mmol, 
88%) as a colorless oil: Rf 0.30 (hexane/EtOAc = 3:1); []24D   +116.85 (c 0.50, CHCl3);  
IR  (film) 3026 (w), 2923 (m), 1717 (s), 1598 (w), 1495 (w), 1304 (s), 1150 (s), 1095 (s), 
1074 (s), 979 (m), 750 (m), 714 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.51  (d,  J = 8.3 
Hz, 2H), 7.30 – 7.23 (m, 3H), 7.22 (d, J = 8.4 Hz, 2H), 7.12 – 7.09 (m, 2H), 4.58 (dddd, J 
= 9.4, 6.3, 6.3, 3.1 Hz, 1H), 4.52 (dddd, J = 8.5, 8.5, 4.2, 4.2 Hz, 1H), 3.15 (dd, J = 18.0, 
4.7 Hz, 1H), 3.12 (dd, J = 14.1, 5.4 Hz, 1H), 2.70 (dd, J = 18.0, 8.4 Hz, 1H), 2.67 – 2.59 
(m, 2H), 2.52 (dd, J = 15.8, 3.9 Hz, 1H), 2.49 (dd, J = 15.9, 3.1 Hz, 1H), 2.40 (s, 3H), 
2.02 (s, 3H); 13C NMR (125 MHz, CDCl3)   δ   206.06,   204.66,   143.93,   138.63,   137.21,  
129.95, 129.37, 128.92, 127.30, 127.05, 56.72, 49.13, 48.12, 45.55, 43.66, 40.97, 30.31, 
21.62; HRMS (ES) m/z 400.1579  [(M+H)+; calcd for C22H26NO4S:  400.1583]. 
 
   
             (S,R,R)-1.34       (S,R,S)-1.34 
(S,R,R)-1.34 and (S,R,S)-1.34: To a stirred solution of (R,R)-1.33 (73 mg, 0.18 mmol) in 
THF (5.0 mL) was added LiHAl(OCEt3)3 (0.5 M in THF, 0.44 mL, 0.22 mmol) at 78 C. 
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The reaction mixture was warmed to room temperature for 3h, quenched with 1N HCl 
and extracted with Et2O (3 x 10 m). The combined organic layers were washed with brine 
and dried over MgSO4. Flash chromatography (hexane:EtOAc, 3:1 to 1:2) afforded 
(S,R,R)-1.34 (16 mg, 0.040mmol, 22%) and (S,R,S)-1.34 (27 mg, 0.067mmol, 37%) as 
colorless oils.  
(S,R,R)-1.34: Rf 0.30 (hexane/EtOAc = 1:1); []25D +44.92 (c 1.00, CHCl3);  IR  (film) 
3420 (m, br), 3031 (w), 2929 (m), 1717 (s), 1599 (w), 1496 (m), 1455 (m), 1309 (s), 1154 
(s), 1095 (s), 985 (m), 863 (m), 700 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.30  – 7.25 
(m, 3H), 7.23 (dd, J = 7.6, 1.7 Hz, 2H), 7.15 – 7.11 (m, 2H), 7.09 (d, J = 8.1 Hz, 2H), 
4.54 (qd, J = 8.0, 2.5 Hz, 1H), 4.19 – 4.09 (m, 2H), 3.08 – 3.01 (m, 2H), 2.86 (dd, J = 9.3, 
7.8 Hz, 1H), 2.83 (dd, J = 13.8, 7.8 Hz, 1H), 2.36 (s, 3H), 2.02 – 1.96 (m, 1H), 1.98 (s, 
3H), 1.93 – 1.88 (m, 1H), 1.71 – 1.63 (m, 2H), 1.62 (brs, 1H); 13C NMR (125 MHz, 
CDCl3)  δ  205.52,  143.15,  139.86,  138.62,  129.63,  129.34,  128.82,  127.17,  126.70,  65.50,  
57.30, 49.10, 46.65, 40.01, 38.29, 36.96, 30.46, 21.57; HRMS (ES) m/z 402.1727  
[(M+H)+; calcd for C22H28NO4S:  402.1739]. 
 
(S,R,S)-1.34: Rf 0.30 (hexane/EtOAc = 1:1); []25D +43.09  (c 1.35, CHCl3);  IR  (film) 
3412 (m, br), 3062 (w), 3026 (w), 2924 (m), 1713 (s), 1600 (w), 1309 (m), 1152 (s), 1097 
(s), 971 (m), 816 (m), 704 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.31  (d,  J = 8.3 Hz, 
2H), 7.27 – 7.21 (m, 3H), 7.17 – 7.13 (m, 2H), 7.11 (d, J = 8.1 Hz, 2H), 4.63 (ddd, J = 
9.4, 7.9, 3.2 Hz, 1H), 4.19 (tt, J = 7.8, 5.4 Hz, 1H), 4.15 – 4.09 (m, 1H), 3.32 (dd, J = 
13.6, 7.5 Hz, 1H), 3.03 (dd, J = 13.2, 7.7 Hz, 1H), 2.98 (dd, J = 17.3, 6.0 Hz, 1H), 2.75 
(dd, J = 17.5, 8.0 Hz, 1H), 2.37 (s, 2H), 2.08 (ddd, J = 13.6, 9.7, 3.8 Hz, 3H), 2.00 (s, 3H), 
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1.95 (ddd, J = 9.5, 7.2, 3.9 Hz, 1H), 1.73 – 1.66 (m, 3H), 1.60 (ddd, J = 13.7, 4.9, 3.4 Hz, 
1H); 13C NMR (125 MHz, CDCl3)   δ   205.55,   143.10,   139.93,   139.45,   129.63,   129.60, 
128.63, 127.22, 126.44, 65.78, 57.07, 46.88, 46.41, 39.95, 38.07, 34.90, 30.37, 21.57; 
HRMS (ES) m/z 401.1717 [(M+H)+; calcd for C22H28NO4S:  402.1739]. 
 
                                        
                 (S,R,R,R)-17                      (R,R,R,R)-17 
(S,R,R,R)-17and (R,R,R,R)-17: To a stirred solution of (S,R,R)-19 (16 mg, 0.040 mmol) in 
THF (3.0 mL) was added BH3THF (1.0 M in THF, 50 L, 0.050 mmol) at 0oC. After 
being stirred for 1 h, the reaction mixture was quenched with MeOH (1.0 mL) and 
concentrated in vacuo, then filtered through a plug of silica gel affording a 1:1 mixture 
(14 mg, 0.036 mmol, 91%) of (S,R,R,R)-17 and (R,R,R,R)-17 as a white sold, 5.0 mg of 
which was separated by SFC affording (S,R,R,R)-17 (1.5 mg) as a white solid and 
(R,R,R,R)-17 (2.1 mg) which was crystalized in Et2O. 
 
(S,R,R,R)-17: Rf 0.20 (hexane/EtOAc = 1:1); m.p. 134~ 136 oC;  IR  (film) 3389 (s, br), 
3061 (w), 2927 (m), 1651 (w), 1600 (w), 1495 (w),  1312 (m), 1147 (s), 1114 (s), 983 (w), 
861 (w), 816 (w), 745 (m) cm-1; 1H NMR (500 MHz, CDCl3)  δ  7.36  (d,  J = 8.2 Hz, 2H), 
7.32 – 7.26 (m, 3H), 7.20 (d, J = 6.7 Hz, 2H), 7.14 (d, J = 8.2 Hz, 2H), 4.42 (dddd, J = 
13.7, 13.0, 8.1, 4.8 Hz, 1H), 4.07 (tt, J = 8.2, 4.1 Hz, 1H), 4.01 (dq, J = 14.1, 4.4 Hz, 1H), 
3.50 (s, 1H), 3.24 (dd, J = 13.7, 7.9 Hz, 1H), 2.87 (dd, J = 13.8, 8.1 Hz, 1H), 2.38 (s, 3H), 
2.29 (ddd, J = 14.9, 10.0, 2.2 Hz, 1H), 1.93 - 1.88 (m, 2H), 1.81 – 1.74 (m, 1H), 1.75 – 
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1.67 (m, 1H), 1.63 (ddd, J = 12.6, 8.1, 4.5 Hz, 1H), 1.51 (ddd, J = 14.6, 9.8, 4.8 Hz, 1H), 
1.00 (d, J = 6.2 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ  143.16,  140.11,  139.06,  129.61,  
129.36, 128.74, 127.33, 126.68, 65.81, 65.01, 55.29, 52.00, 42.76, 39.08, 38.21, 37.08, 
24.00, 21.60; HRMS (ES) m/z 426.1705  [(M+H)+; calcd for C22H29NO4SNa:  426.1715]. 
 
(R,R,R,R)-17: Rf 0.20 (hexane/EtOAc = 1:1); IR  (film)  3398 (s, br), 2926 (m), 1600 (w), 
1495 (w),  1452 (m), 1378 (m), 1315 (m), 1097 (s), 862 (w), 813 (w), 742 (m) cm-1 ; 1H 
NMR (500 MHz, CDCl3)  δ  7.30  – 7.25 (m, 3H), 7.21 – 7.15 (m, 4H), 7.06 (d, J = 8.1 Hz, 
2H), 4.62 (tt, J = 9.0, 9.0, 4.5, 4.5 Hz, 1H), 4.13 (dq, J = 9.0, 4.5, 4.5, 4.5 Hz, 1H), 3.88 
(dddd, J = 9.7, 9.7, 4.2, 3.1 Hz, 1H), 3.81 – 3.73 (m, 1H), 3.08 (dd, J = 13.7, 8.9 Hz, 1H), 
2.85 (dd, J = 13.7, 7.4 Hz, 1H), 2.36 (s, 3H), 2.11 (dt, J = 13.0, 3.1 Hz, 1H), 2.05 (dt, J = 
13.4, 3.9 Hz, 1H), 1.93 (ddd, J = 13.1, 9.7, 3.1 Hz, 1H), 1.75 – 1.65 (m, 3H), 1.46 (d, J = 
4.6 Hz, 1H), 1.32 (d, J = 4.9 Hz, 1H), 1.14 (d, J = 6.2 Hz, 3H); 13C NMR (125 MHz, 
CDCl3)  δ  142.84,  140.64,  138.86,  129.48,  129.37,  128.86,  127.08,  126.68,  65.92,  65.52,  
56.78, 51.60, 42.29, 38.55, 38.24, 37.77, 24.57, 21.58; HRMS (ES) m/z 426.1705  
[(M+H)+; calcd for C22H29NO4SNa:  426.1715]. 
 
      
             (S,R,R,S)-1.32              (R,R,R,S)-1.32 
(S,R,R,S)-1.32 and (R,R,R,S)-1.32: To a stirred solution of (S,R,S)-1.31 (27 mg, 0.067 
mmol) in THF (4.0 mL) was added BH3THF (1.0 M in THF, 84 L, 0.084 mmol) at 0oC. 
After being stirred for 1 h, the reaction mixture was quenched with MeOH (1.0 mL) and 
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concentrated in vacuo filtered through a plug of silica gel to afford a1:1 mixture of 
(R,R,R,S)-1.32 and (S,R,R,S)-1.32 (25 mg, 0.062 mmol, 93%)  as a white solid, which 
was separated by SFC affording (S,R,R,R)-1.32 (12 mg) and (R,R,R,S)-1.32(6.7 mg). 
 
(S,R,R,S)-1.32: Rf 0.23 (hexane/EtOAc = 1:1); []26D 20.14 (c 0.48, CH2Cl2);  IR  (film)  
3391 (s, br), 3028 (w), 2927 (m), 1600 (w), 1496 (w),  1454 (m), 1317 (s), 1150 (s), 1086 
(m), 854 (w), 814 (w), 715 (m) cm-1 ;  1H NMR (500 MHz, CDCl3)  δ  7.62  (d,  J = 8.2 Hz, 
2H), 7.32 – 7.26 (m, 2H), 7.26 – 7.20 (m, 3H), 7.15 (d, J = 7.1 Hz, 2H), 4.52 (app dt, J = 
9.5, 4.4 Hz, 1H), 3.85 – 3.77 (m, 2H), 3.68 - 3.62 (m, 1H), 3.59 (dd, J = 13.1, 5.3 Hz, 1H), 
2.88 (dd, J = 13.1, 9.8 Hz, 1H), 2.46 – 2.42 (m, 1H), 2.41 (s, 3H), 2.01 – 1.94 (ddd, J = 
13.6, 11.2, 2.4 Hz, 1H), 1.90 – 1.81 (m, 2H), 1.46 (ddd, J = 11.9, 9.1, 4.6 Hz, 1H), 1.43 – 
1.35 (m, 2H), 1.30 (dt, J = 12.8, 9.6 Hz, 1H), 1.16 (d, J = 6.2 Hz, 3H); 13C NMR (126 
MHz, CDCl3)  δ  143.48,  139.91,  139.29,  129.89,  129.53,  128.74,  127.32,  126.73,  66.01,  
64.10, 56.49, 51.97, 41.26, 40.07, 37.83, 37.34, 23.42, 21.66; HRMS (ES) m/z 426.1695  
[(M+H)+; calcd for C22H29NO4SNa:  426.1715]. 
 
(R,R,R,S)-1.32: Rf 0.23 (hexane/EtOAc = 1:1); []26D 12.63 (c 0.55, CHCl3);  IR  (film) 
3389 (s, br), 3062 (w), 3025 (w), 2927 (m), 1599 (w), 1316 (m), 1149 (s), 854 (w), 815 
(w), 750 (m) cm-1 ; 1H NMR (500 MHz, CDCl3)  δ  7.36  (d,  J = 8.2 Hz, 2H), 7.29 – 7.20 
(m, 3H), 7.13 (t, J = 7.1 Hz, 4H), 4.41 – 4.33 (m, 1H), 4.05 (m, 2H), 3.82 (m, 1H), 3.35 
(dd, J = 13.4, 6.9 Hz, 1H), 2.90 (dd, J = 13.4, 8.6 Hz, 1H), 2.55 (brs, 1H), 2.37 (s, 3H), 
2.18 (brs, 1H), 2.04 (ddd, J = 13.4, 6.8, 4.3 Hz, 1H), 1.97 (dt, J = 13.6, 4.1 Hz, 1H), 1.80 
– 1.66 (m, 3H), 1.61 (dt, J = 13.7, 6.9 Hz, 1H), 1.17 (d, J = 6.2 Hz, 2H); 13C NMR (500 
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MHz, CDCl3)  δ  143.06,  140.47,  139.33,  129.60,  129.56,  128.73,  127.13,  126.57, 65.90, 
65.55, 56.93, 50.81, 41.67, 39.94, 36.85, 36.78, 24.06, 21.59; HRMS (ES) m/z 426.1695 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 1-2-1: X-ray Determination of Compound (R,R,S,R)-1.32 
Compound (R,R,S,R)-1.32, C22H29NSO4, crystallizes in the orthorhombic space group 
P212121 (systematic absences h00: h=odd, 0k0: k=odd, and h00: l=odd) with a=8.0248(5)Å, 
b=12.4438(8)Å, c=20.5847(14)Å, V=2055.6(2)Å3, Z=4, and dcalc=1.304 g/cm3. X-ray intensity 
data were collected on a Rigaku Mercury CCD area detector employing graphite-monochromated 
Mo-K radiation (=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed 
from a series of twelve 0.5° rotation images with exposures of 30 seconds. A total of 1060 
rotation images were collected with a crystal to detector distance of 35 mm, a 2 swing angle of -
12°, rotation widths of 0.5° and exposures of 15 seconds: scan no. 1 was a -scan from 150° to 
450° at  = 10° and  = 20°; scan no. 2 was an -scan from -20° to 20° at  = -90° and  = 0°; 
scan no. 3 was a -scan from 300° to 450° at  = 0° and  = -30°; scan no. 4 was an -scan from 
-20° to 20° at  = -90° and   = 45°. Rotation images were processed using CrystalClear1, 
producing a listing of unaveraged F2 and (F2) values which were then passed to the 
CrystalStructure2 program package for further processing and structure solution on a Dell 
Pentium 4 computer. A total of 27757 reflections were measured over the ranges 2.57  
25.02°, -9  h  9, -14  k  14, -24  l  24 yielding 3629 unique reflections (Rint = 0.0191). The 
intensity data were corrected for Lorentz and polarization effects and for absorption using 
REQAB3 (minimum and maximum transmission 0.8654, 1.0000). 
The structure was solved by direct methods (SIR974). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ 0.0476P2 + 0.3973P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0292 and wR2=0.0750 for 3564 observed reflections for which F 
> 4(F) and R1=0.0298 and wR2=0.0759 and GOF =1.068 for all 3629 unique, non-zero 
reflections and 258 variables.6 The maximum  in the final cycle of least squares was 0.008 
and the two most prominent peaks in the final difference Fourier were +0.147 and -0.314 e/Å3. 
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Table A1-2-1-1 lists cell information, data collection parameters, and refinement data. 
Final positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  
Anisotropic thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and bond 
angles.  Figure A1-2-1-1. is an ORTEP7 representation of the molecule with 30% probability 









Figure A1-2-1-1: ORTEP Drawing of (R,R,S,R)-1.32 with 30% Probability Thermal Ellipsoids 
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Table A1-2-1-1:  Summary of Structure Determination of Compound (R,R,S,R)-1.32 
Empirical formula  C22H29NSO4 
Formula weight  403.52 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121  
Cell constants:   
a  8.0248(5) Å 
b  12.4438(8) Å 
c  20.5847(14) Å 
Volume 2055.6(2) Å3 
Z 4 
Density (calculated) 1.304 Mg/m3 
Absorption coefficient 0.185 mm-1 
F(000) 864 
Crystal size 0.32 x 0.30 x 0.22 mm3 
Theta range for data collection 2.57 to 25.02° 
Index ranges -9  h  9, -14  k  14, -24  l  24 
Reflections collected 27757 
Independent reflections 3629 [R(int) = 0.0191] 
Completeness to theta = 25.02° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8654 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3629 / 0 / 258 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0292, wR2 = 0.0750 
R indices (all data) R1 = 0.0298, wR2 = 0.0759 
Absolute structure parameter 0.02(6) 
Largest diff. peak and hole 0.147 and -0.314 e.Å-3 
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Table A1-2-1-2: Refined Positional Parameters for (R,R,S,R)-1.32 
Atom x y z Ueq,Å2 
C1 0.39500(18) 0.51080(12) 0.35065(7) 0.0236(3) 
C2 0.24205(19) 0.44020(13) 0.33936(8) 0.0260(3) 
C3 0.22873(19) 0.39532(13) 0.27078(8) 0.0288(3) 
C4 0.3903(2) 0.33820(13) 0.25287(8) 0.0298(4) 
C5 0.54972(18) 0.40537(13) 0.26112(7) 0.0250(3) 
C6 0.65640(18) 0.29654(13) 0.41080(7) 0.0263(3) 
C7 0.72574(19) 0.20745(14) 0.38061(8) 0.0299(3) 
C8 0.7036(2) 0.10657(13) 0.40766(8) 0.0311(3) 
C9 0.6138(2) 0.09313(14) 0.46483(8) 0.0306(4) 
C10 0.5462(2) 0.18369(15) 0.49450(8) 0.0345(4) 
C11 0.5661(2) 0.28515(15) 0.46801(8) 0.0335(4) 
C12 0.5904(2) -0.01704(15) 0.49339(9) 0.0398(4) 
C13 0.3816(2) 0.62633(12) 0.32359(8) 0.0280(3) 
C14 0.2591(2) 0.69410(12) 0.36123(7) 0.0256(3) 
C15 0.3085(2) 0.74481(13) 0.41800(8) 0.0314(3) 
C16 0.1976(3) 0.80578(14) 0.45431(8) 0.0406(4) 
C17 0.0345(3) 0.81629(16) 0.43391(10) 0.0440(5) 
C18 -0.0175(2) 0.76574(15) 0.37735(10) 0.0421(4) 
C19 0.0942(2) 0.70523(14) 0.34111(8) 0.0334(4) 
C20 0.58273(19) 0.48476(14) 0.20513(7) 0.0277(3) 
C21 0.76531(19) 0.50419(14) 0.18764(8) 0.0288(3) 
C22 0.7841(2) 0.57317(15) 0.12763(8) 0.0371(4) 
N1 0.54971(16) 0.45821(10) 0.32641(6) 0.0249(3) 
O1 0.84647(13) 0.41757(10) 0.34275(6) 0.0366(3) 
O2 0.68169(16) 0.50106(10) 0.43140(6) 0.0383(3) 
O3 0.19728(14) 0.47678(10) 0.22318(5) 0.0332(3) 
O4 0.85595(16) 0.55886(11) 0.23798(6) 0.0425(3) 
S1 0.69268(5) 0.42613(3) 0.378701(19) 0.02777(11) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
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Table A1-2-1-3: Positional Parameters for Hydrogens in (R,R,S,R)-1.32 
Atom x y z Uiso,Å2 
H1 0.4076 0.5176 0.3978 0.031 
H2a 0.2450 0.3807 0.3698 0.035 
H2b 0.1428 0.4820 0.3486 0.035 
H3 0.1374 0.3431 0.2695 0.038 
H4a 0.3829 0.3152 0.2079 0.040 
H4b 0.4002 0.2741 0.2794 0.040 
H5 0.6429 0.3545 0.2611 0.033 
H7 0.7866 0.2154 0.3425 0.040 
H8 0.7496 0.0469 0.3873 0.041 
H10 0.4864 0.1759 0.5329 0.046 
H11 0.5197 0.3449 0.4882 0.045 
H12a 0.6900 -0.0381 0.5159 0.060 
H12b 0.5677 -0.0675 0.4592 0.060 
H12c 0.4986 -0.0159 0.5233 0.060 
H13a 0.4905 0.6601 0.3252 0.037 
H13b 0.3471 0.6232 0.2785 0.037 
H15 0.4181 0.7378 0.4320 0.042 
H16 0.2330 0.8394 0.4922 0.054 
H17 -0.0404 0.8571 0.4580 0.058 
H18 -0.1274 0.7724 0.3637 0.056 
H19 0.0588 0.6719 0.3031 0.044 
H20a 0.5258 0.4585 0.1667 0.037 
H20b 0.5329 0.5533 0.2165 0.037 
H21 0.8187 0.4346 0.1796 0.038 
H22a 0.7318 0.6415 0.1348 0.056 
H22b 0.7321 0.5381 0.0914 0.056 
H22c 0.9003 0.5837 0.1186 0.056 
H3a 0.1015 0.4988 0.2271 0.050 
H4 0.8527 0.5232 0.2714 0.064 
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Table A1-2-1-4:   Refined Thermal Parameters (U's) for (R,R,S,R)-1.32 
 Atom U11   U22   U33 U23 U13 U12 
C1 0.0227(7)  0.0246(8) 0.0235(7)  -0.0006(6) 0.0021(6)  0.0002(6) 
C2 0.0213(7)  0.0258(8) 0.0310(8)  0.0010(7) 0.0043(6)  -0.0014(6) 
C3 0.0213(7)  0.0300(8) 0.0353(8)  -0.0022(7) -0.0004(6)  -0.0063(6) 
C4 0.0265(8)  0.0291(8) 0.0340(8)  -0.0069(6) 0.0010(7)  -0.0034(7) 
C5 0.0208(7)  0.0275(8) 0.0267(7)  -0.0049(6) 0.0013(6)  0.0011(6) 
C6 0.0219(8)  0.0313(8) 0.0255(7)  0.0019(6) -0.0038(6)  -0.0009(6) 
C7 0.0286(8)  0.0379(8) 0.0230(7)  -0.0009(7) 0.0010(6)  0.0017(7) 
C8 0.0320(8)  0.0332(8) 0.0280(8)  -0.0034(7) -0.0016(7)  0.0028(7) 
C9 0.0231(8)  0.0376(9) 0.0310(8)  0.0047(7) -0.0055(6)  -0.0011(7) 
C10 0.0315(9)  0.0420(10) 0.0302(8)  0.0051(8) 0.0063(7)  0.0020(7) 
C11 0.0290(8)  0.0397(9) 0.0318(8)  -0.0044(7) 0.0023(7)  0.0055(7) 
C12 0.0409(10)  0.0383(10) 0.0402(9)  0.0087(8) -0.0028(8)  -0.0013(8) 
C13 0.0283(8)  0.0242(8) 0.0315(8)  -0.0008(6) 0.0046(7)  -0.0017(6) 
C14 0.0296(8)  0.0191(7) 0.0280(8)  0.0028(6) 0.0030(6)  -0.0005(6) 
C15 0.0359(9)  0.0271(8) 0.0314(8)  0.0012(6) -0.0009(7)  -0.0002(7) 
C16 0.0619(12)  0.0291(8) 0.0307(9)  -0.0024(7) 0.0061(9)  0.0033(9) 
C17 0.0527(12)  0.0359(10) 0.0432(10)  0.0072(8) 0.0215(9)  0.0153(9) 
C18 0.0322(9)  0.0433(10) 0.0507(11)  0.0124(9) 0.0058(9)  0.0089(8) 
C19 0.0326(9)  0.0325(9) 0.0351(8)  0.0026(7) -0.0021(7)  0.0000(7) 
C20 0.0224(8)  0.0342(9) 0.0265(7)  -0.0019(7) 0.0009(6)  0.0017(7) 
C21 0.0224(8)  0.0340(8) 0.0300(8)  -0.0024(7) 0.0014(6)  -0.0018(7) 
C22 0.0326(9)  0.0451(10) 0.0336(8)  0.0010(8) 0.0047(7)  -0.0043(8) 
N1 0.0211(6)  0.0282(7) 0.0254(7)  -0.0012(5) -0.0010(5)  0.0026(5) 
O1 0.0186(5)  0.0446(7) 0.0466(7)  0.0102(6) -0.0023(5)  -0.0025(5) 
O2 0.0409(7)  0.0347(6) 0.0392(6)  -0.0081(5) -0.0142(6)  -0.0039(6) 
O3 0.0236(5)  0.0445(7) 0.0313(6)  0.0013(5) -0.0020(5)  0.0004(5) 
O4 0.0378(7)  0.0567(8) 0.0330(6)  0.0046(6) -0.0049(5)  -0.0195(6) 
S1 0.02176(18)  0.0300(2) 0.0315(2)  0.00057(16) -0.00505(15)  -0.00247(15) 
The form of the anisotropic displacement parameter is: 
exp[-2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table A1-2-1-5:   Bond Distances in (R,R,S,R)-1.32, Å 
C1-N1  1.4895(19) C1-C2  1.527(2) C1-C13  1.546(2) 
C2-C3  1.522(2) C3-O3  1.432(2) C3-C4  1.524(2) 
C4-C5  1.538(2) C5-N1  1.4964(19) C5-C20  1.541(2) 
C6-C7  1.387(2) C6-C11  1.390(2) C6-S1  1.7669(16) 
C7-C8  1.385(2) C8-C9  1.390(2) C9-C10  1.392(3) 
C9-C12  1.503(2) C10-C11  1.385(3) C13-C14  1.510(2) 
C14-C15  1.386(2) C14-C19  1.393(2) C15-C16  1.388(2) 
C16-C17  1.381(3) C17-C18  1.387(3) C18-C19  1.388(3) 
C20-C21  1.528(2) C21-O4  1.437(2) C21-C22  1.512(2) 
N1-S1  1.6230(13) O1-S1  1.4431(12) O2-S1  1.4332(12) 
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Table A1-2-1-6:   Bond Angles in (R,R,S,R)-1.32, ° 
N1-C1-C2 111.48(12) N1-C1-C13 110.22(12) C2-C1-C13 115.11(13) 
C3-C2-C1 114.13(12) O3-C3-C2 112.78(13) O3-C3-C4 108.34(13) 
C2-C3-C4 109.62(13) C3-C4-C5 115.32(12) N1-C5-C4 109.76(12) 
N1-C5-C20 112.96(12) C4-C5-C20 114.14(13) C7-C6-C11 120.48(15) 
C7-C6-S1 119.71(12) C11-C6-S1 119.72(13) C8-C7-C6 119.53(14) 
C7-C8-C9 121.06(15) C8-C9-C10 118.44(15) C8-C9-C12 120.36(16) 
C10-C9-C12 121.21(15) C11-C10-C9 121.37(15) C10-C11-C6 119.13(17) 
C14-C13-C1 112.32(12) C15-C14-C19 118.50(16) C15-C14-C13 120.05(15) 
C19-C14-C13 121.43(15) C14-C15-C16 121.31(17) C17-C16-C15 119.71(17) 
C16-C17-C18 119.80(17) C17-C18-C19 120.20(18) C18-C19-C14 120.48(17) 
C21-C20-C5 116.26(13) O4-C21-C22 105.66(13) O4-C21-C20 112.97(13) 
C22-C21-C20 112.20(14) C1-N1-C5 119.61(12) C1-N1-S1 118.37(10) 
C5-N1-S1 119.18(10) O2-S1-O1 119.26(8) O2-S1-N1 107.37(7) 
O1-S1-N1 106.41(7) O2-S1-C6 107.49(7) O1-S1-C6 105.39(7) 
N1-S1-C6 110.86(7)     
 
References: 
1CrystalClear: Rigaku Corporation, 1999 
2CrystalStructure:  Crystal Structure Analysis Package, Rigaku Corp. Rigaku/MSC (2002). 
3REQAB4: R.A. Jacobsen, (1994). Private Communication. 
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6R1 = ||Fo| - |Fc|| /  |Fo| 
wR2 = [w(Fo2 - Fc2)2/w(Fo2)2]½ 
GOF = [w(Fo2 - Fc2)2/(n - p)]½ 
where n = the number of reflections and p = the number of parameters refined. 
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Appendix 1-2-2: X-ray Determination of Compound (S,R,S,R)-1.32 
   (S,R,S,R)-1.32, C22H29NSO4, crystallizes in the orthorhombic space group P212121 (systematic 
absences h00: h=odd, 0k0: k=odd, and h00: l=odd) with a=8.2223(5)Å, b=13.0939(8)Å, 
c=19.2454(12)Å, V=2072.0(2)Å3, Z=4, and dcalc=1.294 g/cm3. X-ray intensity data were collected 
on a Rigaku Mercury CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of 
twelve 0.5° rotation images with exposures of 30 seconds. A total of 920 rotation images were 
collected with a crystal to detector distance of 35 mm, a 2 swing angle of -12°, rotation widths of 
0.5° and exposures of 30 seconds: scan no. 1 was a -scan from 20° to 360° at  = 0° and  = -
60°; scan no. 2 was an -scan from -20° to 20° at  = -90° and  = 0°; scan no. 3 was an -scan 
from -20° to 20° at  = -90° and   = 135°; scan no. 4 was an -scan from -20° to 20° at  = -90° 
and   = 225°. Rotation images were processed using CrystalClear1, producing a listing of 
unaveraged F2 and (F2) values which were then passed to the CrystalStructure2 program 
package for further processing and structure solution on a Dell Pentium 4 computer. A total of 
24575 reflections were measured over the ranges 2.63  25.02°, -9  h  9, -15  k  13, -20 
 l  22 yielding 3651 unique reflections (Rint = 0.0309). The intensity data were corrected for 
Lorentz and polarization effects and for absorption using REQAB3 (minimum and maximum 
transmission 0.8933, 1.0000). 
   The structure was solved by direct methods (SIR974). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ 0.0907P2 + 0.3133P P = (Fo 2 + 2Fc2)/3. Non-
hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0358 and wR2=0.0892 for 3504 observed reflections for 
which F > 4(F) and R1=0.0378 and wR2=0.0915 and GOF =1.061 for all 3651 unique, non-zero 
reflections and 258 variables.6 The maximum  in the final cycle of least squares was 0.011 
and the two most prominent peaks in the final difference Fourier were +0.157 and -0.298 e/Å3. 
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   Table A1-2-2-1 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables A1-2-2-2 and A1-2-2-3.  
Anisotropic thermal parameters are in Table A1-2-2-4, Tables A1-2-2-5 and A1-2-2-6 list bond 
distances and bond angles.  Figure A1-2-2-1. is an ORTEP7 representation of the molecule with 










Figure A1-2-2-1: ORTEP drawing of (S,R,S,R)-1.32 with 30% probability thermal ellipsoids 
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Table A1-2-2-1:  Summary of Structure Determination of (S,R,S,R)-1.32 
Empirical formula  C22H29NSO4 
Formula weight  403.52 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121 
Cell constants:   
a  8.2223(5) Å 
b  13.0939(8) Å 
c  19.2454(12) Å 
Volume 2072.0(2) Å3 
Z 4 
Density (calculated) 1.294 Mg/m3 
Absorption coefficient 0.184 mm-1 
F(000) 864 
Crystal size 0.38 x 0.10 x 0.08 mm3 
Theta range for data collection 2.63 to 25.02°. 
Index ranges -9  h  9, -15  k  13, -20  l  22 
Reflections collected 24575 
Independent reflections 3651 [R(int) = 0.0309] 
Completeness to theta = 25.02° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8933 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3651 / 0 / 258 
Goodness-of-fit on F2 1.061 
Final R indices [I>2sigma(I)] R1 = 0.0358, wR2 = 0.0892 
R indices (all data) R1 = 0.0378, wR2 = 0.0915 
Absolute structure parameter 0.01(7) 
Largest diff. peak and hole 0.157 and -0.298 e.Å-3 
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Table A1-2-2-2: Refined Positional Parameters (S,R,S,R)-1.32 
 
Atom x y z Ueq,Å2 
C1 0.5985(2) 0.49849(14) 0.35228(10) 0.0273(4) 
C2 0.7377(2) 0.57286(15) 0.34002(10) 0.0295(4) 
C3 0.7348(2) 0.62493(15) 0.26871(10) 0.0296(4) 
C4 0.5688(2) 0.67130(14) 0.25486(10) 0.0289(4) 
C5 0.4237(2) 0.59894(14) 0.26500(9) 0.0270(4) 
C6 0.3341(2) 0.70066(15) 0.41785(9) 0.0274(4) 
C7 0.2512(2) 0.77667(16) 0.38252(10) 0.0349(5) 
C8 0.2715(3) 0.87794(16) 0.40239(11) 0.0397(5) 
C9 0.3703(3) 0.90403(16) 0.45778(11) 0.0357(5) 
C10 0.4499(3) 0.82638(16) 0.49328(11) 0.0382(5) 
C11 0.4335(3) 0.72473(17) 0.47390(10) 0.0346(5) 
C12 0.3931(4) 1.01442(18) 0.47872(13) 0.0516(6) 
C13 0.6183(3) 0.39310(14) 0.31727(11) 0.0323(4) 
C14 0.7394(3) 0.32593(14) 0.35380(10) 0.0319(5) 
C15 0.6913(3) 0.26918(15) 0.41127(11) 0.0414(5) 
C16 0.8006(4) 0.20659(17) 0.44617(12) 0.0543(7) 
C17 0.9581(4) 0.2000(2) 0.42364(15) 0.0643(9) 
C18 1.0089(3) 0.2562(2) 0.36703(14) 0.0618(8) 
C19 0.9004(3) 0.31852(19) 0.33230(12) 0.0433(5) 
C20 0.3934(2) 0.52806(16) 0.20314(10) 0.0291(4) 
C21 0.2467(2) 0.45744(16) 0.20918(10) 0.0328(4) 
C22 0.2138(3) 0.40150(17) 0.14241(11) 0.0404(5) 
N1 0.43922(19) 0.54411(12) 0.33261(7) 0.0261(3) 
O1 0.14971(17) 0.56620(13) 0.36269(7) 0.0406(4) 
O2 0.34473(19) 0.50877(11) 0.45221(7) 0.0397(4) 
O3 0.77160(16) 0.55680(11) 0.21283(7) 0.0349(3) 
O4 0.10194(17) 0.51288(15) 0.22670(8) 0.0474(4) 
S1 0.30947(6) 0.57162(4) 0.39335(2) 0.02975(14) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
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Table A1-2-2-3: Positional Parameters for Hydrogens in (S,R,S,R)-1.32 
 
Atom x y z Uiso,Å2 
H1 0.5942 0.4861 0.4025 0.036 
H2a 0.8397 0.5364 0.3449 0.039 
H2b 0.7344 0.6251 0.3757 0.039 
H3 0.8156 0.6799 0.2687 0.039 
H4a 0.5669 0.6964 0.2075 0.038 
H4b 0.5548 0.7296 0.2854 0.038 
H5 0.3271 0.6424 0.2690 0.036 
H7 0.1825 0.7601 0.3458 0.046 
H8 0.2177 0.9291 0.3780 0.053 
H10 0.5157 0.8428 0.5309 0.051 
H11 0.4881 0.6736 0.4980 0.046 
H12a 0.3417 1.0261 0.5228 0.077 
H12b 0.3450 1.0580 0.4443 0.077 
H12c 0.5071 1.0292 0.4824 0.077 
H13a 0.5136 0.3589 0.3164 0.043 
H13b 0.6530 0.4029 0.2696 0.043 
H15 0.5842 0.2732 0.4266 0.055 
H16 0.7669 0.1693 0.4847 0.072 
H17 1.0312 0.1575 0.4466 0.086 
H18 1.1163 0.2521 0.3522 0.082 
H19 0.9355 0.3560 0.2941 0.058 
H20a 0.3800 0.5698 0.1619 0.039 
H20b 0.4896 0.4864 0.1963 0.039 
H21 0.2682 0.4072 0.2458 0.044 
H22a 0.1205 0.3582 0.1482 0.061 
H22b 0.3066 0.3607 0.1304 0.061 
H22c 0.1931 0.4500 0.1060 0.061 
H3a 0.8696 0.5453 0.2122 0.052 
H4 0.1113 0.5371 0.2658 0.071 
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Table A1-2-2-4:   Refined Thermal Parameters (U's) for (S,R,S,R)-1.32 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0247(10)  0.0282(9) 0.0289(9)  -0.0009(8) -0.0049(8)  0.0021(8) 
C2 0.0253(10)  0.0297(9) 0.0335(9)  -0.0040(8) -0.0032(7)  -0.0013(8) 
C3 0.0256(10)  0.0292(9) 0.0340(10)  -0.0043(8) 0.0002(8)  -0.0034(8) 
C4 0.0289(10)  0.0239(9) 0.0340(10)  0.0034(8) 0.0019(8)  -0.0004(8) 
C5 0.0245(10)  0.0279(10) 0.0287(9)  0.0026(8) 0.0001(8)  0.0038(8) 
C6 0.0266(10)  0.0321(9) 0.0235(9)  -0.0010(7) 0.0026(7)  0.0006(8) 
C7 0.0368(11)  0.0408(11) 0.0271(10)  0.0001(8) -0.0021(9)  0.0047(9) 
C8 0.0484(13)  0.0367(10) 0.0341(11)  0.0054(9) 0.0035(9)  0.0081(10) 
C9 0.0355(11)  0.0340(11) 0.0375(10)  -0.0036(9) 0.0107(9)  -0.0023(9) 
C10 0.0333(11)  0.0409(11) 0.0403(11)  -0.0125(10) -0.0042(9)  0.0001(10) 
C11 0.0288(10)  0.0399(11) 0.0350(10)  -0.0034(9) -0.0045(8)  0.0065(9) 
C12 0.0636(16)  0.0365(12) 0.0548(14)  -0.0071(11) 0.0132(12)  -0.0033(11) 
C13 0.0347(11)  0.0249(9) 0.0373(10)  -0.0021(8) -0.0065(9)  0.0010(8) 
C14 0.0408(12)  0.0242(9) 0.0308(10)  -0.0044(8) -0.0063(8)  0.0037(8) 
C15 0.0516(13)  0.0321(10) 0.0406(11)  -0.0007(9) -0.0065(10)  0.0000(11) 
C16 0.089(2)  0.0348(11) 0.0393(12)  0.0027(10) -0.0168(14)  0.0072(14) 
C17 0.089(2)  0.0520(15) 0.0521(15)  -0.0101(12) -0.0303(15)  0.0363(16) 
C18 0.0516(16)  0.0721(18) 0.0618(17)  -0.0185(15) -0.0118(13)  0.0305(14) 
C19 0.0424(13)  0.0487(13) 0.0387(12)  -0.0040(10) 0.0003(10)  0.0109(11) 
C20 0.0245(9)  0.0336(10) 0.0292(9)  0.0021(8) 0.0005(8)  0.0021(8) 
C21 0.0217(10)  0.0418(11) 0.0351(10)  -0.0004(8) -0.0021(8)  0.0008(8) 
C22 0.0357(12)  0.0466(12) 0.0389(11)  -0.0041(10) -0.0060(9)  -0.0046(10) 
N1 0.0220(8)  0.0306(8) 0.0256(8)  -0.0004(6) 0.0021(6)  0.0031(7) 
O1 0.0237(7)  0.0529(9) 0.0452(8)  -0.0161(7) 0.0048(6)  -0.0070(7) 
O2 0.0517(10)  0.0341(7) 0.0332(7)  0.0064(6) 0.0097(7)  -0.0029(7) 
O3 0.0236(7)  0.0437(8) 0.0373(7)  -0.0093(6) 0.0023(6)  -0.0001(6) 
O4 0.0230(7)  0.0714(11) 0.0479(9)  -0.0194(9) -0.0013(7)  0.0045(7) 
S1 0.0272(2)  0.0322(2) 0.0299(2)  -0.0025(2) 0.00476(19)  -0.0030(2) 
The form of the anisotropic displacement parameter is: 
exp[-2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table A1-2-2-5: Bond Distances in (S,R,S,R)-1.32, Å 
C1-N1  1.488(2) C1-C2  1.522(3) C1-C13  1.544(3) 
C2-C3  1.533(3) C3-O3  1.430(2) C3-C4  1.517(3) 
C4-C5  1.536(3) C5-N1  1.492(2) C5-C20  1.530(3) 
C6-C7  1.385(3) C6-C11  1.389(3) C6-S1  1.7658(19) 
C7-C8  1.390(3) C8-C9  1.383(3) C9-C10  1.389(3) 
C9-C12  1.512(3) C10-C11  1.389(3) C13-C14  1.503(3) 
C14-C15  1.390(3) C14-C19  1.391(3) C15-C16  1.390(3) 
C16-C17  1.369(4) C17-C18  1.379(4) C18-C19  1.381(3) 
C20-C21  1.524(3) C21-O4  1.435(2) C21-C22  1.504(3) 
N1-S1  1.6231(15) O1-S1  1.4417(15) O2-S1  1.4299(15) 
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Table A1-2-2-6: Bond Angles in (S,R,S,R)-1.32, ° 
N1-C1-C2 111.46(15) N1-C1-C13 109.92(15) C2-C1-C13 115.14(16) 
C1-C2-C3 114.31(15) O3-C3-C4 107.95(15) O3-C3-C2 113.12(16) 
C4-C3-C2 110.46(15) C3-C4-C5 115.44(15) N1-C5-C20 113.62(15) 
N1-C5-C4 109.95(15) C20-C5-C4 113.68(15) C7-C6-C11 120.50(19) 
C7-C6-S1 120.01(15) C11-C6-S1 119.46(15) C6-C7-C8 119.43(18) 
C9-C8-C7 121.21(19) C8-C9-C10 118.36(19) C8-C9-C12 120.9(2) 
C10-C9-
C12 
























115.94(16) O4-C21-C22 107.32(16) O4-C21-C20 111.57(17) 
C22-C21-
C20 
111.91(17) C1-N1-C5 119.37(14) C1-N1-S1 118.97(12) 
C5-N1-S1 117.71(12) O2-S1-O1 118.72(10) O2-S1-N1 108.03(9) 
O1-S1-N1 107.05(8) O2-S1-C6 108.42(9) O1-S1-C6 105.13(9) 
N1-S1-C6 109.23(9)     
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Appendix 1-2-3: X-ray Determination of Compound (S,S,S,S)-1.32 
   (S,S,S,S)-1.32, C22H29NSO4, crystallizes in the orthorhombic space group P212121 (systematic 
absences h00:  h=odd, 0k0:  k=odd, and 00l:  l=odd) with a=13.8629(4)Å, b=16.9650(4)Å, 
c=17.9277(4)Å, V=4216.31(18)Å3, Z=8, and dcalc=1.271 g/cm3 . X-ray intensity data were 
collected on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K 
radiation (=0.71073 Å) at a temperature of 100(1)K. Preliminary indexing was performed from a 
series of thirty-six 0.5° rotation frames with exposures of 20 seconds. A total of 1969 frames were 
collected with a crystal to detector distance of 37.600 mm, rotation widths of 0.5° and exposures 
of 20 seconds:  
scan type     frames 
 27.00 -74.46 5.00 57.63 191 
 -18.00 -116.80 -49.03 36.30 208 
 -15.50 -81.80 18.69 41.79 129 
 19.50 59.55 -261.85 -26.26 345 
 -23.00 315.83 -156.99 28.88 357 
 24.50 7.41 -347.52 28.88 739 
   Rotation frames were integrated using SAINT1, producing a listing of unaveraged F2 and (F2) 
values which were then passed to the SHELXTL2 program package for further processing and 
structure solution. A total of 87053 reflections were measured over the ranges 1.65  27.55°, 
-18  h  18, -22  k  21, -23  l  23 yielding 9722 unique reflections (Rint = 0.0324). The 
intensity data were corrected for Lorentz and polarization effects and for absorption using 
SADABS3 (minimum and maximum transmission 0.7022, 0.7456). 
   The structure was solved by direct methods (SHELXS-974). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ (0.0511P)2 + 0.5644P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0290 and wR2=0.0754 for 8999 observed reflections for 
which F > 4(F) and R1=0.0333 and wR2=0.0779 and GOF =1.006 for all 9722 unique, non-zero 
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reflections and 514 variables.6 The maximum  in the final cycle of least squares was 0.004 
and the two most prominent peaks in the final difference Fourier were +0.299 and -0.224 e/Å3. 
   Table A1-2-3-1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables A1-2-3-2 and A1-2-3-3.  
Anisotropic thermal parameters are in Table A1-2-3-4,  Tables A1-2-3-5, and A1-2-3-6 list bond 
distances and bond angles.  Figures A1-2-3-1 and A1-2-3-2 are ORTEP7 representations of the 
















Table A1-2-3-1:  Summary of Structure Determination of (S,S,S,S)-1.32 
Empirical formula  C22H29NSO4 
Formula weight  403.52 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121  
Cell constants:   
a  13.8629(4) Å 
b  16.9650(4) Å 
c  17.9277(4) Å 
Volume 4216.31(18) Å3 
Z 8 
Density (calculated) 1.271 Mg/m3 
Absorption coefficient 0.181 mm-1 
F(000) 1728 
Crystal size 0.35 x 0.18 x 0.06 mm3 
Theta range for data collection 1.65 to 27.55° 
Index ranges -18  h  18, -22  k  21, -23  l  23 
Reflections collected 87053 
Independent reflections 9722 [R(int) = 0.0324] 
Completeness to theta = 27.55° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.7022 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9722 / 0 / 514 
Goodness-of-fit on F2 1.006 
Final R indices [I>2sigma(I)] R1 = 0.0290, wR2 = 0.0754 
R indices (all data) R1 = 0.0333, wR2 = 0.0779 
Absolute structure parameter -0.03(3) 
Largest diff. peak and hole 0.299 and -0.224 e.Å-3 
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Table A1-2-3-2: Refined Positional Parameters for (S,S,S,S)-1.32 
  Atom x y z Ueq, Å2 
C1 0.37810(10) 0.19794(8) 0.65331(7) 0.0193(3) 
C2 0.48323(10) 0.22569(9) 0.64604(8) 0.0223(3) 
C3 0.50741(10) 0.26044(10) 0.56978(8) 0.0257(3) 
C4 0.43396(10) 0.32256(9) 0.54766(8) 0.0251(3) 
C5 0.33030(10) 0.29248(8) 0.55259(7) 0.0205(3) 
C6 0.35435(11) 0.12034(9) 0.61372(8) 0.0247(3) 
C7 0.25344(11) 0.09292(8) 0.63142(8) 0.0247(3) 
C8 0.22771(12) 0.07751(10) 0.70521(9) 0.0313(3) 
C9 0.13477(13) 0.05558(11) 0.72385(10) 0.0380(4) 
C10 0.06504(13) 0.04726(10) 0.66883(10) 0.0362(4) 
C11 0.09035(13) 0.06090(10) 0.59509(11) 0.0355(4) 
C12 0.18268(12) 0.08461(9) 0.57699(9) 0.0304(3) 
C13 0.25580(11) 0.35298(9) 0.52618(7) 0.0235(3) 
C14 0.26478(11) 0.37609(8) 0.44463(8) 0.0237(3) 
C15 0.18713(13) 0.43538(10) 0.42377(9) 0.0317(3) 
C16 0.14870(10) 0.33778(8) 0.67413(7) 0.0202(3) 
C17 0.08613(10) 0.27496(9) 0.66587(8) 0.0233(3) 
C18 -0.01026(10) 0.29011(9) 0.64912(8) 0.0241(3) 
C19 -0.04349(10) 0.36703(9) 0.64050(8) 0.0236(3) 
C20 0.02169(11) 0.42916(9) 0.64915(8) 0.0246(3) 
C21 0.11749(10) 0.41504(9) 0.66669(8) 0.0232(3) 
C22 -0.14747(11) 0.38373(10) 0.62179(10) 0.0319(3) 
N1 0.30963(8) 0.26113(7) 0.62902(6) 0.0185(2) 
O1 0.59866(8) 0.29883(7) 0.57015(7) 0.0342(3) 
O2 0.25544(8) 0.30510(6) 0.40144(6) 0.0266(2) 
O3 0.32001(7) 0.39588(6) 0.69296(6) 0.0250(2) 
O4 0.27585(8) 0.27663(6) 0.76314(5) 0.0268(2) 
S1 0.27172(2) 0.32091(2) 0.694394(18) 0.01900(7) 
C1' 0.19692(10) 0.77054(9) 0.66590(7) 0.0224(3) 
C2' 0.09291(11) 0.74064(10) 0.65835(8) 0.0267(3) 
C3' 0.06414(11) 0.72052(10) 0.57830(9) 0.0286(3) 
C4' 0.13854(11) 0.66712(10) 0.54203(8) 0.0287(3) 
C5' 0.24113(10) 0.69900(8) 0.54897(8) 0.0221(3) 
C6' 0.21481(10) 0.85437(9) 0.63718(8) 0.0245(3) 
C7' 0.31803(11) 0.87978(8) 0.64685(8) 0.0226(3) 
C8' 0.35972(11) 0.88386(9) 0.71776(8) 0.0265(3) 
C9' 0.45514(12) 0.90531(9) 0.72707(9) 0.0287(3) 
C10' 0.51169(11) 0.92394(9) 0.66602(9) 0.0297(3) 
C11' 0.47160(11) 0.92050(10) 0.59536(9) 0.0298(3) 
C12' 0.37605(11) 0.89805(9) 0.58594(8) 0.0259(3) 
C13' 0.31653(11) 0.64851(9) 0.50895(7) 0.0239(3) 
C14' 0.30467(11) 0.64690(9) 0.42449(8) 0.0244(3) 
C15' 0.38023(12) 0.59383(10) 0.38898(9) 0.0311(3) 
C16' 0.42364(10) 0.62640(9) 0.65503(8) 0.0212(3) 
C17' 0.48616(10) 0.68996(9) 0.64950(8) 0.0223(3) 
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C18' 0.58058(10) 0.67614(9) 0.62704(8) 0.0229(3) 
C19' 0.61265(11) 0.60011(9) 0.61070(7) 0.0237(3) 
C20' 0.54825(12) 0.53751(9) 0.61746(9) 0.0275(3) 
C21' 0.45364(11) 0.55004(9) 0.63983(8) 0.0256(3) 
C22' 0.71465(11) 0.58494(10) 0.58590(9) 0.0302(3) 
N1' 0.26541(8) 0.71435(7) 0.62910(6) 0.0195(2) 
O1' -0.02480(8) 0.67842(8) 0.57661(7) 0.0397(3) 
O2' 0.31482(8) 0.72648(6) 0.39869(6) 0.0262(2) 
O3' 0.25112(8) 0.56949(7) 0.66576(7) 0.0347(3) 
O4' 0.30224(8) 0.66962(8) 0.75705(6) 0.0341(3) 
S1' 0.30249(3) 0.64120(2) 0.681197(19) 0.02298(8) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
 
Table A1-2-3-3: Positional Parameters for Hydrogens in (S,S,S,S)-1.32 
  Atom x y z Uiso, Å2 
H1 0.3664 0.1892 0.7066 0.026 
H2a 0.4958 0.2651 0.6840 0.030 
H2b 0.5257 0.1813 0.6555 0.030 
H3 0.5078 0.2183 0.5324 0.034 
H4a 0.4469 0.3395 0.4970 0.033 
H4b 0.4411 0.3680 0.5800 0.033 
H5 0.3257 0.2476 0.5184 0.027 
H6a 0.3607 0.1275 0.5603 0.033 
H6b 0.4001 0.0803 0.6291 0.033 
H8 0.2739 0.0821 0.7426 0.042 
H9 0.1189 0.0463 0.7735 0.051 
H10 0.0024 0.0328 0.6812 0.048 
H11 0.0448 0.0540 0.5576 0.047 
H12 0.1979 0.0952 0.5275 0.040 
H13a 0.1918 0.3316 0.5345 0.031 
H13b 0.2620 0.4001 0.5565 0.031 
H14 0.3285 0.3994 0.4359 0.032 
H15a 0.1913 0.4470 0.3714 0.047 
H15b 0.1963 0.4829 0.4519 0.047 
H15c 0.1248 0.4137 0.4348 0.047 
H17 0.1080 0.2235 0.6714 0.031 
H18 -0.0530 0.2483 0.6436 0.032 
H20 0.0005 0.4808 0.6430 0.033 
H21 0.1602 0.4567 0.6734 0.031 
H22a -0.1791 0.4061 0.6645 0.048 
H22b -0.1791 0.3355 0.6081 0.048 
H22c -0.1505 0.4202 0.5809 0.048 
H1a 0.6401 0.2681 0.5848 0.051 
H2 0.2483 0.3165 0.3573 0.040 
H1' 0.2124 0.7706 0.7192 0.030 
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H2a' 0.0852 0.6940 0.6891 0.036 
H2b' 0.0493 0.7807 0.6773 0.036 
H3' 0.0579 0.7692 0.5492 0.038 
H4a' 0.1228 0.6610 0.4896 0.038 
H4b' 0.1355 0.6155 0.5651 0.038 
H5' 0.2414 0.7504 0.5240 0.029 
H6a' 0.1980 0.8569 0.5847 0.033 
H6b' 0.1732 0.8907 0.6638 0.033 
H8' 0.3225 0.8719 0.7594 0.035 
H9' 0.4815 0.9072 0.7747 0.038 
H10' 0.5758 0.9386 0.6723 0.040 
H11' 0.5089 0.9333 0.5540 0.040 
H12' 0.3504 0.8952 0.5381 0.034 
H13a' 0.3802 0.6686 0.5208 0.032 
H13b' 0.3126 0.5950 0.5278 0.032 
H14' 0.2401 0.6274 0.4119 0.032 
H15a' 0.3728 0.5947 0.3357 0.047 
H15b' 0.3721 0.5409 0.4068 0.047 
H15c' 0.4435 0.6124 0.4019 0.047 
H17' 0.4653 0.7407 0.6606 0.030 
H18' 0.6231 0.7183 0.6228 0.030 
H20' 0.5689 0.4866 0.6068 0.037 
H21' 0.4111 0.5080 0.6445 0.034 
H22a' 0.7471 0.5533 0.6225 0.045 
H22b' 0.7479 0.6342 0.5803 0.045 
H22c' 0.7141 0.5576 0.5390 0.045 
H1a'' -0.0687 0.7076 0.5900 0.060 
H2' 0.2971 0.7293 0.3551 0.039 
 
Table A1-2-3-4:   Refined Thermal Parameters (U's) for (S,S,S,S)-1.32 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0197(6) 0.0191(7) 0.0191(6) 0.0027(5) -0.0002(5) 0.0031(5) 
C2 0.0194(6) 0.0245(7) 0.0231(7) 0.0036(6) -0.0017(5) 0.0030(6) 
C3 0.0202(7) 0.0314(8) 0.0254(7) 0.0046(6) 0.0019(5) 0.0011(6) 
C4 0.0243(7) 0.0269(7) 0.0241(7) 0.0082(6) 0.0010(5) 0.0013(6) 
C5 0.0239(7) 0.0215(6) 0.0160(6) 0.0016(5) -0.0004(5) 0.0022(5) 
C6 0.0274(7) 0.0209(7) 0.0258(7) -0.0002(6) -0.0016(6) 0.0049(6) 
C7 0.0299(8) 0.0142(6) 0.0300(7) 0.0017(5) -0.0043(6) 0.0016(6) 
C8 0.0333(8) 0.0296(8) 0.0310(8) 0.0079(6) -0.0080(7) -0.0071(7) 
C9 0.0401(10) 0.0363(9) 0.0375(9) 0.0114(7) -0.0031(7) -0.0123(8) 
C10 0.0313(8) 0.0271(8) 0.0501(10) 0.0055(7) -0.0051(7) -0.0059(7) 
C11 0.0350(9) 0.0271(8) 0.0443(9) -0.0015(7) -0.0159(8) 0.0006(7) 
C12 0.0370(8) 0.0254(7) 0.0286(7) -0.0020(6) -0.0073(6) 0.0030(7) 
C13 0.0248(7) 0.0241(7) 0.0216(6) 0.0012(5) -0.0027(5) 0.0036(6) 
C14 0.0257(7) 0.0228(7) 0.0227(6) 0.0029(5) -0.0033(6) -0.0002(6) 
C15 0.0374(9) 0.0277(8) 0.0299(8) 0.0032(6) -0.0086(7) 0.0072(7) 
C16 0.0174(6) 0.0241(7) 0.0191(6) -0.0006(5) 0.0002(5) 0.0017(5) 
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C17 0.0249(7) 0.0192(7) 0.0259(7) 0.0000(6) 0.0026(6) 0.0009(6) 
C18 0.0212(7) 0.0242(7) 0.0269(7) -0.0026(6) 0.0021(5) -0.0056(6) 
C19 0.0199(7) 0.0280(8) 0.0229(7) -0.0047(6) 0.0027(5) 0.0014(6) 
C20 0.0237(7) 0.0219(7) 0.0283(7) -0.0032(6) 0.0013(6) 0.0043(6) 
C21 0.0224(7) 0.0195(7) 0.0276(7) -0.0045(6) 0.0013(5) -0.0009(5) 
C22 0.0199(7) 0.0324(8) 0.0435(9) -0.0072(7) -0.0021(6) 0.0023(6) 
N1 0.0202(5) 0.0178(5) 0.0174(5) 0.0014(4) 0.0004(4) 0.0038(4) 
O1 0.0203(5) 0.0385(7) 0.0437(7) 0.0121(5) 0.0020(5) -0.0009(5) 
O2 0.0328(6) 0.0268(5) 0.0201(5) -0.0003(4) -0.0050(4) 0.0054(4) 
O3 0.0219(5) 0.0215(5) 0.0316(5) -0.0038(4) -0.0039(4) -0.0001(4) 
O4 0.0290(5) 0.0315(5) 0.0198(5) 0.0020(4) 0.0009(4) 0.0080(5) 
S1 0.01822(15) 0.01961(15) 0.01917(15) -0.00105(12) -0.00133(12) 0.00166(13) 
C1' 0.0196(6) 0.0279(7) 0.0196(6) -0.0046(5) 0.0018(5) 0.0042(6) 
C2' 0.0203(7) 0.0343(8) 0.0256(7) -0.0062(6) 0.0024(5) 0.0006(6) 
C3' 0.0204(7) 0.0368(8) 0.0285(7) -0.0065(7) -0.0004(6) 0.0010(6) 
C4' 0.0230(7) 0.0369(8) 0.0263(7) -0.0103(6) -0.0005(5) -0.0004(7) 
C5' 0.0230(7) 0.0257(7) 0.0176(6) -0.0028(5) -0.0014(5) 0.0017(6) 
C6' 0.0223(7) 0.0242(7) 0.0271(7) -0.0054(6) -0.0012(5) 0.0035(6) 
C7' 0.0241(7) 0.0169(6) 0.0268(7) -0.0036(5) -0.0009(6) 0.0050(6) 
C8' 0.0291(8) 0.0264(7) 0.0239(7) -0.0054(6) 0.0013(6) -0.0011(6) 
C9' 0.0319(8) 0.0253(8) 0.0290(7) -0.0063(6) -0.0077(6) 0.0000(6) 
C10' 0.0242(7) 0.0225(7) 0.0424(9) -0.0023(6) -0.0032(6) 0.0001(6) 
C11' 0.0282(8) 0.0271(8) 0.0341(8) 0.0023(6) 0.0054(6) 0.0026(6) 
C12' 0.0294(8) 0.0238(7) 0.0245(7) -0.0004(6) -0.0010(6) 0.0056(6) 
C13' 0.0245(7) 0.0262(7) 0.0210(6) -0.0007(6) 0.0021(5) 0.0039(6) 
C14' 0.0236(7) 0.0276(7) 0.0221(6) -0.0038(6) -0.0006(5) 0.0030(6) 
C15' 0.0341(8) 0.0318(8) 0.0274(8) -0.0020(6) 0.0060(6) 0.0081(7) 
C16' 0.0182(6) 0.0255(7) 0.0199(6) 0.0022(5) 0.0003(5) 0.0018(5) 
C17' 0.0253(7) 0.0206(7) 0.0209(6) -0.0017(5) -0.0017(5) 0.0004(6) 
C18' 0.0234(7) 0.0240(7) 0.0212(6) -0.0007(6) -0.0022(5) -0.0036(6) 
C19' 0.0244(7) 0.0289(8) 0.0177(6) 0.0031(5) -0.0007(5) 0.0022(6) 
C20' 0.0306(8) 0.0208(7) 0.0312(8) 0.0042(6) 0.0036(6) 0.0053(6) 
C21' 0.0269(7) 0.0204(7) 0.0296(7) 0.0064(6) 0.0013(6) -0.0023(6) 
C22' 0.0269(8) 0.0335(8) 0.0302(8) 0.0022(6) 0.0035(6) 0.0040(6) 
N1' 0.0203(5) 0.0216(6) 0.0166(5) -0.0019(4) 0.0011(4) 0.0024(5) 
O1' 0.0201(5) 0.0488(7) 0.0502(7) -0.0184(6) 0.0005(5) -0.0028(5) 
O2' 0.0285(5) 0.0291(5) 0.0209(5) 0.0006(4) -0.0027(4) 0.0059(5) 
O3' 0.0257(6) 0.0247(5) 0.0536(7) 0.0084(5) 0.0045(5) -0.0035(5) 
O4' 0.0343(6) 0.0473(7) 0.0208(5) 0.0066(5) 0.0054(4) 0.0104(5) 
S1' 0.02113(16) 0.02423(17) 0.02357(16) 0.00524(13) 0.00403(13) 0.00043(13) 




  Table A1-2-3-5: Bond Distances in (S,S,S,S)-1.32, Å 
C1-N1  1.4964(17) C1-C6  1.5314(19) C1-C2  1.5371(19) 
C2-C3  1.5260(19) C3-O1  1.4229(18) C3-C4  1.518(2) 
C4-C5  1.527(2) C5-N1  1.4976(16) C5-C13  1.5311(19) 
C6-C7  1.508(2) C7-C12  1.391(2) C7-C8  1.395(2) 
C8-C9  1.382(2) C9-C10  1.388(2) C10-C11  1.387(3) 
C11-C12  1.380(3) C13-C14  1.5189(19) C14-O2  1.4376(17) 
C14-C15  1.520(2) C16-C17  1.382(2) C16-C21  1.387(2) 
C16-S1  1.7669(14) C17-C18  1.393(2) C18-C19  1.392(2) 
C19-C20  1.397(2) C19-C22  1.507(2) C20-C21  1.386(2) 
N1-S1  1.6366(11) O3-S1  1.4376(10) O4-S1  1.4445(10) 
C1'-N1'  1.4985(17) C1'-C6'  1.533(2) C1'-C2'  1.535(2) 
C2'-C3'  1.528(2) C3'-O1'  1.4252(19) C3'-C4'  1.519(2) 
C4'-C5'  1.527(2) C5'-N1'  1.4981(17) C5'-C13'  1.5302(19) 
C6'-C7'  1.505(2) C7'-C12'  1.391(2) C7'-C8'  1.398(2) 
C8'-C9'  1.382(2) C9'-C10'  1.383(2) C10'-C11'  1.385(2) 
C11'-C12'  1.388(2) C13'-C14'  1.5232(19) C14'-O2'  1.4342(18) 
C14'-C15'  1.521(2) C16'-C21'  1.388(2) C16'-C17'  1.387(2) 
C16'-S1'  1.7617(14) C17'-C18'  1.389(2) C18'-C19'  1.395(2) 
C19'-C20'  1.393(2) C19'-C22'  1.504(2) C20'-C21'  1.388(2) 
N1'-S1'  1.6361(12) O3'-S1'  1.4366(12) O4'-S1'  1.4428(11) 
 
Table A1-2-3-6: Bond Angles in (S,S,S,S)-1.32, ° 
N1-C1-C6 110.16(11) N1-C1-C2 110.94(11) C6-C1-C2 115.33(12) 
C3-C2-C1 113.74(11) O1-C3-C4 106.24(12) O1-C3-C2 111.59(12) 
C4-C3-C2 110.78(12) C3-C4-C5 112.58(12) N1-C5-C4 110.58(11) 
N1-C5-C13 113.08(11) C4-C5-C13 113.13(12) C7-C6-C1 111.54(12) 
C12-C7-C8 117.78(15) C12-C7-C6 122.54(14) C8-C7-C6 119.64(13) 
C9-C8-C7 121.20(15) C8-C9-C10 120.31(17) C9-C10-C11 118.95(16) 
C12-C11-C10 120.47(15) C11-C12-C7 121.24(16) C14-C13-C5 114.55(12) 
O2-C14-C15 110.99(12) O2-C14-C13 107.14(11) C15-C14-C13 110.47(12) 
C17-C16-C21 121.51(13) C17-C16-S1 120.20(11) C21-C16-S1 118.29(11) 
C16-C17-C18 118.87(14) C19-C18-C17 120.93(14) C18-C19-C20 118.74(13) 
C18-C19-C22 121.15(14) C20-C19-C22 120.10(14) C21-C20-C19 120.97(14) 
C20-C21-C16 118.96(14) C5-N1-C1 113.53(10) C5-N1-S1 119.78(9) 
C1-N1-S1 116.06(9) O3-S1-O4 117.19(6) O3-S1-N1 112.70(6) 
O4-S1-N1 106.02(6) O3-S1-C16 107.61(6) O4-S1-C16 107.33(6) 
N1-S1-C16 105.25(6) N1'-C1'-C6' 109.87(11) N1'-C1'-C2' 110.25(12) 
C6'-C1'-C2' 115.42(12) C3'-C2'-C1' 113.70(12) O1'-C3'-C4' 106.23(13) 
O1'-C3'-C2' 110.95(13) C4'-C3'-C2' 110.98(13) C3'-C4'-C5' 112.72(12) 
N1'-C5'-C4' 110.43(11) N1'-C5'-C13' 113.17(11) C4'-C5'-C13' 113.56(12) 
C7'-C6'-C1' 112.41(12) C12'-C7'-C8' 117.62(14) C12'-C7'-C6' 121.55(13) 
C8'-C7'-C6' 120.81(13) C9'-C8'-C7' 121.24(14) C10'-C9'-C8' 120.47(14) 
C9'-C10'-C11' 119.14(14) C10'-C11'-C12' 120.37(15) C11'-C12'-C7' 121.15(14) 
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C14'-C13'-C5' 113.73(12) O2'-C14'-C15' 110.77(12) O2'-C14'-C13' 107.05(11) 
C15'-C14'-C13' 110.63(12) C21'-C16'-C17' 121.63(13) C21'-C16'-S1' 118.11(11) 
C17'-C16'-S1' 120.26(11) C16'-C17'-C18' 118.57(13) C17'-C18'-C19' 121.13(14) 
C20'-C19'-C18' 118.84(13) C20'-C19'-C22' 119.85(14) C18'-C19'-C22' 121.31(14) 
C21'-C20'-C19' 120.95(14) C16'-C21'-C20' 118.88(14) C1'-N1'-C5' 112.97(11) 
C1'-N1'-S1' 115.49(9) C5'-N1'-S1' 119.09(9) O3'-S1'-O4' 117.61(7) 
O3'-S1'-N1' 112.12(7) O4'-S1'-N1' 106.49(6) O3'-S1'-C16' 107.50(7) 
O4'-S1'-C16' 107.51(7) N1'-S1'-C16' 104.81(6)   
 
 
1Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
2Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
3Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
4Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
5Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
6R1 = ||Fo| - |Fc|| /  |Fo| 
wR2 = [w(Fo2 - Fc2)2/w(Fo2)2]½ 
GOF = [w(Fo2 - Fc2)2/(n - p)]½ 
where n = the number of reflections and p = the number of parameters refined. 
7“ORTEP-II:  A  Fortran  Thermal  Ellipsoid  Plot  Program  for  Crystal  Structure  Illustrations”.  C.K.  
Johnson (1976) ORNL-5138. 
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Part 2:  A Highly Convergent Synthesis of ()-Secu’amamine A 
Exploiting Type II Anion Relay Chemistry 
2-1: Securinega Alkaloids  
   The Securinega alkaloids (Figure 2-1) are isolated from plants of the Securinega and 
Phyllanthus species.1 Since ()-securinine (2.1), the most abundant among these alkaloids, 
was isolated in 1956,2 along with around 30 congeners, these alkaloids have drawn 
considerable attention3 due to a wide range of biological activities,1b as well as their 
intriguing structure. In particular, securinine displays the most diverse and impressive 
biological activity, including anti-malarial,4 anti-bacterial,5 and cytotoxic activities,6 as 
well as GAVA receptor antagonism.7 From the structural perspective, the securinega 
alkaloids have a compact tetracyclic core, containing , , , -unsaturated bicyclic -
lactone motif.  
 
   In 1978, Parry published an experimental investigation on the biosynthesis of the 
Securinga alkaloids.8 They found that the piperidine ring and the remaining skeleton of 
eight carbons are derived from lysine and tyrosine respectively. A plausible biosynthetic 
pathway leading to securinine is outlined in Figure 2-2. Tyrosine and lysine were 
suggested to arise from 4’-hydroxyphenylpyruvic acid (2.5) and ∆1-piperidine (2.6) 
respectively, which would be combined to eventually form the quinone (2.7) via 
173 
 
condensation, decarboxylation and oxidation. Ring closure of 2.7 would then afford 
butenolide (2.8); further reductive cyclization would produce securinine (2.1). 
 
2-2: ()-Secu’amamine A 
   (–)-Secu’amamine  A   (2.4), a tetracyclic securinega alkaloid isolated from the leaves 
and twigs of Securinega suffruticosa var. amamiensis by Osaki and co-workers in 2003,9 
embodies a novel azabicyclo-[3.3.1]-nonane core with four stereogenic centers. Recently, 
Magnus and Padilla proposed a biogenetic pathway to (–)-secu’amamine  A (2.4) from 
3-hydroxyallosecurinine (2.9), the latter derived via oxidation of allosecurinine (2.3), 







2-3: The Weinreb Synthesis of ()-Secu’amamine A 
   Weinreb and co-workers reported the first and to date only total synthesis of 
secu’amamine A in 2008.11 The synthetic strategy features a sequential cyclization of 
aza-Michael/aldol/lactonization to access the tetracyclic ring core of secu’amamine A 
(Figure 2-4). 
 
   The synthesis commenced with addition of readily available vinyl Grignard reagent 2.6 
to N-tritylpyrrolidine 2-carboxaldehyde (2.5) via a Felkin–Ahn-type addition to produce 
amino alcohol 2.7 as a single stereoisomer (Scheme 2-1). After protection group 
elaborations and oxidation, aldehyde 2.8 was treated with the ylid derived from 
phosphonate 2.9 to provide the E-enone 2.10 required for indolizidine ring formation. To 
this end, cyclization entailed treatment of trifluoroacetic acid, followed by neutralizing 
the resultant amine salt with Hunig’s base at low temperature to afford the kinetic 




   After cleavage of exo-methylene group in the major indolizidine 2.11, the resultant 
diketoester 2.13 was treated with sodium methoxide in methanol at room temperature to 
produce the desired tetracyclic lactone 2.15, along with a small amount of the epimeric 
hydroxyl ester 2.14 (Scheme 2-2). Completion of the synthesis involved a two-step 
conversion of the ketone to alkene 2.16, followed by ,-dehydrogenation via selenoxide 
elimination of phenylselenide 2.17. Removal of the MOM protecting group in acidic 





2-4: Development of a New Approach to ()-Secu’amamine A 
2-4-1: Initial Retrosynthetic Plan 
   As shown in retrosynthetic form (Scheme 2-3), the -lactone ring of the known 
tetracyclic core 2.15 was envisioned to be formed from the -hydroxy ketone of 
azabicyclo-[3.3.1]-nonane system 2.18 via an intramolecular alkylation of the initially 
formed -halo acetate. I next envisioned that the rigid indolizidine core of the diketone 
2.19 would facilitate cyclization to give the azabicyclo-[3.3.1]-nonane core 2.18. 
Indolizidine 20 in turn would be generated from the fully protected multicomponent 
adduct 22 via intramolecular SN2 cyclization. 
 
 
2-4-2: A Rational Approach to Optimize the Multi-component Reaction 
   According to the synthetic plan, the initial task was to discover optimal conditions for 
the central multi-component reaction. It is known that the diastereoselectivity of the 
nucleophilic addition to N-tritylpyrrolidine 2-carboxaldehyde (2.5) was high in non-polar 
solvent such as diethyl ether.12 The Brook rearrangement in turn can be triggered in three 
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ways, by raising the reaction temperature, by changing the counter cation, or by adding 
polar solvents or additives such as HPMA, DMPU or crown ether.13  
   With this knowledge in mind, I initially investigated a temperature-triggered Brook 
rearrangement with exclusion of polar solvent in order to achieve high 
diastereoselectivity. In 2005, the Smith Laboratory first reported a multicomponent tactic 
utilizing the bifunctional linchpin 2.23.14 The effect of temperature and solvent on the 
union of dithiane 2.22 and bifunctional linchpin 2.23 is shown in Table 2-1. There were 
two important points in this study. First, dithiane 2.22 was used in excess (2.0 equiv) to 
achieve maximum conversion of the linchpin (2.23). Second, when ether was used as the 
solvent, Brook rearrangement was almost completely blocked (Table 2-1, entry 2 and 4). 
 
entry Solvent Reaction temperature/time 
Yield  (%) 
  A                            B   
1 Et2O −78  to  −20  °C 0 0 
2 Et2O r.t./3  h 71 <5 
3 THF −30  °C/20  min 47 24 
4 THF/Et2O(1/3) −30  °C/20  min 87 <5 
   To minimize the simple addition product 2.26 (Scheme 2-4), it proved critical to find 
the optimal conditions to afford maximum epoxide opening employing a minimal excess 
of dithiane 2.22. At the same time, it was also important to complete the Brook 
178 
 
rearrangement of alkoxide 2.27 to dithiane anion 2.28 to avoid complex reaction 
pathways via enolization of the proline carboxaldehyde 2.5 (Scheme 2-4).  
 
   Optimization commenced with changing the combination of solvent, temperature and 
reaction time (Table 2-2 entry 1-3). After extensive screening, I found that the maximum 
conversion of alkoxide I-1 to dithiane anion I-2 was about 50% in THF. As the 
temperature goes up, the dithiane anion begins to decompose substantially. Next, we 
tested HMPA to trigger the Brook rearrangement at low temperature upon maximum 
generation of alkoxide 2.27 in THF/Et2O (3:1). I found however that the addition of 
dithiane anion I-2 to aldehyde 2.5 was low yielding (Table 2-2 entry 3).  
   My focus next shifted from solvent to cation exchange to trigger the Brook 
rearrangement at low temperature. After extensive screening of a combination of solvent 
and cation exchange, I found optimal conditions for the deprotonation/Brook 
rearrangement sequence by employing a modification of the Schlosser base conditions. 
However, the subsequent addition of the dithiane anion to aldehyde 2.5 resulted in 
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extensive quenching by the acidic  aldehydic proton, which I reason was attributable to 
the one equivalent of t-BuOLi/t-BuOK in the reaction (Table 1, entry 4). Quenching of 
the dithiane anion could be significantly reduced by diluting the reaction mixture with 
ether (at least five fold relative to THF), before addition of aldehyde 2.5, which 
precipitated near completely the tBuOLi/tBuOK at 78 oC (Table 2-2 entry 6). 
 
entry base condition 1 condition 2d Yield
e 
(%) 
1 nBuLi, THF rt, 5 min.a THF, 78 
oC ~ 10 oC, 1 h Reverse addition Et2O, 70 oC ~ 30 oC, 1 h 
20 
2 nBuLi, THF rt, 5 min a 
THF, 45 oC ~ 0 oC, 1.5 h 
Et2O (twice of THF) 
Normal addition 
Et2O, 78 oC, 2 h 
50 
3 nBuLi, THF rt, 5 min a 
Et2O, -30 oC, 20 min.; 
HMPA/Et2O, 78 oC 
Normal addition 
Et2O, 78 oC, 2 h 
<10 
4 KOtBu, nBuLi THF,  78 oC, 0.5 h b 
THF, 78 oC , 0.5 h; 
Et2O (five times of THF) 
Reverse addition 
Et2O, 78 oC ~ 0 oC, 2 h 
30 
5 KOtBu (0.5 eq.), nBuLi THF,  78 oC, 0.5 hc 
THF, 78 oC , 0.5 h; 
Et2O (five times of THF) 
Normal addition 
THF/ Et2O (1/5) 
78 oC ~ 0 oC, 2 h 
45 
6 KOtBu, nBuLi THF,  78 oC, 0.5 h b 
THF, 78 oC, 0.5 h; 
Et2O (five times of THF) 
Normal addition 
THF/ Et2O (1/5) 
78 oC ~ 0 oC, 2 h 
75 
a: 1.5 equiv of dithiane and 1.5 equiv nBuLi were used. b:1.2 equiv of dithiane and 1.2 equiv KOtBu and 
nBuLi were used. c: 1.2 equiv of dithiane and 0.5 equiv KOtBu and 1.2 equiv nBuLi were used. d: 1.5 
equiv of aldehyde 2.5 were used in entry 1-3, 1. 2 equiv of aldehyde 2.5 were used in entry 4-6. e: Isolated 






2-4-3: Synthesis of the Indolizidine Core 
   Following the optimized conditions for the key ARC sequence, the resultant secondary 
alkoxide was treated with MOMBr to provide the fully protected multicomponent adduct 
2.26 in one pot with 76% yield. The TBS group was then removed with TBAF in THF at 
reflux and the resulting alcohol 2.27 was then successfully mesylated.  
 
   The next challenging issue was to discover mild conditions to remove the N-trityl group 
and to achieve cyclization successively to provide the indoizidine core. I found that the 
mesylate, sterically encumbered by two dithiane moieties, slowly decomposes via an 
elimination reaction under mild acidic conditions. Pleasingly however, the trityl group 
could be removed successfully using silica-supported sodium hydrogen sulfate 
(NaHSO4–SiO2)15 as a heterogeneous catalyst in CH2Cl2:MeOH (10:1). No 
decomposition occurred. Next I observed that treatment of the crude mixture with excess 
triethylamine led to the desired product, as a mixture of the indolizidine 2.20 and alkenes 
2.28, the latter via an elimination reaction. Fortunately, dilution of the reaction mixture 
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with CH2Cl2 (0.02M) minimized the elimination pathway.  Mesylation, deprotection of 
N-Trityl  group and cyclization was then successfully carried out without purification to 
generate indolizidine 2.20 in 85% yield. 
2-4-4: Cyclization Leading to the Azabicyclo-[3.3.1]-nonane Core 
   Upon obtaining the indolizidine core 2.20, I next explored the cyclization to lead to the 
azabicyclo-[3.3.1]-nonane core (Scheme 2-6). The cyclization substrate dione 2.19 was 
obtained in 52% yield after removal of both dithianes in indolizidine 2.20 employing 
Fleming’s modified conditions of the Stork protocol.16 When dione 2.19 was treated with 
NaOMe in methanol, a mixture of several compounds, including the desired cyclization 
product (2.18) was obtained. I also found that the kinetic enolate of diketone 2.19 
generated with LDA at low temperature underwent cyclization smoothly, to furnish 
tricyclic alcohol 2.18 in 84% yield as the reaction was slowly warmed to 0 oC. X-ray 
crystallographic analysis confirmed the stereochemistry and configuration of the desired 





2-4-5: Attempts to Generate the Requisite -Lactone of ()-Secu’amamine A 
   With the tricyclic core 2.18 in hand, my focus turned to installation of the lactone 
moiety. Unfortunately, all our attempts to generate the lactone were unsuccessful, as 
summarized in Table 2-3.  In particular, we found that -haloacetylation of the 
corresponding tertiary alcohol was not viable. Even though the hydroxyl group is located 
at bridge head, decomposition can occur after the hydroxyl group was activated by 
acylation. 
 
entry conditions  result 
1 2.30, pyridine, CH2Cl2, rt No reaction 
2 2.30, NaH, THF, 0 oC Complex mixture 
3 2.30, KHMDS, THF, 78 oC ~ 0 oC Complex mixture 
4 2.31, EDC, CH2Cl2, rt No reaction 
5 2.31, DIPC, Sc(OTf)3, DMAP, CH2Cl2,8 oC ~  rt Complex mixture 
6 2.32, pyridine, CH2Cl2, rt Decomposition 




2-5: A Revised Approach to ()-Secu’amamine A 
2-5-1: A Second Generation Retrosynthetic Plan 
   Upon discovery that the installation of -lactone at the late stage was problematic, a 
minor revision to the initial retrosynthesis was made (Scheme 2-7). In particular, we 
envisioned that the -lactone moiety in the known tetracyclic intermediate 2.15 could be 
formed by oxidation of diol 2.33. We then envisioned that the more stable trans-fused 
indolizidine conformer 2.34a would facilitate cyclization to give the rigid azabicyclo-
[3.3.1]-nonane core of 2.33. Indolizidine ring 2.35 in turn would be obtained by 
intramolecular SN2 cyclization. Finally, exploiting the Type II ARC protocol, the three 
components (2.5, 2.23, 2.37) would unite to furnish the cyclization substrate 2.36, which 
contains the full carbon skeleton of the target, as well as the essential functionalities to 




2-5-2: Generation of the Indolizidine Core Possessing Full Carbon Skeleton 
   Employing the optimized conditions, multicomponent adduct 2.36 was obtained via 
Type II ARC, followed by trapping the subsequent alkoxide with MOMBr in a single pot 
(Scheme 2-8). After the removal of TBS group, the sterically hindered secondary alcohol 
of 2.38 was mesylated in the presence of excess triethylamine. Removal of N-Trityl 
group under heterogeneous condition, followed by treatment of the resultant mixture with 
triethylamine in a diluted solution (0.02M) furnished the indolizidine 2.35 in 72% yield. 
 
2-5-3: Cyclization Leading to the Azabicyclo-[3.3.1]-nonane Core 
   Removal of both dithianes using the Fleming’s  protocol  led to dione 2.34 in 62% yield. 
Initial attempts at the required cyclization employing the previous conditions   (i.e., LDA 
or KHMDS,  78 oC ~ 0 oC in THF) proved unsuccessful, generating a complex mixture 
along with the desired azabicyclo-[3.3.1]-nonane 2.39 as the minor component. After 
considerable experimentation, I discovered that the cyclization to form the desired 
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azabicyclo-[3.3.1]-nonane 2.39 could be achieved with sodium methoxide in high yield, 
with only a trace amount of diastereomeric aldol product 2.40 produced (Scheme 2-9).  
 
   To confirm the structure of  2.40, the cyclization reaction was quneched after six hours 
to isolate 2.40 as a minor product. It was found that 2.40 undergoes slow isomerization 
generating a mixture of 2.39 and 2.40, whereas 2.39 was not converted to 2.40 under the 
same conditions. The stereochemistry and the conformational rigidity of 2.39 and 2.40 
were confirmed by observation of an NOE inhencement in the NMR spectrum between 
the axial protons and by the 4JH,H-coupling between the equatorial protons in the chair 




   Generation of the kinetic product under equilibrating conditions is surprising. We 
presumed that the kinetic product 2.39* (via enolate B) would be converted to the stable 
chair conformer 2.39, in which C3 center would not be enolized because the rigid chair 
conformation locks the equatorial proton at room temperature. Moreover, the retro-aldol 
reaction would  not occur to generate E-enolate D via highly strained transition state D* 
under these conditions. On the other hand, the thermodynamic product 2.40 (via enolate 
A) could undergo either retro-aldol, followed by aldol reaction (via conformer B) or 
enolization, followed by protonation on the less favored concave face (via enolate C) to 





2-5-4: Completion of A Formal Total Synthesis of ()-Secu’amamine A 
   With advanced intermediate 2.39 now in hand, all that remained to complete a formal 
total synthesis was to convert 2.39 to lactone 2.15. In this regard, it is noteworthy that the 
hydrogenolysis of the benzyl ether moiety of 2.39 with Pd/C resulted in the partial 
reduction of ketone. Complete hydrogenolysis was  however possible employing Raney-
Ni in ethanol at reflux, importantly without redution of the ketone in 2.39. Finally, Ley-
Griffith oxidation17 of the primary alcohol afforded the known tetracyclic -lactone 2.15 
in 75% yield, via further oxidation of the initially formed lactol 2.42. Pleasingly the 
spectral properties of 2.15 were identical in all aspects with those reported by Weinreb.11 
 
   In summary, an effective, highly convergent synthesis of common intermediate 2.15 
toward ()-secu’amamine A has been achieved. Highlights of this synthesis include Type 
II ARC employing readily available components [i.e., aldehyde 2.5, linchpin 2.22 and 
dithiane 2.37] to generate the full linear carbon skeleton of the target with the requisite 
functional groups and stereo-centers to permit an efficient synthesis involving an 
intramolecular cyclization leading to the azabicyclo-[3,3,1]-nonane system bearing the 
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axial alkyl substituent required for lactone formation. The synthesis of 2.15 proceeds in 8 
steps in 16% overall yield, as such constitutes a formal total synthesis based on the 
Weinreb total synthesis. 
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2-8: Experimental Section 
2-8-1: Materials and Methods 
   Reactions were carried out in oven or flame-dried glassware under an argon atmosphere, 
unless otherwise noted. All solvents were reagent grade. Diethyl ether and THF were 
obtained from a Pure Solve TM PS-400. Reactions were magnetically stirred and 
monitored by thin layer chromatography (TLC) with 0.25 mm E. Merck precoated silica 
gel plates. In aqueous work-up, all organic solutions were dried over sodium sulfate or 
magnesium sulfate, and filtered prior to rotary evaporation at water aspirator pressure. 
Flash chromatography was performed with silica gel 60 (particle size 0.040 – 0.062 mm) 
supplied by Silicycle and Sorbent Technologies. Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated. Infrared spectra were 
recorded on a Perkin-Elmer Model 283B spectrophotometer or a Jasco Model FT/IR-480 
Plus spectrometer. 1H and 13C NMR spectra were recorded on a Bruker AMX-500 
spectrometer.  Chemical  shifts  are  reported  as  δ  values  relative  to  the  internal  chloroform  
(δ  7.26 ppm for 1H  and  δ  77.16  ppm  for  13C). Optical rotations were measured on a Jasco 
Perkin-Elmer model 241 polarimeter. High resolution mass spectra were measured at the 
University of Pennsylvania Mass Spectrometry Service Center on either a VG Micromass 




2-8-2: Experimental Procedures 
                        
 
 
2.25: To a solution of 2.22 (0.54g, 4.0mmol) in THF (2.5mL) at – 78 oC was added 1.0M 
THF solution of tBuOK (4.0mL, 4.0mmol) dropwise via syringe and then tBuLi (2.4mL, 
4.0mmol). The resulting solution was stirred for 30 min at – 78 oC, and a solution of 
epoxide linchpin 2.23 (0.98g, 3.4mmol) in THF (3.0mL) was added. The resulting 
solution was stirred for 30 min at -78 oC and then diluted with Et2O (25mL). To the 
diluted solution was added aldehyde 2.5 (1.0g, 3.0mmol) in THF/Et2O (2.0mL:10mL) via 
cannula at – 78 oC. After 30 min, the reaction was quenched with a saturated aqueous 
NaHCO3 solution. Then the mixture was extracted with Et2O (50mL × 3) and the 
combined organic layers were washed with brine (100mL), dried over Na2SO4, filtered 
and concentrated in vacuo. Flash chromatography on silica gel (hexane/EtOAc/triethyl 
amine = 8/2/0.4 to 7/3/0.2) provided 2.25 (1.4g, 75%) as a pale yellow oil: []26D = + 
(c 1.60, CH2Cl2);  IR  (film) 3179 (m, br), 3025 (w), 2923 (s), 1599 (w), 1494 (w), 1420 
(m), 1326 (m), 1157 (s), 1090 (s), 908 (w), 754 (m), 703 (s) cm-1; 1H NMR (500 MHz, 
CDCl3)  δ  7.87  (d,  J = 8.3 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 7.5 Hz, 2H), 7.22 
192 
 
(d, J = 6.9 Hz, 2H), 7.19 (t, J = 7.2 Hz, 1H), 4.38 (t, J = 10.0 Hz, 1H), 3.92 – 3.86 (m, 
1H), 3.17 (dd, J = 6.5, 3.0 Hz, 1H), 3.16 – 3.14 (m, 2H), 3.14 – 3.11 (m, 1H), 3.07 (ddd, J 
= 14.3, 11.4, 2.6 Hz,1H), 2.77 (ddd, J = 14.6, 5.4, 3.1 Hz, 2H), 2.62 – 2.51 (m, 2H), 2.48 
(dd, J = 13.3, 10.7 Hz, 1H), 2.41 (s, 3H), 2.29 (d, J = 15.3 Hz, 1H), 2.23 (dd, J = 15.6, 9.3 
Hz, 1H), 2.16 – 2.09 (m, 1H), 2.07 – 2.02 (m, 1H), 1.90 – 1.85 (m, 1H), 1.85 (dd, J = 
14.8, 10.5 Hz, 1H), 1.72 – 1.66 (m, 1H), 1.63 – 1.50 (m, 4H), 1.58 (s, 3H), 1.43 (d, J = 
15.1 Hz, 1H); 13C NMR (125 MHz, CDCl3)   δ  143.09,  139.44,  138.57,  130.05,  129.64, 
128.59, 127.37, 126.61, 65.62, 53.35, 51.21, 47.34, 47.13, 44.28, 44.20, 38.26, 28.35, 
26.93, 26.73, 25.96, 25.22, 24.79, 24.47, 21.66; HRMS (ES) m/z 766.3275  [(M+H)+; 
calcd for C42H59NO2S4Si:  766.3276]. 
 
2.26: To a solution of 2.22 (1.2g, 8.9mmol) in THF (2.0mL) at – 78 oC was added 1.0M 
THF solution of tBuOK (8.9mL, 8.9mmol) dropwise via syringe and then nBuLi (3.87mL, 
8.9mmol). The resulting solution was stirred for 30 min at – 78 oC, and a solution of 
epoxide linchpin 2.23 (2.2g, 7.5mmol) in THF (5.0mL) was added. The resulting solution 
was stirred for 30 min at 78 oC and then diluted with Et2O (50mL). To the diluted 
solution was added aldehyde 2.5 (2.5g, 7.5mmol) in THF/Et2O (4.0mL:20mL) via 
cannula at – 78 oC. After 30 min, MOMBr (1.2mL, 14.9mmol) in THF (10mL) was 
added and the resulting solution was warmed to ambient temperature for 2h. The reaction 
was quenched with a saturated aqueous NaHCO3 solution. Then the mixture was 
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extracted with Et2O (50mL × 3) and the combined organic layers were washed with brine 
(100mL), dried over Na2SO4, filtered and concentrated in vacuo. Flash chromatography 
on silica gel (hexane/EtOAc/triethyl amine = 20/1/0.4 to 8/2/0.2) provided 2.26 (4.6g, 
76%) as a pale yellow oil: []25D = +14.3 (c 2.00, CH2Cl2);  IR  (film) 3179 (m, br), 3025 
(w), 2923 (s), 1599 (w), 1494 (w), 1420 (m), 1326 (m), 1157 (s), 1090 (s), 908 (w), 754 
(m), 703 (s) cm-1; 1H NMR (500MHz ,CDCl3)  = 7.61 (br. s., 6 H), 7.32 7.21 (m, 6 H), 
7.19  7.12 (m, 3 H), 5.62 (d, J = 5.9 Hz, 1 H), 5.14 (d, J = 5.9 Hz, 1 H), 4.77  4.73 (m, 
1 H), 4.47 (t, J = 9.3 Hz, 2 H), 4.41 (t, J = 7.4 Hz, 1 H), 3.68 3.65 (s, 3 H), 3.42 (ddd, J 
= 2.2, 11.9, 14.1 Hz, 1 H), 3.22 (d, J = 14.1 Hz, 1 H), 3.17  3.04 (m, 3 H), 2.96 ((ddd, J 
= 2.6, 12.3, 14.9 Hz, 1 H), 2.67 (td, J = 3.7, 14.6 Hz, 1 H), 2.57 (td,  J = 3.4, 14.7 Hz, 2 
H), 2.46 (td, J = 3.2, 14.5 Hz, 1 H), 2.39 (dd, J = 2.4, 14.9 Hz, 2 H), 2.07 – 2.01 (m, 1 H), 
1.87  1.79 (m, 2 H), 1.71  1.65 (m, 1 H), 1.67 (dd, J = 9.1, 14.9 Hz,1 H) 1.62 (s, 3H), 
1.59  1.54 (m, 1 H), 1.53  1.43 (m, 2 H), 1.21 - 1.13 (m, 2 H), 1.03 - 0.96 (m, 1 H), 0.5 
(s, 9 H), 0.17 (s, 3 H), 0.12 (s, 3 H), 0.13 0.25 (m, 1 H); 13C NMR (125 MHz, CDCl3) 
δ  130.35, 128.05, 127.87, 126.11, 98.81, 81.10, 79.07, 69.73, 62.80, 57.58, 55.52, 52.55, 
49.46, 49.40, 43.61, 29.51, 27.49, 27.32, 26.92, 26.30, 25.52, 25.41, 25.34, 24.81, 24.56, 





2.27: A solution of 2.26 (4.6g, 5.7mmol) in THF was treated with a 1.0 M solution of 
TBAF in THF (8.6mL, 8.6mmol) and stirred at reflux for 12 h. The reaction mixture was 
concentrated in vacuo and flash chromatography on silica gel 
(hexane/EtOAc/triethylamine = 20/1/0.4 to 8/2/0.2) provided alcohol 2.27(3.5g, 89%) as 
a pale yellow oil: []25D = + (c 2.00, CH2Cl2);  IR  (film) 3179 (m, br), 3025 (w), 
2923 (s), 1599 (w), 1494 (w), 1420 (m), 1326 (m), 1157 (s), 1090 (s), 908 (w), 754 (m), 
703 (s) cm-1; 1H NMR (500MHz ,CDCl3)  = 7.57 (d, J = 7.3 Hz, 6 H), 7.29  7.23 (m, 6 
H), 7.19  7.12 (m, 3 H), 5.60 (d, J = 5.5 Hz, 1 H), 5.20 (d, J = 5.7 Hz, 1 H), 4.77 (d, J = 
1.4 Hz, 1 H), 4.43 (qt, J = 2.0, 7.9 Hz, 1 H), 4.32 (tt, J = 1.6, 7.3 Hz, 1 H), 4.04 (d, J = 
1.8 Hz, 1 H), 3.65 (s, 3 H), 3.14  3.01 (m, 2 H), 2.93 (ddd, J = 3.0, 10.1, 14.3 Hz, 1 H), 
2.87 (ddd, J = 3.2, 10.1, 14.1 Hz, 2 H), 2.80 - 2.71 (m, 2 H), 2.54 (td, J = 4.1, 14.6 Hz, 1 
H), 2.21  2.12 (m, 2 H), 2.09 (td, J = 4.2, 14.5 Hz, 1 H), 2.03  1.96 (m, 2 H), 1.93  
1.83 (m, 2 H), 1.80 (dd, J = 1.8, 15.5 Hz, 1 H), 1.69 (s, 3 H), 1.68 - 1.59 (m, 2 H), 1.37 
(ddd, J = 3.5, 10.5, 14.2 Hz, 1 H), 1.27 - 1.17 (m, 2 H), 0.09 0.21 (m, 1 H); 13C 
NMR (125 MHz, CDCl3)  δ  130.23, 128.04, 127.89, 126.19, 99.00, 83.49, 78.97, 65.79, 
62.98, 57.68, 56.31, 52.30, 48.88, 48.56, 46.11, 28.45, 27.53, 26.89, 26.69, 25.78, 25.40, 





2.20: To a stirred solution of alcohol 2.27 (0.47g, 0.68mmol,) in CH2Cl2 (15.0mL) were 
added triethylamine (0.47mL, 3.4 mmol) and methanesulfonyl chloride (0.078mL, 1.0 
mmol) at room temperature. After being stirred for 0.5 h, a saturated aqueous NaHCO3 
solution (5.0mL) was added, and the resulting mixture was extracted with CH2Cl2 (15mL 
x 3). The combined organic layers were dried over Mg2SO4, filtered and concentrated in 
vacuo. The crude mesylate was dissolved in CH2Cl2/MeOH(10mL:1mL) and then 
NaHSO4-SiO2 (0.50g)was treated in one portion. As soon as N-Trityl group was removed 
(usually finished in 10 min), the reaction mixture was filtered and rinsed with dry CH2Cl2 
until the concentration becomes under 0.02M. Then the filtrate was treated with excess 
triethylamine (2.0mL) and stirred overnight and the reaction was concentrated in vacuo. 
Flash chromatography (hexane/EtOAc/triethylamine = 8/2/0.2 to 5/5/0.2) afforded 
indolizidine 2.20 (0.25g, 85%) as a pale yellow oil: []25D = + (c 2.00, CH2Cl2);  IR  
(film) 3179 (m, br), 3025 (w), 2923 (s), 1599 (w), 1494 (w), 1420 (m), 1326 (m), 1157 
(s), 1090 (s), 908 (w), 754 (m), 703 (s) cm-1; 1H NMR (500MHz ,CDCl3)  = 5.19 (d, J = 
6.7 Hz, 1 H), 4.75 (d, J = 6.7 Hz, 1 H), 3.43 (s, 3 H), 3.43 (t, J = 4.9 Hz, 1 H),  3.25  
3.20 (m, 1 H), 3.15  3.10 (m, 1 H), 3.10 (ddd, J = 3.2, 11.1, 14.3 Hz, 1 H), 3.02 – 2.97 
(m, 1 H), 2.95  2.82 (m, 6 H), 2.80  2.73 (m, 2 H), 2.70 - 2.64 (m, 1 H), 2.42 (dd, J = 
7.3, 14.3 Hz, 1 H), 2.36 (dd, J = 7.2, 15.2 Hz, 1 H), 2.14 (dd, J = 1.8, 15.1 Hz, 1 H), 2.09 
 2.01 (m, 2 H), 2.00  1.93 (m, 3 H), 1.85  1.80 (m, 1 H), 1.80  1.72 (m, 2 H), 1.69 (s, 
3 H); 13C NMR (125 MHz, CDCl3)   δ  97.83, 84.39, 56.89, 56.64, 55.00, 52.59, 50.90, 
48.89, 43.69, 43.48, 29.02, 28.39, 27.80, 26.84, 26.75, 26.31, 25.59, 25.29, 23.12; HRMS 





2.19: To a stirred solution of 2.20 (36mg, 0.083mmol) in CH3CN:H2O (1:1) was added 
trifluoroacetic acid (0.061mml, 0.83mmol) was added. Then PhI(O2CCF3)2 (71mg, 
0.165mmol) was added in to the solution in one portion at room temperature. After 0.5 
hour, additional PhI(O2CCF3)2 (71mg, 0.165mmol) was added. The reaction mixture was 
stirred for 2.5 hours. The resultant mixture was extracted with hexane (5mlx3), the 
aqueous layer was neutralized with solid K2CO3 (until to basic), and then treated with 
EtSH (0.5ml) followed by being stirred for 5 min. The resulting solution was diluted with 
saturated aqueous NaHCO3 and extracted with CH2Cl2 (15mlx3). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. Flash 
chromatography (hexane/EtOAc/triethylamine = 7/3/0.4 to 3/7/0.2) afforded dione 2.19 
(16mg, 52%) as a pale yellow oil: []25D = + (c 0.25, CH2Cl2);   1H NMR (500MHz , 
CDCl3)  = 4.75 (d, J = 6.9 Hz, 1 H), 4.66 (d, J = 6.9 Hz, 1 H), 3.99 (d, J = 9.5 Hz, 1 H), 
3.97  3.92 (m, 1 H), 3.40 (s, 3 H), 2.98 (dt, J = 5.2, 8.7 Hz, 1 H), 2.92 (ddd, J = 5.4, 6.5, 
9.3 Hz, 1 H), 2.86 (dd, J = 6.1, 13.3 Hz, 5 H), 2.75 (dt, J = 5.9, 8.5 Hz, 1 H), 2.60 (dd, J = 
5.0, 16.8 Hz, 1 H), 2.41 (dd, J = 8.6, 16.9 Hz, 1 H), 2.22 (dd, J = 1.8, 13.3 Hz, 1 H), 2.16 
(dd, J = 4.2, 12.7 Hz,  1 H), 2.13 (s, 3 H), 1.99 – 1.93 (m, 1 H), 1.88 - 1.78 (m, 2 H); 13C 
NMR (125 MHz, CDCl3)   δ   207.80, 206.86, 96.27, 81.12, 62.71, 56.11, 52.99, 49.58, 
43.58, 42.06, 31.07, 30.13, 22.27; HRMS (ES) m/z 256.1456  [(M+H)+; calcd for 





2.18: To a stirred solution of 2.19 (5.0mg, 0.020mmol) in THF (2.0mL) was added 
0.39M THF solution of LDA (0.054mL, 0.022mmol) at 78 oC. The reaction was 
warmed to 0 oC for 3 hours. Then the reaction was quenched with saturated aqueous 
NaHCO3 (0.1mL) and diluted with CH2Cl2. The mixture was dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo. Flash chromatography (MeOH/CH2Cl2/TEA 
= 20:1:1) afforded 2.18 (4.2 mg, 84%) as a crystalline solid: 1H NMR (500 MHz, CDCl3) 
δ  1H NMR (500MHz ,CDCl3)  = 4.75 (d, J = 6.9 Hz, 1 H), 4.67 (d, J = 6.9 Hz, 1 H), 
4.59 (s, 1 H), 3.51 (brs, 1 H), 3.47 (s, 3 H), 3.17 (d, J = 9.5 Hz, 1 H), 3.00 (td, J = 2.4, 
16.7 Hz, 1 H), 2.86 (dt, J = 3.9, 8.7 Hz, 1 H), 2.72 (dd, J = 1.9, 17.3 Hz, 1 H), 2.66 - 2.60 
(m, 1 H), 2.30 (d, J = 16.5 Hz, 1 H), 2.27 - 2.23 (m, 1 H), 2.23 - 2.17 (m, 1 H), 2.13 -2.08 
(m, 1 H), 2.05 (dd, , J = 2.8, 13.5 Hz, 1 H), 2.01 - 1.93 (m, 1 H), 1.88 - 1.81 (m, 1 H), 
1.77 - 1.68 (m, 1 H), 1.53 - 1.44 (m, 1 H); HRMS (ES) m/z 256.1456  [(M+H)+; calcd for 





2.36: To a solution of 2.37 (1.5g, 5.6mmol) in THF (5.0mL) at – 78 oC was added 1.0 M 
THF solution of tBuOK (0.56mL, 0.56mmol) dropwise via syringe and then 1.7M 
pentane solution of tBuLi (3.3mL, 0.56mmol). The resulting solution was stirred for 30 
min at – 78 oC, and a solution of epoxide linchpin 2.23 (1.3g, 4.3mmol) in THF (4.0mL) 
was added via cannula. The resulting solution was stirred for 30 min at 78 oC and then 
diluted with Et2O (60mL). To the diluted solution was added aldehyde 2.5 (1.9g, 
0.56mmol) in THF/Et2O (5.0mL:25mL) via cannula at – 78 oC. After 30 min, MOMBr 
(0.53mL, 6.5mmol) in THF (10mL) was added and the resulting solution was warmed to 
0 oC for 2h. The reaction was quenched with a saturated aqueous NaHCO3 solution. Then 
the mixture was extracted with Et2O (50mL × 3) and the combined organic layers were 
washed with brine (100mL), dried over Na2SO4, filtered and concentrated in vacuo. Flash 
chromatography on silica gel (hexane/EtOAc/triethyl amine = 20/1/0.4 to 8/2/0.2) 
provided 2.36 (2.6g, 64%) as a pale yellow oil: []25D =  (c 2.00, CH2Cl2); 1H NMR 
(500MHz , CDCl3)   7.61 (br. s., 6 H), 7.31 (d, J = 4.6 Hz, 4 H), 7.29 – 7.22 (m, 7H), 
7.18 – 7.09 (m, 3H), 5.63 (d, J = 5.7 Hz, 1H), 5.12 (d, J = 5.9 Hz, 1H), 4.75 (s, 1 H), 4.49 
(t, J=9.51 Hz, 1H), 4.47 (s, 2H), 4.41 (t, J = 7.7 Hz, 1H), 3.66 (s, 2 H), 3.51 – 3.45 (m, 1 
H), 3.44 (t, J=6.3 Hz, 2H), 3.19 (d, J = 14.1 Hz, 1H), 3.16 – 3.08 (m, 1H), 3.08 – 3.02 (m, 
2 H), 2.99 – 2.90 (m, 1H), 2.72 (br. s., 1H), 2.70 – 2.64 (m, 1H), 2.59 – 2.52 (m, 1H), 
2.49 – 2.43 (m, 1H), 2.40 (dd, J = 15, 2.3 Hz, 1H), 2.08 – 1.95 (m, 3H), 1.95 – 1.85 (m, 
3H), 1.85 – 1.78(m, 2H), 1.75 (dd, J = 9.5, 15.1 Hz, 1H), 1.72 – 1.62 (m, 2H), 1.58 – 1.52 
(m, 2H), 1.52 – 1.46 (m, 1H), 1.43 (dd, J = 9.9, 14.8 Hz, 1H), 1.18 – 1.13 (m, 2H), 1.01 – 
0.93 (m, 1H), 0.82 (m, 9H), 0.15 (s, 3 H), 0.09 (s, 3 H), –0.13 – –0.25 (m, 1H); 13C NMR 
(125 MHz, CDCl3)   δ   138.89, 130.34, 128.39, 128.06, 127.88, 127.74, 127.45, 126.13, 
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98.80, 80.94, 79.10, 72.75, 70.66, 69.87, 62.78, 57.60, 55.44, 54.07, 52.57, 46.29, 43.79, 
36.95, 27.51, 26.76, 26.61, 26.26, 25.77, 25.50, 25.35, 24.84, 24.69, 24.52, 18.15, –2.97, 
–3.90; HRMS (ES) m/z 944.4267  [(M+H)+; calcd for C53H73NO4S4Si:  944.4270]. 
 
2.38: A solution of 2.36 (0.50g, 0.53mmol) in THF was treated with a 1.0 M solution of 
TBAF in THF (0.79mL, 0.79mmol) and stirred at reflux for 12 h. The reaction mixture 
was concentrated in vacuo and flash chromatography on silica gel 
(hexane/EtOAc/triethylamine = 20/1/0.4 to 8/2/0.2) provided alcohol 2.27 (0.40g, 91%) 
as a pale yellow oil: []26D = + (c 2.00, CH2Cl2);  1H NMR (500MHz , CDCl3)  = 
7.57 (d, J = 7.3 Hz, 6 H), 7.35  7.30 (m, 4 H), 7.30 7.23 (m, 7 H), 7.18 7.12 (m, 3 H), 
5.57 (d, J = 5.5 Hz, 1 H), 5.19 (d, J = 5.5 Hz, 1 H), 4.76 (d, J = 1.4 Hz, 1 H), 4.50 (s, 2 H), 
4.43 (td, J = 8.3, 1.8 Hz,  1 H), 4.33 – 4.28 (m, 1 H), 3.92 (d, J = 2.0 Hz, 1 H), 3.64 (s, 3 
H), 3.52 – 3.48 (m, 2 H), 3.14  3.07 (m, 1 H), 3.07  3.01 (m, 1 H), 2.90 - 2.75 (m, 5 H), 
2.56  2.50 (m, 1 H), 2.12 (dd, J = 15.5, 1.8 Hz,  1 H),  2.17  2.04 (m, 4 H), 1.99  1.86 
(m, 6 H), 1.86  1.80 (m, 1 H), 1.78 (dd, J = 12.3, 8.3 Hz,   1 H), 1.67  1.58 (m, 2 H), 
1.44 1.37 (m, 1 H), 1.24  1.17 (m, 1 H), 0.09  0.21 (m, 1 H); 13C NMR (125 MHz, 
CDCl3)  δ  138.82, 130.23, 128.41, 129.03, 127.87, 127.67, 127.52, 126.17, 98.98, 83.65, 
78.94, 77.42, 76.91, 72.68, 70.41, 65.54, 62.95, 57.60, 56.38, 52.78, 52.27, 46.25, 45.85, 
200 
 
35.67, 27.53, 26.37, 26.28, 25.83, 25.41, 25.32, 25.05, 24.74, 24.49; HRMS (ES) m/z 
830.3406  [(M+H)+; calcd  for C47H60NO4S4:  830.3405]. 
 
2.35: To a stirred solution of alcohol 2.38 (0.35g, 0.42mmol,) in CH2Cl2 (15mL) were 
added triethylamine (0.59mL, 4.2mmol) and methanesulfonyl chloride (0.049mL, 0.63 
mmol) at room temperature. After being stirred for 0.5 h, a saturated aqueous NaHCO3 
solution (5.0mL) was added, and the resulting mixture was extracted with CH2Cl2 (15mL 
x 3). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The crude mesylate was dissolved in CH2Cl2/MeOH(10mL:1mL) and then 
NaHSO4-SiO2 (0.50g)was treated in one portion. As soon as N-Trityl group was removed 
(usually finished in 10 min), the reaction mixture was filtered and rinsed with dry CH2Cl2 
till the concentration becomes under 0.02M. Then the filtrate was treated with excess 
triethylamine (1.0mL) and stirred overnight and the reaction was concentrated in vacuo. 
Flash chromatography (hexane/EtOAc/triethylamine = 8/2/0.2 to 5/5/0.2) afforded 
indolizidine 2.20 (0.17g, 72%) as a pale yellow oil: []25D = + (c 1.00, CH2Cl2);  1H 
NMR (500MHz ,CDCl3)  = 7.35 7.31 (m, 4 H), 7.30  7.26 (m, 1 H), 5.16 (d, J = 6.7 
Hz, 1 H), 4.76 (d, J = 6.7 Hz, 1 H), 4.50 (s, 1 H), 3.55  3.47 (m, 1 H), 3.43 (s, 3 H), 3.40 
(d, J = 9.7 Hz, 3 H), 3.29 - 3.24 (m, 3 H), 3.20 (ddd, J = 5.3, 7.2, 9.9 Hz, 3 H), 3.14 (ddd, 
J = 3.2, 11.0, 14.2 Hz, 3 H), 3.00  2.95 (m, 1 H), 2.93 (td, J = 3.4, 6.6 Hz, 1 H), 2.91  
2.88 (m, 1 H), 2.88  2.84 (m, 1 H), 2.84  2.80 (m, 1 H), 2.80  2.71 (m, 4 H), 2.71  
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2.65 (m, 1 H), 2.44 (dd, J = 6.6, 14.4 Hz, 1 H), 2.29 (dd, J = 7.1, 15.3 Hz, 1 H), 2.17  
2.10 (m, 1 H), 2.07 (dd, J = 2.7, 15.6 Hz, 1 H), 2.06  1.99 (m, 3 H), 1.99  1.93 (m, 2 H), 
1.93  1.88 (m, 1 H), 1.88 - 1.66 (m, 6 H); 13C NMR (125 MHz, CDCl3)  δ  138.71, 128.47, 
127.69, 127.62, 97.99, 84.19, 72.89, 70.32, 56.69, 56.58, 55.28, 53.48, 52.25, 50.82, 
42.73, 40.79, 36.02, 28.83, 27.65, 26.29, 26.24, 26.23, 25.61, 25.35, 25.20, 22.95; HRMS 
(ES) m/z 570.2206 [(M+H)+; calcd  for C28H44NO3S4:  570.2204]. 
 
2.34: To a stirred solution of 2.35 (36mg, 0.063mmol) in CH3CN:H2O (1:1) was added 
trifluoroacetic acid (0.047mml, 0.63mmol) was added. Then PhI(O2CCF3)2 (54mg, 
0.13mmol) was added in to the solution in one portion at room temperature. After 0.5 
hour, additional PhI(O2CCF3)2 (81mg, 0.19mmol) was added. The reaction mixture was 
stirred for 0.5 hour. The resultant mixture was extracted with hexane (5mlx3), the 
aqueous layer was neutralized with solid K2CO3 (until to basic), and then treated with 
EtSH (0.5ml) folled by being stirred for 5 min. The resulting solution was diluted with 
saturated aquoues NaHCO3 and extracted with EtOAc (15mlx3). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. Flash 
chromatography (hexane/EtOAc/triethylamine = 5/5/0.2) afforded dione 2.34 (15mg, 
62%) as a pale yellow oil: []25D = + (c 1.00, CH2Cl2);   1H NMR (500MHz ,CDCl3) 
 = 7.37  7.26 (m, 5 H), 4.76 (d, J = 7.1 Hz, 1 H), 4.67 (d, J = 6.9 Hz, 1 H), 4.46 (s, 2 H), 
3.99 (d, J = 9.3 Hz, 1 H), 3.97  3.92 (m, 1 H), 3.45  (t, J = 6.1 Hz, 2 H), 3.41 (s, 3 H), 
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2.99  2.94 (m, 1 H), 2.94  2.89 (m, 1 H), 2.84 (dd, J = 6.3, 13.3 Hz, 1 H), 2.71 (dt, J = 
6.1, 8.5 Hz, 1 H), 2.58 (dd, J = 5.0, 16.4 Hz, 4 H), 2.55  2.44 (m, 2 H), 2.38 (dd, J = 8.5, 
16.6 Hz, 1 H), 2.21 (dd, J = 2.0, 13.3 Hz, 1 H), 2.17  2.09 (m, 1 H), 2.00  1.92 (m, 1 H), 
1.90  1.77 (m, 4 H); 13C NMR (125 MHz, CDCl3)   δ  208.74, 207.81, 138.50, 128.52, 
127.79, 127.73, 96.30, 81.23, 73.02, 69.32, 62.67, 56.12, 52.98, 49.56, 43.72, 41.12, 
40.67, 30.16, 23.88, 22.30; HRMS (ES) m/z 390.2277  [(M+H)+; calcd  for C22H32NO5:  
390.2280]. 
 
2.39: To a stirred solution of dione 2.34 (25mg, 0.064mmol) in MeOH (10mL) was 
added NaOMe (0.050mL, ca. 30% W/W in MeOH). Then the solution was stirred for 12 
hours and quenched with saturated aqueous NaHCO3 and extracted with CH2Cl2 (20mL x 
3) and the combined organic layers were dried over anhydrous Na2SO4. Flash 
chromatography (MeOH/CH2Cl2/triethylamine = 1/19/0.5) afforded alcohol 2.39 (22mg, 
90%) as a pale yellow oil: []26D =  (c 1.00, CH2Cl2);   1H NMR (500MHz ,CDCl3) 
 = 7.35  7.30 (m, 4 H), 7.28  7.24 (m, 1 H), 4.70 (d, J = 6.7 Hz, 1 H), 4.61 (d, J = 6.9 
Hz, 1 H), 4.48 (s, 2 H), 4.35 (s, 1 H), 3.55 (dd, J = 5.4, 7.3 Hz, 3 H), 3.41 – 3.38 (m, 1 H), 
3.33 (s, 3 H), 3.21 (d, J = 9.7 Hz, 1 H), 2.96 – 2.93 (m, 1 H), 2.84 (dt, J = 4.0, 8.7 Hz, 1 
H), 2.68  2.63 (m, 1 H), 2.63  2.58 (m, 1 H), 2.48  2.40 (m, 2 H), 2.37 (dd, J = 5.0, 
12.1 Hz, 3 H), 2.12 (dd, J = 2.9, 13.2 Hz, 1 H), 2.00  1.92 (m, 1 H), 1.87 – 1.83 (m, 2 H), 
1.84  1.78 (m, 1 H), 1.76  1.68 (m, 1 H), 1.61 (ddd, J = 5.3, 9.5, 14.6 Hz, 1 H), 1.51  
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1.43 (m, 1 H); 13C NMR (125 MHz, CDCl3)  δ  212.75, 138.38, 128.45, 127.96, 127.71, 
98.86, 90.66, 73.22, 72.89, 68.60, 58.90, 56.21, 52.71, 50.56, 48.73, 38.39, 33.88, 29.29, 




2.40: To a stirred solution of dione 2.34 (18mg, 0.046mmol) in MeOH (10mL) was 
added NaOMe (0.050 mL, ca. 30% W/W in MeOH). Then the solution was stirred for 12 
hours and quenched with saturated aqueous NaHCO3 and concentrated in vacuo. Flash 
chromatography (MeOH/CH2Cl2/triethylamine = 1/19/0.5 to 1/9/0.5) afforded alcochol 
2.39 (13mg, 75%) and 2.40 (2.5mg, 15%) as a pale yellow oil: []24D =  (c 0.37, 
CH2Cl2);   1H NMR (500MHz ,CDCl3)  = 7.36  7.31 (m, 4 H), 7.31  7.27 (m, 1 H), 
4.75 (br. s., 1 H), 4.74 (d, J = 6.1 Hz, 1 H), 4.54 (d, J = 11. 9 Hz, 1 H), 4.50 (d, J = 6.1 Hz 
1 H), 4.49 (d, J = 11. 9 Hz, 1 H), 3.71 (ddd, J = 4.3, 5.5, 9.5 Hz, 1 H), 3.46 (br. s., 1 H), 
3.39  (s, 3 H), 3.38  3.34 (m, 1 H), 3.29 (d, J = 9.7 Hz, 1 H), 2.89  2.83 (m, 1 H), 2.78 
(d, J = 16.2 Hz, 1 H), 2.72 – 2.67 (m, 1 H), 2.55 (dd, J = 3.8, 7.3 Hz, 1 H), 2.41  2.34 (m, 
2 H), 2.28 (dd, J = 5.0, 12.9 Hz, 1 H), 2.25  2.20 (m, 1 H), 2.19  2.15 (m, 1 H), 2.09 
(dd, J = 2.6, 12.9 Hz, 1 H), 1.96  1.88 (m, 1 H), 1.87  1.80 (m, 1 H), 1.76  1.68 (m, 1 
H), 1.54 – 1.46 (m, 1 H); 13C NMR (125 MHz, CDCl3)  δ  209.37, 138.32, 128.55, 128.03, 
127.81, 98.86, 89.41, 74.65, 73.03, 70.59, 60.16, 59.62, 58.04, 56.22, 51.01, 48.70, 41.42, 
29.85, 28.86, 24.08, 21.61; HRMS (ES) m/z 634.1599  [(M+H)+; calcd  for 




2.33: A solution of 2.39 (5.0mg, 0.013mmol) in EtOH (4.0mL) was treated with Raney 
Ni and stirred at 50 oC under H2(g) (1atm) for 24h. Then the mixture was filtered through 
celite and concentrated in vacuo. Flash chromatography (MeOH/CH2Cl2/triethylamine = 
1/9/0.5) afforded diol 2.33 (3.5mg, 91%) as a pale yellow oil: []25D =  (c 0.50, 
CH2Cl2);  1H NMR (500MHz ,CDCl3)  = 4.74 (d, J = 6.9 Hz, 1 H), 4.66 (d, J = 6.9 Hz, 1 
H), 4.53 (s, 1 H), 3.73 (qd, J = 5.5, 11.2 Hz, 1 H), 3.65 - 3.58 (m, 1 H), 3.47 – 3.43 (m, 1 
H), 3.45 (s, 3 H), 3.24 (d, J = 9.7 Hz, 1 H), 3.00 (dd, J = 4.9, 9.6 Hz, 1 H), 2.87 (dt, J = 
4.1, 8.6 Hz, 1 H), 2.73  2.61 (m, 2 H), 2.46 (t, J = 5.8 Hz, 1 H), 2.44  2.39 (m, 1 H), 
2.37 (dd, J = 5.0, 17.0 Hz, 1H), 2.34  2.28 (m, 1 H), 2.16 (dd, J = 2.9, 13.4 Hz, 1 H), 
2.01  1.94 (m, 1 H), 1.89 (d, J = 15.1 Hz, 1 H), 1.88 - 1.81 (m, 1 H), 1.79  1.69 (m, 1 
H), 1.58 (tdd, J = 4.8, 9.7, 14.5 Hz, 1 H), 1.54  1.45 (m, 1 H); 13C NMR (125 MHz, 
CDCl3)   δ  213.77, 98.92, 90.63, 72.65, 61.09, 58.95, 56.31, 53.02, 50.54, 48.74, 38.54, 
33.68, 30.64, 29.12, 21.57; HRMS (ES) m/z 634.1599  [(M+H)+; calcd  for 
C29H41NO3S3Na:  634.1588]. 
 
2.15: To a solution of 2.33 (4.0mg, 0.013mmol) in CH2Cl2 (0.50mL) were added 4Å MS 
(4.0mg) and NMO (2.0mg, 0.017mmol). After 5 min, TPAP was treated to the reaction 
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mixture. After 1 h, the reaction mixture was treated with additional NMO (1.6mg, 
0.013mmol) and stirred for 1h. Then the reaction mixture was filtered through celite and 
concentrated in vacuo. Flash chromatography (EtOAc/hexane/triethylamine = 3/7/0.2) 
afforded diol 2.33 (3.1mg, 75%) as a pale yellow oil: 1H NMR (500MHz ,CDCl3)  = 
4.77 (d, J = 6.8 Hz, 1 H), 4.65 (d, J = 6.8 Hz, 1 H), 3.68 (d, J = 9.1Hz, 1 H), 3.60  3.56 
(m, 1 H), 3.51 (t, J = 10.5 Hz, 1 H), 3.38 (s, 3 H), 2.90 (dd, J = 9.5, 18.5 Hz, 1 H), 2.90 – 
2.87 (m, 1H), 2.78 (dd, J = 11.3, 18.5 Hz, 1 H), 2.58 (d, J = 18.5 Hz, 1 H), 2.50  2.43 (m, 
1 H), 2.43 – 2.37 (m, 2H), 2.28 – 2.23 (m, 1H), 2.12  2.09 (m, 1 H), 1.96  1.89 (m, 1 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 2-2-1: X-ray Structure Determination of Compound 2.18 
   Compound 2.18, C13H21NO4, crystallizes in the orthorhombic space group P212121 (systematic 
absences h00:  h=odd, 0k0:  k=odd, and 00l:  l=odd) with a=8.4095(10)Å, b=9.5036(11)Å, 
c=15.7044(17)Å, V=1255.1(2)Å3, Z=4, and dcalc=1.351 g/cm3 . X-ray intensity data were collected 
on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 3889 frames were collected 
with a crystal to detector distance of 45.047 mm, rotation widths of 0.5° and exposures of 15 
seconds:  
 
scan type     frames 
 -25.50 321.01 14.21 32.61 739 
 -15.50 227.27 278.96 253.93 739 
 -25.50 22.70 157.76 -33.72 107 
 19.50 51.06 16.57 -58.65 80 
 19.50 274.52 36.71 32.61 241 
 -13.00 333.28 212.59 -39.24 242 
 -28.00 340.03 328.61 -63.64 739 
 27.00 341.68 145.93 89.24 103 
 -23.00 191.40 91.29 96.28 681 
 -13.00 318.59 96.10 99.72 704 
   Rotation frames were integrated using SAINT1, producing a listing of unaveraged F2 and (F2) 
values which were then passed to the SHELXTL2 program package for further processing and 
structure solution. A total of 31873 reflections were measured over the ranges 2.50  25.35°, 
-10  h  10, -11  k  11, -18  l  18 yielding 2305 unique reflections (Rint = 0.0216). The 
intensity data were corrected for Lorentz and polarization effects and for absorption using 
SADABS3 (minimum and maximum transmission 0.7084, 0.7452). 
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   The structure was solved by direct methods (SHELXS-974). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ (0.0348P)2 + 0.2852P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0258 and wR2=0.0647 for 2255 observed reflections for 
which F > 4(F) and R1=0.0264 and wR2=0.0651 and GOF =1.050 for all 2305 unique, non-zero 
reflections and 166 variables.6 The maximum  in the final cycle of least squares was 0.000 
and the two most prominent peaks in the final difference Fourier were +0.157 and -0.132 e/Å3. 
   Table A-2-2-1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables A-2-2-2. and A-2-2-3.  
Anisotropic thermal parameters are in Table A-2-2-4.  Tables 5. and 6. list bond distances and 
bond angles.  Figure A-2-2-1. is an ORTEP7 representation of the molecule with 30% probability 








Figure A 2-2-1: ORTEP Drawing of 2.18 with 30% Probability Thermal Ellipsoids 
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Table A 2-2-1.  Summary of Structure Determination of Compound 2.18 
Empirical formula  C13H21NO4 
Formula weight  255.31 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121  
Cell constants:   
a  8.4095(10) Å 
b  9.5036(11) Å 
c  15.7044(17) Å 
Volume 1255.1(2) Å3 
Z 4 
Density (calculated) 1.351 Mg/m3 
Absorption coefficient 0.099 mm-1 
F(000) 552 
Crystal size 0.35 x 0.12 x 0.08 mm3 
Theta range for data collection 2.50 to 25.35° 
Index ranges -10  h  10, -11  k  11, -18  l  18 
Reflections collected 31873 
Independent reflections 2305 [R(int) = 0.0216] 
Completeness to theta = 25.35° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.7084 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2305 / 0 / 166 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0258, wR2 = 0.0647 
R indices (all data) R1 = 0.0264, wR2 = 0.0651 
Absolute structure parameter 0.0(8) 
Largest diff. peak and hole 0.157 and -0.132 e.Å-3 
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Table A 2-2-2. Refined Positional Parameters for Compound 2.18 
 
  Atom x y z Ueq, Å2 
C1 0.86815(15) 0.48293(14) 0.43291(9) 0.0272(3) 
C2 0.89787(15) 0.56438(14) 0.51591(10) 0.0304(3) 
C3 0.74164(16) 0.55352(14) 0.56631(9) 0.0263(3) 
C4 0.62086(15) 0.52361(12) 0.49663(7) 0.0187(2) 
C5 0.46055(14) 0.46333(12) 0.52274(7) 0.0184(2) 
C6 0.36708(14) 0.40838(12) 0.44502(7) 0.0183(2) 
C7 0.47031(14) 0.30479(12) 0.39573(8) 0.0194(2) 
C8 0.62335(15) 0.37769(12) 0.36650(7) 0.0195(2) 
C9 0.58141(15) 0.49666(13) 0.30389(7) 0.0224(3) 
C10 0.44866(16) 0.59278(13) 0.33299(7) 0.0219(3) 
C11 0.31699(15) 0.52939(13) 0.38614(8) 0.0207(3) 
C12 0.30811(18) 0.53910(17) 0.64385(9) 0.0331(3) 
C13 0.4634(2) 0.68809(18) 0.72903(9) 0.0417(4) 
N1 0.70840(11) 0.42191(10) 0.44380(6) 0.0191(2) 
O1 0.22243(9) 0.34508(9) 0.47244(6) 0.0245(2) 
O2 0.44301(14) 0.71443(10) 0.31004(6) 0.0346(3) 
O3 0.37213(11) 0.57254(9) 0.56398(5) 0.0246(2) 
O4 0.42028(14) 0.54639(11) 0.70944(6) 0.0389(3) 







Table A 2-2-3. Positional Parameters for Hydrogens in Compound 2.18 
 
  Atom x y z Uiso, Å2 
H1a 0.8711 0.5455 0.3842 0.036 
H1b 0.9471 0.4097 0.4252 0.036 
H2a 0.9234 0.6619 0.5039 0.040 
H2b 0.9849 0.5228 0.5476 0.040 
H3a 0.7456 0.4775 0.6074 0.035 
H3b 0.7178 0.6409 0.5956 0.035 
H4 0.6035 0.6097 0.4636 0.025 
H5 0.4774 0.3858 0.5629 0.024 
H7a 0.4124 0.2701 0.3466 0.026 
H7b 0.4964 0.2251 0.4317 0.026 
H8 0.6891 0.3085 0.3365 0.026 
H9a 0.6759 0.5530 0.2942 0.030 
H9b 0.5513 0.4550 0.2499 0.030 
H11a 0.2347 0.4952 0.3481 0.028 
H11b 0.2705 0.6033 0.4207 0.028 
H12a 0.2216 0.6034 0.6563 0.044 
H12b 0.2644 0.4447 0.6418 0.044 
H13a 0.4940 0.7359 0.6777 0.063 
H13b 0.5510 0.6881 0.7683 0.063 
H13c 0.3743 0.7355 0.7543 0.063 




Table A 2-2-4.   Refined Thermal Parameters (U's) for Compound 2.18 
 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0172(6) 0.0291(7) 0.0353(7) 0.0034(6) 0.0013(5) -0.0029(5) 
C2 0.0211(6) 0.0229(6) 0.0472(8) -0.0032(6) -0.0066(6) -0.0022(5) 
C3 0.0255(6) 0.0248(6) 0.0286(6) -0.0031(5) -0.0059(6) -0.0024(5) 
C4 0.0201(6) 0.0157(5) 0.0204(6) 0.0010(5) -0.0017(5) 0.0006(5) 
C5 0.0195(6) 0.0184(5) 0.0173(5) 0.0015(4) 0.0004(5) 0.0033(5) 
C6 0.0157(5) 0.0181(5) 0.0211(6) 0.0031(5) 0.0003(5) -0.0009(5) 
C7 0.0201(6) 0.0164(5) 0.0216(5) -0.0002(4) -0.0029(5) -0.0007(5) 
C8 0.0204(6) 0.0177(6) 0.0203(6) -0.0019(5) 0.0031(5) 0.0023(5) 
C9 0.0262(6) 0.0226(6) 0.0185(5) 0.0003(5) 0.0027(5) -0.0010(5) 
C10 0.0297(7) 0.0208(6) 0.0151(5) 0.0022(5) -0.0030(5) 0.0012(5) 
C11 0.0195(6) 0.0209(6) 0.0217(6) 0.0008(5) -0.0028(5) 0.0039(5) 
C12 0.0327(7) 0.0378(8) 0.0287(7) -0.0040(6) 0.0129(6) -0.0034(6) 
C13 0.0507(10) 0.0468(9) 0.0274(7) -0.0059(6) -0.0074(7) 0.0027(8) 
N1 0.0143(5) 0.0194(5) 0.0236(5) 0.0002(4) -0.0001(4) -0.0001(4) 
O1 0.0160(4) 0.0217(4) 0.0358(5) 0.0073(4) 0.0019(4) -0.0003(4) 
O2 0.0489(6) 0.0234(5) 0.0316(5) 0.0096(4) 0.0074(5) 0.0058(5) 
O3 0.0269(5) 0.0265(5) 0.0205(4) -0.0014(4) 0.0038(4) 0.0061(4) 
O4 0.0569(7) 0.0374(6) 0.0225(5) 0.0042(4) 0.0028(5) 0.0069(5) 








  Table A 2-2-5. Bond Distances in Compound 2.18, Å 
C1-N1  1.4732(16) C1-C2  1.5364(19) C2-C3  1.5373(19) 
C3-C4  1.5198(17) C4-N1  1.4712(15) C4-C5  1.5212(16) 
C5-O3  1.4316(14) C5-C6  1.5429(16) C6-O1  1.4237(14) 
C6-C7  1.5238(16) C6-C11  1.5346(16) C7-C8  1.5320(17) 
C8-N1  1.4703(16) C8-C9  1.5394(16) C9-C10  1.5132(18) 
C10-O2  1.2119(16) C10-C11  1.5118(18) C12-O4  1.3984(18) 
C12-O3  1.4015(16) C13-O4  1.428(2)   
Table A 2-2-6. Bond Angles in Compound 2.18, ° 
N1-C1-C2 104.37(10) C1-C2-C3 105.30(10) C4-C3-C2 102.30(10) 
N1-C4-C3 101.22(10) N1-C4-C5 110.37(9) C3-C4-C5 117.95(10) 
O3-C5-C4 108.02(9) O3-C5-C6 109.79(9) C4-C5-C6 111.45(9) 
O1-C6-C7 111.55(10) O1-C6-C11 105.33(9) C7-C6-C11 109.54(9) 
O1-C6-C5 109.82(9) C7-C6-C5 109.29(9) C11-C6-C5 111.28(9) 
C6-C7-C8 109.79(9) N1-C8-C7 106.89(9) N1-C8-C9 115.40(10) 
C7-C8-C9 109.33(10) C10-C9-C8 114.80(10) O2-C10-C11 121.04(12) 
O2-C10-C9 121.00(12) C11-C10-C9 117.81(10) C10-C11-C6 115.48(10) 
O4-C12-O3 112.89(11) C8-N1-C4 114.20(9) C8-N1-C1 117.41(10) 
C4-N1-C1 105.26(10) C12-O3-C5 116.10(10) C12-O4-C13 112.14(11)  
References: 
1Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
2Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
3Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
4Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
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5Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
6R1 = ||Fo| - |Fc|| /  |Fo| 
wR2 = [w(Fo2 - Fc2)2/w(Fo2)2]½ 
GOF = [w(Fo2 - Fc2)2/(n - p)]½ 
where n = the number of reflections and p = the number of parameters refined. 
7“ORTEP-II:  A  Fortran  Thermal  Ellipsoid  Plot  Program  for  Crystal  Structure  Illustrations”.  C.K.  




Part 3:  Facile Access to Diverse Carbobicyclic Systems via  
                 Type II Anion Relay Chemistry (ARC) 
3-1: Introduction of Anion Relay Chemistry (ARC) 
   Over the past few years, the Smith Laboratory has designed and developed various bi-
functional linchpins for Type II Anion Relay Chemistry (ARC)1. In particular, the Smith 
group has demonstrated that the ARC tactic holds great utility to access structurally 
complex, biologically active natural2 and unnatural products3 with high efficiency. Of 
further significance, the ARC tactic yields terminal sp2 carbon anions amenable to either 
alkylation or Pd-catalyzed cross-coupling reactions (CCR).1c Recently, the Smith group 
also developed a unified reaction manifold of ARC with the Takeda and Hiyama cross-
coupling reactions, in turn identifying a competent silicon-based   “transfer   agent”   for  
intermolecular cross-coupling reactions of aryl and alkenyl organolithium reagents.4  
 
   To expand the utility of ARC, I recognized that our previous effort on expanding the 
scope of ARC has been focused on generating linear complex molecules such as 
polyketides. Because the scope of the initial nucleophiles is currently limited to alkyl 
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lithiums, alkyl cuprates and dithiane anions, the newly generated anion after the Brook 
rearrangement can only be trapped by an external electrophile yielding linear multi-
component products (5 and 10). 
3-2: Development of One-Pot Strategy to Diverse Fused Cyclic Systems  
        via Type II ARC 
   In order to construct cyclic systems utilizing Type I and Type II ARC, two possible 
strategies were envisioned (Scheme 3-2). For the Type I ARC case, the electrophile must 
contain a second electrophilic carbon to trap the newly generated anion after the Brook 
rearrangement. For the Type II ARC case, the initial nucleophile should contain latent 
electrophilic carbon center, which should be unreactive over the reaction course of 
linchpin attack and Brook rearrangement, that in turn would form C-C bonds with the 
newly generated anion after Brook rearrangement. 
 
   Toward this end, I envisioned an enolate as the initial nucleophile which would 
comprise a latent carbonyl carbon for an aldol reaction leading to a cyclized product that 
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might arise via Aldol-Brook-Cyclization cascade (Scheme 3-3). There are however two 
possible competing reaction pathways in this process; retro-aldol and elimination 
reactions. To effect this cascade reaction, precise control of Aldol/Retro-Aldol and 
Brook/Retro-Brook rearrangement would be critical. Based on the possible reaction 
pathways, the first goal would be to investigate the reaction conditions where both the 
Brook rearrangement and cyclization reactions are faster than competing retro-Aldol and 
elimination reactions, respectively. 
 
   In the Smith Laboratory, the counter cation, solvent and temperature conditions that 
trigger the Brook rearrangement on TBS-dithiane linchpins have been extensively 
studied.1 Therefore, my initial investigation for the proposed cascade reaction began with 
bifunctional linchpin 19, embodied with a dithiane as an anion stabilizing group (ASG). 
To facilitate the Brook rearrangement and cyclization reaction cascade, a cyclic enolate, 
of which geometry is locked in E-form, was employed to furnish bicyclic systems 
containing three adjacent stereocenters and orthogonally protected functional groups 
which in the end would comprise a useful scaffold for natural product synthesis and 




3-3: Discovery of an Aldol-Brook -Cyclization Cascade Reaction 
   Initially, we investigated a cascade reaction that would permit the cyclized product to 
arise from cyclopentenone, based on an L-selectride-mediated reductive aldol reaction.  
Knowing that Brook rearrangement does not occur in Et2O (i.e., is blocked), THF was 
used as a solvent in which the Brook rearrangement is anticipated to occur around 30 oC. 
Initially, I found the reaction furnished a complex mixture containing starting materials 
(Table 3-1, entry 1). Next, to trigger the Brook rearrangement at low temperature, HMPA 
was added after the addition of linchpin aldehyde 3.19 (Table 3-1, entry 2). Again, a 
complex mixture containing starting materials resulted. From these two experiments, we 
presumed that that retro-aldol reaction was faster than Brook rearrangement in polar 
solvent. Next, the cascade reaction was investigated in Et2O. Addition of the bifunctional 
linchpin 3.19 to lithium enolate generated from cyclopentenone via L-selectride in Et2O 
provided the aldol adduct at 78 oC in 30 min. We found that both the retro-aldol and 
Brook rearrangement did not occur over 5 h under these conditions. Recognizing that the 
Brook rearrangement can be triggered by cation exchange, KOtBu was added after 
completion of the aldol reaction in Et2O. Again, after extensive optimizations, we 
discovered that the cyclization occurred as soon as the Brook rearrangement was 
triggered by the K+ ion (ca, at around –30 oC), by the addition of a catalytic amount of 
KOtBu (0.25 equiv) and THF (half the amount of Et2O used), while the reaction warmed 
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to 0 oC for 2h. Pleasingly, the desired diquinane skeleton 3.23 was obtained in 56% yield 
after silica gel chromatography (Table 3-1 entry 5).  
 
3-4: One-step Synthesis of Diverse Functionalized Bicyclic Compounds 
   After optimizing the conditions for the above cascade reaction, the versatility of the 
reaction was investigated (Table3-2). Cascade reactions with cyclohexenone and 3-
methyl-cyclopentenone furnished hydrindane 3.24 (77%) and diquinane 3.25 (41%) 
respectively. Not surprisingly, the cascade reaction was successfully accomplished with 
enolates generated by LiHMDS to provide tricyclic core 3.26 in 81% and the unsaturated 
hydrindane core 3.28 in 61% respectively, from norcamphor and cyclohexenone, 
respectively. The hydroazulene (bicyclo[5,3,0]decane) skeleton 3.29 could also be 
obtained from cycloheptanone in 59% (dr ca. 5:2). Equally interesting, 
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The ketones, 2-methyl-cyclopentenone and 1-indanone however did not participate 
effectively in this cascade reaction under these conditions. Presumably the retro-aldol 
reaction dominates in both cases, due to the steric hindrance at the quaternary center and 




3-5: Stereoselectivity in the Reductive Aldol-Brook-Cyclization Cascade 
   The stereoselectivity observed in the sequential aldol and cyclization reactions is 
proposed in Scheme 3-5 based on the result and analysis of the reaction intermediates 
obtained by quenching the reaction at different temperatures: Brook rearrangement and 
cyclization occurs around  30 oC after the addition of KOtBu and THF. First, the aldol 
reaction with the enolates derived from cyclopentanone and cyclohexanone would 
generate threo aldol adduct 3.34-threo via the preferred chelated transition state 3.33-
threo, assuming a Zimmerman-Traxler model.5 Threo aldol adduct would then undergo 
















attack the carbonyl carbon stereoselectively from the more accessible Si face to furnish 
the cis-fused bicyclic system 3.36. However, the minor erythro aldol adduct 3.34-erythro, 
after cation exchange, might not undergo fast cyclization due to the steric perturbation of 
the pseudo axial TBS ether moiety in cyclization transition state 3.35C. As a result, in 
spite of incomplete diastereoselectivity in the aldol reaction (cyclopentenone enolate ca. 
6:1, cyclohexenone enolate ca. 10:1), only the cis-isomer was observed in diquinane and 
hydrindane systems. Not surprisingly, two diastereomers were observed in hydroazulene 
system. First, lower diastereoselection in the aldol reaction with the cycloheptanone 
enolate would be the reason for the result. Within the context of the diastereoisomeric 
chair transition states illustrated in Figure 3-1, the pseudo-1,3-diaxial interaction between 
the R group and endocyclic methylene moieties might decrease due to a slight increase of 
dihedral angle as the ring size increases from five to eight. On the other hand, the gauche-
interaction in the favored transition state might increase as the ring size increases. Also 









cyclization transition state, which in turn might allow fast cyclization after cation 
exchange to furnish both diastereomers. 
   In the case of cyclooctanone, diastereoselection was found to be more complex. Due to 
the flexible conformation of the cyclooctanone ring, a trans-fused ring system could be 
formed. Indeed all four possible diastereomers of bicyclo[6,3,0]undecane core were 
observed in the NMR spectrum (dr, ca. 28:7:4:1). Based on conformational analysis 
studies on cycloctane,6 the proposed transition states for the aldol and cyclization 
reactions are depicted in Figure 3-2.   
 
Among the four diastereomers, two isomers could be purified by careful chromatography 
respectively in 50% and 12% yields. The stereochemistry of the major diastereomer was 




3-6: Specific Examples of Natural Products Accessible via Aldol-Brook-
Cyclization Cascade Reaction 
   Fused carbobicyclic systems are prevalent in natural products, such as diquinane (or 
bicycle[3,3,0]octane), hydrindane (or bicycle[4,3,0]nonane) and hydroazulene (or 
bicycle[5,3,0]decane) cores.7 Among these bicyclic natural products, cis-fused cyclic 
products with an angular hydroxyl group are quite common. For example, 9(12)-
capnellene-8,10-diol,8 barbacenic acid,9 africanol,10  and fusicogigantone B11 have 
these structural and functional features in common with the Aldol-Brook-Cyclization 












Moreover, the additional substituents in these natural products can be readily accessible 
by simple modification of the dithiane group. Thus the Aldol-Brook-Cyclization cascade 
reaction tactic holds considerable promise for the future access to these important natural 
products. 
3-7 Summary 
   In summary, a successful Aldol-Brook-Cyclization cascade reaction has been 
discovered and validated, thereby expending the scope of Type II Anion Relay Chemistry 
(ARC).  
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3-9: Experimental Section 
3-9-1: Materials and Methods 
   Reactions were carried out in oven or flame-dried glassware under an argon atmosphere, 
unless otherwise noted. All solvents were reagent grade. Diethyl ether and THF were 
obtained from a Pure Solve TM PS-400. Reactions were magnetically stirred and 
monitored by thin layer chromatography (TLC) with 0.25 mm E. Merck precoated silica 
gel plates. In aqueous work-up, all organic solutions were dried over sodium sulfate or 
magnesium sulfate, and filtered prior to rotary evaporation at water aspirator pressure. 
Flash chromatography was performed with silica gel 60 (particle size 0.040 – 0.062 mm) 
supplied by Silicycle and Sorbent Technologies. Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated. Infrared spectra were 
recorded on a Perkin-Elmer Model 283B spectrophotometer or a Jasco Model FT/IR-480 
Plus spectrometer. 1H and 13C NMR spectra were recorded on a Bruker AMX-500 
spectrometer.  Chemical  shifts  are  reported  as  δ  values  relative  to  the  internal  chloroform  
(δ  7.26 ppm for 1H  and  δ  77.16  ppm  for  13C). Optical rotations were measured on a Jasco 
Perkin-Elmer model 241 polarimeter. High resolution mass spectra were measured at the 
University of Pennsylvania Mass Spectrometry Service Center on either a VG Micromass 
70/70 H or VG ZAB-E spectrometer. 
3-9-2: Experimental Procedures 
3-9-2-1: General procedure for Reductive Aldol-Brook-Cyclization Cascade 





3.38: To a solution of cyclic enone (0.20mmol, 1.0equiv) in Et2O (3.0mL) was added 
1.0M solution of L-selectride (0.21mL, 0.21mmo, 1.05equiv) dropwise at – 78 oC. After 
15 min, aldehyde linchpin 19 (0.19mmol, 0.90 equiv) in Et2O (3.0mL) was added via 
cannula at – 78 oC. After 1h, 1.0M solution of KOtBu (0.05mL, 0.050mmol, 0.25 equiv) 
was added, then THF (3.0mL) was added. The reaction was warmed slowly to room 
temperature for 2h. The reaction was quenched with saturated aqueous NH4Cl and 
extracted with Et2O (5mL x 3). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. Flash column chromatography (hexane:EtOAc = 8:1 
to 4:1) on silica gel provided bicyclic compound 3.38. 
 
3.23: Following the general procedure cyclopentenone (15mg, 0.18 mmol), linchpin 3.19 
(48mg, 0.17mmol) afforded 3.23 (35mg, 0.097mmol, 56% yield) as a pale yellow oil: 1H 
NMR (500 MHz, CDCl3)  δ  4.49 (td, J = 9.5, 6.5 Hz, 1H), 3.17 – 3.11 (m, 1H), 3.01 – 
2.96 (m, 1H), 2.85 – 2.76 (m, 2H), 2.60 (ddd, J = 13.5, 6.5, 1.0 Hz, 1H), 2.47 (s, 1H), 
2.42 – 2.38 (m, 1H), 2.02 – 1.97 (m, 2H), 1.96 – 1.80 (m, 4H), 1.78 – 1.70 (m, 3H), 0.87 
(s, 9H), 0.030 (s, 3H), 0.027 (s, 3H); 13C NMR (125 MHz, CDCl3)  δ  96.29, 68.60, 59.79, 
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55.45, 48.30, 39.43, 28.26, 27.61, 26.19, 26.00, 25.96, 25.45, 18.28, 4.71, 4.86; HRMS 
(ES) m/z 361.1689  [(M+H)+; calcd for C17H33O2S2Si:  361.1691]. 
 
3.24: Following the general procedure cyclohexenone (5.5mg, 0.057 mmol), linchpin 
3.19 (14mg, 0.052mmol) afforded 3.24 (15mg, 0.040mmol, 77% yield) as a white sold: 
1H NMR (500 MHz, CDCl3)  δ  4.26 (td, J = 9.5, 6.5 Hz, 1H), 3.18 – 3.12 (m, 1H), 3.07 – 
3.02 (m, 1H), 2.85 – 2.76 (m, 2H), 2.87 (dd, J = 14.5, 8.0 Hz, 1H), 2.81 – 2.71 (m, 2H), 
2.42 – 2.39 (m, 1H), 2.26 (s, 1H), 2.02 – 1.93 (m, 3H), 1.94 (dd, J = 14.5, 5.0 Hz, 1H), 
1.71 – 1.52 (m, 6H), 1.48 – 1.43 (m, 1H), 0.87 (s, 9H), 0.031 (s, 3H), 0.028 (s, 3H); 13C 
NMR (125 MHz, CDCl3)  δ  83.64, 7.86, 61.92, 51.01, 45.59, 32.72, 28.50, 27.17, 26.03, 
25.31, 22.97, 22.17, 21.39, 18.13,  4.46, 4.81; HRMS (ES) m/z 375.1856  [(M+H)+; 
calcd for C18H35O2S2Si:  375.1848]. 
 
3.25: Following the general procedure cyclohexenone (9.6mg, 0.10 mmol), linchpin 3.19 
(25mg, 0.091mmol) afforded 3.25 (14mg, 0.037mmol, 77% yield) as a white solid: 1H 
NMR (500 MHz, CDCl3)  δ  4.60 (td, J = 10, 6.0 Hz, 1H), 3.17 – 3.12 (m, 1H), 3.00 – 2.95 
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(m, 1H), 2.82 – 2.72 (m, 2H), 2.60 (ddd, J = 13.0, 6.0, 1.0 Hz, 1H), 2.46 (s, 1H), 2.28 – 
2.21 (m, 1H), 2.02 – 1.95 (m, 2H), 1.92 – 1.80 (m, 5H), 1.53 – 1.47 (m, 1H), 1.05 (d, J= 
6.5Hz, 3H), 0.88 (s, 9H), 0.054 (s, 3H), 0.047 (s, 3H); 13C NMR (125 MHz, CDCl3)  δ  
96.61, 68.64, 63.06, 59.45, 47.80, 39.59, 35.42, 34.46, 28.30, 27.53, 25.98, 25.49, 21.16, 
18.26, 4.72, 4.83; HRMS (ES) m/z 375.1856  [(M+H)+; calcd for C18H35O2S2Si:  
375.1848] 
3-9-2-2: General procedure for Aldol-Brook-Cyclization Cascade Reaction: 




3.38: To a solution of cyclic ketone (0.20mmol, 1.0equiv) in Et2O (3.0mL) was added 
1.0M solution of LiHMDS or LDA (0.21mL, 0.21mmol, 1.05equiv) dropwise at – 78 oC. 
After 15 min, aldehyde linchpin 19 (0.19mmol, 0.90 equiv) in Et2O (3.0mL) was added 
via cannula at – 78 oC. After 1h, 1.0M solution of KOtBu (0.05mL, 0.050mmol, 0.25 
equiv) was added, then THF (3.0mL) was added. The reaction was warmed slowly to 
room temperature for 2h. The reaction was quenched with saturated aqueous NH4Cl and 
extracted with Et2O (5mL x 3). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. Flash column chromatography (hexane:EtOAc = 8:1 




3.26: Following the general procedure norcamphor (44mg, 0.40 mmol), linchpin 3.19 
(92mg, 0.33mmol) afforded 3.26 (104mg, 0.27mmol, 81% yield) as a crystalline solid : 
m.p. 98~ 100 oC; 1H NMR (500 MHz, CDCl3)  δ  4.56 (ddd, J = 10.5, 8.5, 7.5 Hz, 1H), 
3.16 (ddd, J = 13.5, 9.5, 3.5 Hz,  1H), 2.95 (ddd, J = 14.0, 9.0, 2.0 Hz,  1H), 2.79 – 2.70 
(m, 2H), 2.68 (d, J = 3.5 Hz, 1H), 2.64 (dd, J = 14.0,  7.0 Hz, 1H), 2.47 (d, J = 4.5 Hz, 
1H), 2.03 – 1.95 (m, 4H), 1.76 (dd, J = 8.0,  2.0 Hz, 1H), 1.73 – 1.68 (m, 1H), 1.63 – 1.58 
(m, 1H), 1.43 – 1.36 (m, 1H), 1.30 – 1.23 (m, 3H), 0.88 (s, 9H), 0.033 (s, 3H), 0.026 (s, 
3H); 13C NMR (125 MHz, CDCl3)   δ   93.09, 70.50, 62.10, 61.39, 52.54, 45.33, 38.27, 
37.02, 29.69, 28.79, 27.72, 26.01, 25.20, 24.42, 18.30, 4.65, 4.76; HRMS (ES) m/z 
387.1846  [(M+H)+; calcd for C19H35O2S2Si:  387.1848] 
 
3.28: Following the general procedure cyclohexenone (12mg, 0.13 mmol), linchpin 3.19 
(31mg, 0.11mmol) afforded 3.28 (25mg, 0.066mmol, 61% yield) as a crystalline solid: 
m.p. 72~ 74 oC; 1H NMR (500 MHz, CDCl3)  δ  6.07 – 6.04 (m, 1H), 5.98  5.95 (m, 1H), 
4.56 (q, J = 8.0 Hz, 1H), 3.13 (q, J = 6.5 Hz,  1H), 3.07 (ddd, J = 14.5, 8.5, 3.5 Hz,  1H), 
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2.78 (ddd, J = 14.0, 7.0, 3.5 Hz,  1H), 2.72 (ddd, J = 14.5, 7.5, 3.5 Hz,  1H), 2.59 (dd, J = 
13.5,  7.5 Hz, 1H), 2.58 (s, 1H), 2.50 – 2.46 (m, 1H), 2.30 – 2.23 (m, 1H), 2.03 – 1.91 (m, 
5H), 1.74 – 1.67 (m, 1H), 0.88 (s, 9H), 0.045 (s, 3H), 0.036 (s, 3H); 13C NMR (125 MHz, 
CDCl3)  δ  132.81, 128.00, 81.73, 70.85, 61.00, 49.53, 47.89, 28.27, 27.71, 25.97, 25.08, 
23.75, 20.22, 18.20, 4.59, 4.91; HRMS (ES) m/z 373.1690  [(M+H)+; calcd for 
C18H33O2S2Si:  373.1691] 
                           
3.28: Following the general procedure cycloheptanone (11mg, 0.098mmol), linchpin 3.40 
(24mg, 0.88mmol) afforded 3.29 (25mg, 0.049mmol, 59% yield) as a mixture of 
diastereomers (ca. 5:2) 1H NMR (500 MHz, CDCl3)  δ  4.26 (td, J = 6.9, 4.9 Hz, 0.71H), 
4.01 (dt, J = 9.3, 6.1 Hz, 0.29H), 3.18 –2.91 (m, 2H), 2.88 – 2.79 (m, 2H), 2.81 (s, 0.71H), 
2.78 – 2.6 (m, 1H), 2.55 – 2.46 (m, 1.29H), 2.38 – 2.29 (m, 1H), 2.26 – 2.19 (m, 1H), 
2.13 – 2.01 (m, 1.29H), 2.07 (dd, J= 13.9, 4.8 Hz, 0.79H), 2.01 – 1.80 (m, 4H), 1.75 – 
1.64 (m, 2H), 1.58 – 1.47 (m, 1H), 1.37 – 1.22 (m, 2H), 0.95 (t, J= 8.0 Hz, 7.4H), 0.94 (t, 
J= 8.0 Hz, 1.6H), 0.58 (q, J= 8.0 Hz, 6H); HRMS (ES) m/z 389.2002  [(M+H)+; calcd for 





3.30.1 and 3.30.2: Following the general procedure cyclooxtanone (15mg, 0.12 mmol), 
linchpin 3.40 (30mg, 0.11mmol) afforded 3.30.1 (22mg, 0.053mmol, 50% yield) as a 
white solid and 3.30.2 (5.1mg, 0.013mmol, 12%) as pale yellow oil. 
3.30.1 : 1H NMR (500 MHz, CDCl3)  δ  4.03 (td, J = 6.0, 3.5 Hz, 1H), 3.15 (s, 1H), 2.93 – 
2.87 (m, 3H), 2.76 (dt, J= 15, 4.8, 1H), 2.68 (dd, J = 13.5, 6.0 Hz, 1H), 2.46 (dd, J = 13.5, 
6.0 Hz, 1H),  2.12 – 2.05 (m, 1H), 2.05 – 2.01 (m, 2H), 1.97 – 1.93 (m, 1H), 1.93 – 1.67 
(m, 5H), 1.67 – 1.61 (m, 1H), 1.57 – 1.52 (m, 1H), 1.50 – 1.42 (m, 2H), 1.39 – 1.27 (m, 
2H), ), 0.96 (t, J= 8.0 Hz, 9H), 0.61 (q, J= 8.0 Hz, 6H); 13C NMR (125 MHz, CDCl3)  δ  
86.36, 81.95, 66.08, 59.20, 48.03, 32.63, 31.69, 29.28, 28.22, 27.31, 26.16, 25.62, 25.48, 
24.09, 6.92, 4.91; HRMS (ES) m/z 403.2160  [(M+H)+; calcd for C20H39O2S2Si:  
403.2161]. 
3.30.2: 1H NMR (500 MHz, CDCl3)  δ  4.55 (q, J = 8.0 Hz, 1H), 3.07 – 2.81 (m, 4H), 2.63 
(dd, J= 14, 8.0, 1H), 2.51 (s, 1H), 2.43 (ddd, J = 15, 12, 2.8 Hz, 1H), 2.21 – 2.09 (m, 3H), 
2.04 – 1.93 (m, 2H), 1.89 – 1.84 (m, 1H), 1.83 – 1.76 (m, 3H), 1.74 – 1.69 (m, 1H), 1.68 
– 1.63 (m, 1H), 1.60 – 1.48 (m, 3H), 1.45 – 1.37 (m, 1H), 1.27 – 1.21 (m, 1H), 0.95 (t, J= 
8.0 Hz, 9H), 0.57 (q, J= 8.0 Hz, 6H); HRMS (ES) m/z 403.2160  [(M+H)+; calcd for 










































































































































































































































































































































































































































































































































































































































































































































































Appendix 3-2-1: X-ray Structure Determination of Compound 3.26 
   Compound 3.26, C19H34SiS2O2, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=7.3796(8)Å, b=18.508(2)Å, c=15.0590(14)Å, 
=95.686(4)°, V=2046.7(4)Å3, Z=4, and dcalc=1.255 g/cm3 . X-ray intensity data were collected on 
a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 100(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 2526 frames were collected 
with a crystal to detector distance of 37.6 mm, rotation widths of 0.5° and exposures of 20 
seconds:  
scan type     frames 
 -23.00 315.83 12.48 28.88 739 
 -8.00 320.02 26.46 55.93 184 
 -18.00 249.65 310.97 36.30 195 
 -13.00 344.60 17.33 -39.24 369 
 -23.00 334.21 38.95 73.66 739 
 19.50 59.55 348.71 -26.26 300 
   The crystal grew as a non-merohedral twin; the program CELL_NOW1 was used to index the 
diffraction images and to determine the twinning mechanism. The crystal was twinned by a 
rotation of 180° about the 100 direct direction.  Rotation frames were integrated using SAINT2, 
producing a listing of unaveraged F2 and (F2) values which were then passed to the SHELXTL3 
program package for further processing and structure solution. A total of 36185 reflections were 
measured over the ranges 1.75  25.38°, -8  h  8, 0  k  22, 0  l  18 yielding 4127 
unique reflections (Rint = 0.0288). The intensity data were corrected for Lorentz and polarization 
effects and for absorption using TWINABS4 (minimum and maximum transmission 0.6692, 
0.7452). The structure was solved by direct methods (SHELXS-975). Refinement was by full-
matrix least squares based on F2 using SHELXL-97.6 All reflections were used during refinement. 
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The weighting scheme used was w=1/[2(Fo2 )+ (0.0373P)2 + 1.2417P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0248 and wR2=0.0771 for 4037 observed reflections for 
which F > 4(F) and R1=0.0257 and wR2=0.0775 and GOF =1.133 for all 4127 unique, non-zero 
reflections and 225 variables.7 The maximum  in the final cycle of least squares was 0.000 
and the two most prominent peaks in the final difference Fourier were +0.298 and -0.209 e/Å3.  
The twinning parameter refined to a value of 0.3901(9). 
   Table A 3-2-1-1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables A 3-2-1-2. and 3-2-1-3.  
Anisotropic thermal parameters are in Table A 3-2-1-4.  Tables A 3-2-1-5. and 3-2-1-6. list bond 
distances and bond angles.  Figure A 3-2-1. is an ORTEP8 representation of the molecule with 50% 










Figure A3-2-1. ORTEP Drawing of Compound 3.26 with 50% Probability Thermal Ellipsoids. 
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Table A 3-2-1-1.  Summary of Structure Determination of Compound 3.26 
Empirical formula  C19H34SiS2O2 
Formula weight  386.67 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/c      
Cell constants:   
a  7.3796(8) Å 
b  18.508(2) Å 
c  15.0590(14) Å 
 95.686(4)° 
Volume 2046.7(4) Å3 
Z 4 
Density (calculated) 1.255 Mg/m3 
Absorption coefficient 0.328 mm-1 
F(000) 840 
Crystal size 0.36 x 0.20 x 0.10 mm3 
Theta range for data collection 1.75 to 25.38° 
Index ranges -8  h  8, 0  k  22, 0  l  18 
Reflections collected 36185 
Independent reflections 4127 [R(int) = 0.0288] 
Completeness to theta = 25.39° 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6692 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4127 / 0 / 225 
Goodness-of-fit on F2 1.133 
Final R indices [I>2sigma(I)] R1 = 0.0248, wR2 = 0.0771 
R indices (all data) R1 = 0.0257, wR2 = 0.0775 
Largest diff. peak and hole 0.298 and -0.209 e.Å-3 
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Table A 3-2-2-2. Refined Positional Parameters for Compound 3.26 
  Atom x y z Ueq, Å2 
C1 0.5467(3) 0.40781(10) 0.14730(12) 0.0128(4) 
C2 0.3380(3) 0.41487(10) 0.14337(14) 0.0151(4) 
C3 0.2538(3) 0.33957(11) 0.12169(14) 0.0181(4) 
C4 0.2962(3) 0.29663(11) 0.20952(13) 0.0189(4) 
C5 0.4078(3) 0.35115(11) 0.26969(13) 0.0158(4) 
C6 0.5929(3) 0.35986(10) 0.23230(13) 0.0137(4) 
C7 0.3062(3) 0.42201(11) 0.24220(14) 0.0170(4) 
C8 0.7412(3) 0.40048(11) 0.29213(13) 0.0141(4) 
C9 0.7198(3) 0.47986(10) 0.26775(12) 0.0141(4) 
C10 0.6590(3) 0.48081(10) 0.16713(13) 0.0123(4) 
C11 0.6877(3) 0.62991(11) 0.16989(14) 0.0196(4) 
C12 0.8573(3) 0.62743(11) 0.12075(15) 0.0219(4) 
C13 0.9714(3) 0.55957(11) 0.13715(15) 0.0198(4) 
C14 0.7369(3) 0.24013(11) 0.42378(15) 0.0226(5) 
C15 1.0794(3) 0.33271(12) 0.44226(15) 0.0219(5) 
C16 0.7768(3) 0.36129(12) 0.56603(13) 0.0186(4) 
C17 0.5713(4) 0.35604(16) 0.57396(17) 0.0334(6) 
C18 0.8384(4) 0.43973(13) 0.58155(16) 0.0304(5) 
C19 0.8791(4) 0.31275(13) 0.63668(14) 0.0305(6) 
O1 0.7259(2) 0.39275(7) 0.38507(9) 0.0157(3) 
O2 0.6036(2) 0.37251(7) 0.07114(9) 0.0167(3) 
S1 0.52034(7) 0.56067(2) 0.13572(3) 0.01519(12) 
S2 0.85648(7) 0.47635(3) 0.10231(3) 0.01620(12) 
Si1 0.82950(8) 0.33181(3) 0.45197(3) 0.01266(12) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
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Table A 3-2-2-3. Positional Parameters for Hydrogens in Compound 3.26 
  Atom x y z Uiso, Å2 
H2 0.2860 0.4541 0.1052 0.020 
H3a 0.3094 0.3169 0.0730 0.024 
H3b 0.1235 0.3431 0.1057 0.024 
H4a 0.1852 0.2830 0.2348 0.025 
H4b 0.3665 0.2535 0.2001 0.025 
H5 0.4152 0.3402 0.3336 0.021 
H6 0.6387 0.3127 0.2153 0.018 
H7a 0.1783 0.4206 0.2520 0.023 
H7b 0.3639 0.4644 0.2703 0.023 
H8 0.8615 0.3837 0.2788 0.019 
H9a 0.8344 0.5053 0.2805 0.019 
H9b 0.6290 0.5025 0.3009 0.019 
H11a 0.6310 0.6769 0.1605 0.026 
H11b 0.7234 0.6248 0.2333 0.026 
H12a 0.9324 0.6690 0.1384 0.029 
H12b 0.8211 0.6315 0.0572 0.029 
H13a 1.0108 0.5563 0.2004 0.026 
H13b 1.0795 0.5642 0.1059 0.026 
H14a 0.6094 0.2390 0.4317 0.034 
H14b 0.8000 0.2050 0.4623 0.034 
H14c 0.7534 0.2291 0.3628 0.034 
H15a 1.1020 0.3174 0.3834 0.033 
H15b 1.1393 0.3004 0.4856 0.033 
H15c 1.1256 0.3808 0.4527 0.033 
H17a 0.5458 0.3729 0.6317 0.050 
H17b 0.5329 0.3067 0.5665 0.050 
H17c 0.5067 0.3853 0.5286 0.050 
H18a 0.7740 0.4703 0.5376 0.046 
H18b 0.9669 0.4432 0.5768 0.046 
H18c 0.8129 0.4548 0.6400 0.046 
H19a 1.0079 0.3188 0.6349 0.046 
H19b 0.8468 0.2632 0.6247 0.046 
H19c 0.8466 0.3259 0.6947 0.046 




Table A 3-2-2-4.   Refined Thermal Parameters (U's) for Compound 3.26 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0170(10) 0.0114(8) 0.0097(9) 0.0002(7) 0.0007(8) 0.0006(7) 
C2 0.0156(10) 0.0144(9) 0.0147(9) 0.0011(8) -0.0019(8) 0.0015(8) 
C3 0.0187(10) 0.0175(10) 0.0173(10) 0.0006(8) -0.0020(9) -0.0028(8) 
C4 0.0195(10) 0.0190(10) 0.0181(10) 0.0016(8) 0.0013(9) -0.0043(9) 
C5 0.0155(10) 0.0199(10) 0.0119(9) 0.0016(8) 0.0013(8) -0.0026(8) 
C6 0.0155(10) 0.0135(9) 0.0119(9) 0.0022(7) 0.0001(8) 0.0024(8) 
C7 0.0120(9) 0.0208(10) 0.0183(10) -0.0037(8) 0.0018(8) 0.0003(8) 
C8 0.0118(10) 0.0189(10) 0.0116(9) 0.0021(8) 0.0011(8) 0.0009(7) 
C9 0.0138(9) 0.0162(10) 0.0116(9) 0.0006(7) -0.0022(8) -0.0011(8) 
C10 0.0117(9) 0.0123(9) 0.0125(9) 0.0013(7) -0.0007(7) 0.0023(7) 
C11 0.0229(11) 0.0126(9) 0.0220(10) -0.0008(8) -0.0049(10) -0.0011(9) 
C12 0.0245(11) 0.0187(10) 0.0213(10) 0.0048(8) -0.0044(10) -0.0073(9) 
C13 0.0160(10) 0.0229(10) 0.0201(10) 0.0039(8) 0.0005(8) -0.0047(9) 
C14 0.0267(11) 0.0179(10) 0.0233(11) -0.0002(8) 0.0025(10) -0.0023(10) 
C15 0.0157(10) 0.0263(11) 0.0237(11) 0.0038(9) 0.0023(9) 0.0018(9) 
C16 0.0207(11) 0.0233(10) 0.0117(9) -0.0004(8) 0.0004(9) 0.0013(9) 
C17 0.0253(13) 0.0528(16) 0.0235(12) -0.0024(11) 0.0097(10) 0.0031(12) 
C18 0.0444(14) 0.0260(12) 0.0200(11) -0.0074(9) -0.0001(11) 0.0009(12) 
C19 0.0403(15) 0.0393(13) 0.0113(10) 0.0049(9) -0.0009(10) 0.0050(11) 
O1 0.0176(7) 0.0188(7) 0.0103(6) 0.0025(5) -0.0005(6) 0.0014(6) 
O2 0.0238(8) 0.0156(7) 0.0107(7) -0.0012(5) 0.0019(6) 0.0022(6) 
S1 0.0149(2) 0.0121(2) 0.0177(2) 0.00077(18) -0.0029(2) 0.00156(19) 
S2 0.0147(2) 0.0185(2) 0.0157(2) 0.00119(19) 0.0032(2) 0.0007(2) 
Si1 0.0116(2) 0.0154(3) 0.0107(3) 0.0015(2) 0.0000(2) -0.0003(2) 




  Table A 3-2-2-5. Bond Distances in Compound 3.26, Å 
C1-O2  1.419(2) C1-C2  1.541(3) C1-C6  1.567(2) 
C1-C10  1.597(3) C2-C7  1.535(3) C2-C3  1.548(3) 
C3-C4  1.548(3) C4-C5  1.540(3) C5-C6  1.537(3) 
C5-C7  1.547(3) C6-C8  1.542(3) C8-O1  1.422(2) 
C8-C9  1.519(3) C9-C10  1.537(3) C10-S1  1.8328(19) 
C10-S2  1.835(2) C11-C12  1.516(3) C11-S1  1.818(2) 
C12-C13  1.519(3) C13-S2  1.811(2) C14-Si1  1.863(2) 
C15-Si1  1.865(2) C16-C18  1.532(3) C16-C19  1.533(3) 
C16-C17  1.536(3) C16-Si1  1.879(2) O1-Si1  1.6489(14) 
 
Table A 3-2-2-6. Bond Angles in Compound 3.26, ° 
O2-C1-C2 112.50(16) O2-C1-C6 109.96(15) C2-C1-C6 102.43(16) 
O2-C1-C10 110.55(15) C2-C1-C10 115.68(16) C6-C1-C10 105.03(15) 
C7-C2-C1 102.61(16) C7-C2-C3 100.68(16) C1-C2-C3 108.10(17) 
C2-C3-C4 103.84(16) C5-C4-C3 102.55(16) C6-C5-C4 107.24(16) 
C6-C5-C7 103.76(16) C4-C5-C7 100.45(16) C5-C6-C8 116.23(16) 
C5-C6-C1 103.25(16) C8-C6-C1 106.59(15) C2-C7-C5 94.01(15) 
O1-C8-C9 108.58(16) O1-C8-C6 113.89(16) C9-C8-C6 106.23(15) 
C8-C9-C10 105.23(15) C9-C10-C1 105.67(15) C9-C10-S1 111.39(13) 
C1-C10-S1 111.59(13) C9-C10-S2 110.73(13) C1-C10-S2 106.68(13) 
S1-C10-S2 110.58(10) C12-C11-S1 114.25(15) C11-C12-C13 114.64(17) 
C12-C13-S2 114.85(15) C18-C16-C19 109.33(19) C18-C16-C17 109.2(2) 
C19-C16-C17 109.3(2) C18-C16-Si1 109.22(15) C19-C16-Si1 109.38(15) 
C17-C16-Si1 110.38(16) C8-O1-Si1 126.35(13) C11-S1-C10 98.59(9) 
C13-S2-C10 100.45(9) O1-Si1-C14 110.27(9) O1-Si1-C15 110.39(9) 
C14-Si1-C15 109.50(11) O1-Si1-C16 103.55(9) C14-Si1-C16 111.61(10) 
C15-Si1-C16 111.42(10)     
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1Sheldrick, G.M. (2008) CELL_NOW. University of Gottingen, Germany. 
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7R1 = ||Fo| - |Fc|| /  |Fo| 
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wR2 = [w(Fo2 - Fc2)2/w(Fo2)2]½ 
GOF = [w(Fo2 - Fc2)2/(n - p)]½ 
where n = the number of reflections and p = the number of parameters refined. 
8“ORTEP-II:  A  Fortran  Thermal  Ellipsoid  Plot  Program  for  Crystal  Structure  Illustrations”.  C.K.  




Appendix 3-2-2: X-ray Structure Determination of Compound 3.28 
 
   Compound 3.28, C18H32SiS2O2, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=23.3638(19)Å, b=7.2272(5)Å, c=12.2344(10)Å, 
=104.999(4)°, V=1995.5(3)Å3, Z=4, and dcalc=1.240 g/cm3 . X-ray intensity data were collected 
on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 100(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 2956 frames were collected 
with a crystal to detector distance of 37.5 mm, rotation widths of 0.5° and exposures of 15 
seconds:  
scan type     frames 
 -15.50 258.48 62.70 19.46 623 
 -10.50 335.77 25.44 54.21 739 
 22.00 321.06 18.69 41.79 739 
 17.00 321.08 318.36 83.36 116 
 22.00 14.84 73.18 97.50 739 
   Rotation frames were integrated using SAINT1, producing a listing of unaveraged F2 and (F2) 
values which were then passed to the SHELXTL2 program package for further processing and 
structure solution. A total of 50267 reflections were measured over the ranges 1.72  25.43°, 
-28  h  28, -8  k  8, -14  l  14 yielding 3663 unique reflections (Rint = 0.0269). The 
intensity data were corrected for Lorentz and polarization effects and for absorption using 
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SADABS3 (minimum and maximum transmission 0.6843, 0.7452). 
   The structure was solved by direct methods (SHELXS-974). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.5 All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ (0.0596P)2 + 0.8722P] where P = (Fo 2 + 2Fc2)/3. 
Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0275 and wR2=0.0903 for 3579 observed reflections for 
which F > 4(F) and R1=0.0286 and wR2=0.0918 and GOF =1.131 for all 3663 unique, non-zero 
reflections and 216 variables.6 The maximum  in the final cycle of least squares was 0.000 
and the two most prominent peaks in the final difference Fourier were +0.383 and -0.260 e/Å3. 
   Table A 3-2-2-1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables A 3-2-3-2. and 3.  
Anisotropic thermal parameters are in Table A 3-2-2-4.  Tables A 3-2-2-5. and 6. list bond 
distances and bond angles.  Figure 3-2-2. is an ORTEP7 representation of the molecule with 50% 









Figure A 3-2-2. ORTEP drawing of compound 3.28 with 50% probability thermal ellipsoids. 
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Table A 3-2-2-1.  Summary of Structure Determination of Compound 3.28 
Empirical formula  C18H32SiS2O2 
Formula weight  372.65 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/c      
Cell constants:   
a  23.3638(19) Å 
b  7.2272(5) Å 
c  12.2344(10) Å 
 104.999(4)° 
Volume 1995.5(3) Å3 
Z 4 
Density (calculated) 1.240 Mg/m3 
Absorption coefficient 0.334 mm-1 
F(000) 808 
Crystal size 0.42 x 0.40 x 0.02 mm3 
Theta range for data collection 1.72 to 25.43° 
Index ranges -28  h  28, -8  k  8, -14  l  14 
Reflections collected 50267 
Independent reflections 3663 [R(int) = 0.0269] 
Completeness to theta = 25.43° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6843 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3663 / 0 / 216 
Goodness-of-fit on F2 1.131 
Final R indices [I>2sigma(I)] R1 = 0.0275, wR2 = 0.0903 
R indices (all data) R1 = 0.0286, wR2 = 0.0918 
Largest diff. peak and hole 0.383 and -0.260 e.Å-3 
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Table A 3-2-2-2. Refined Positional Parameters for Compound 3.28 
  Atom x y z Ueq, Å2 
C1 0.15966(8) 0.4272(3) 0.31048(17) 0.0141(4) 
C2 0.14188(9) 0.6216(3) 0.26975(19) 0.0201(5) 
C3 0.17832(10) 0.7510(4) 0.25181(19) 0.0226(5) 
C4 0.24364(9) 0.7211(3) 0.2682(2) 0.0224(5) 
C5 0.25744(9) 0.5156(3) 0.2634(2) 0.0183(5) 
C6 0.22768(9) 0.3961(3) 0.33582(18) 0.0144(4) 
C7 0.25205(9) 0.4224(3) 0.46577(18) 0.0150(4) 
C8 0.19927(9) 0.4859(3) 0.50860(19) 0.0163(4) 
C9 0.14598(9) 0.3935(3) 0.42755(18) 0.0140(4) 
C10 0.02176(9) 0.3479(3) 0.3680(2) 0.0198(5) 
C11 0.02708(9) 0.1501(3) 0.4115(2) 0.0199(5) 
C12 0.08078(10) 0.0508(3) 0.3915(2) 0.0208(4) 
C13 0.35825(10) 0.3923(3) 0.71119(19) 0.0191(4) 
C14 0.39847(10) 0.3125(3) 0.4977(2) 0.0223(5) 
C15 0.41167(8) 0.7070(3) 0.59570(19) 0.0144(4) 
C16 0.38076(10) 0.8590(3) 0.64791(19) 0.0189(5) 
C17 0.42004(10) 0.7760(3) 0.4824(2) 0.0213(5) 
C18 0.47248(9) 0.6669(3) 0.6762(2) 0.0223(5) 
O1 0.12667(7) 0.2975(2) 0.23142(13) 0.0199(3) 
O2 0.29974(6) 0.5516(2) 0.49677(13) 0.0167(3) 
S1 0.07912(2) 0.49753(7) 0.45003(5) 0.01848(14) 
S2 0.15107(2) 0.14855(7) 0.46826(5) 0.01651(13) 
Si1 0.36574(2) 0.48973(7) 0.57436(5) 0.01215(14) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
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Table A 3-2-2-3. Positional Parameters for Hydrogens in Compound 3.28 
  Atom x y z Uiso, Å2 
H2 0.1020 0.6525 0.2562 0.027 
H3 0.1627 0.8668 0.2278 0.030 
H4a 0.2651 0.7711 0.3408 0.030 
H4b 0.2567 0.7862 0.2096 0.030 
H5a 0.3000 0.4981 0.2887 0.024 
H5b 0.2446 0.4741 0.1854 0.024 
H6 0.2341 0.2664 0.3187 0.019 
H7 0.2657 0.3024 0.5000 0.020 
H8a 0.1955 0.6196 0.5054 0.022 
H8b 0.2034 0.4454 0.5858 0.022 
H10a -0.0166 0.3967 0.3698 0.026 
H10b 0.0239 0.3480 0.2898 0.026 
H11a -0.0084 0.0824 0.3741 0.027 
H11b 0.0298 0.1511 0.4920 0.027 
H12a 0.0785 0.0537 0.3112 0.028 
H12b 0.0794 -0.0779 0.4133 0.028 
H13a 0.3408 0.4834 0.7498 0.029 
H13b 0.3967 0.3589 0.7574 0.029 
H13c 0.3334 0.2846 0.6967 0.029 
H14a 0.3726 0.2073 0.4810 0.033 
H14b 0.4363 0.2745 0.5442 0.033 
H14c 0.4033 0.3644 0.4284 0.033 
H16a 0.3756 0.8169 0.7192 0.028 
H16b 0.3428 0.8858 0.5976 0.028 
H16c 0.4047 0.9689 0.6595 0.028 
H17a 0.4431 0.8876 0.4943 0.032 
H17b 0.3820 0.8004 0.4315 0.032 
H17c 0.4402 0.6832 0.4503 0.032 
H18a 0.4918 0.5712 0.6447 0.033 
H18b 0.4675 0.6271 0.7481 0.033 
H18c 0.4962 0.7771 0.6863 0.033 




Table A 3-2-2-4.   Refined Thermal Parameters (U's) for Compound 3.28 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0114(9) 0.0157(10) 0.0143(10) 0.0004(8) 0.0018(8) -0.0021(7) 
C2 0.0126(10) 0.0244(11) 0.0223(11) 0.0069(9) 0.0030(9) 0.0031(8) 
C3 0.0198(11) 0.0240(11) 0.0237(12) 0.0101(10) 0.0050(9) 0.0032(9) 
C4 0.0143(10) 0.0248(12) 0.0266(12) 0.0096(10) 0.0024(9) -0.0031(8) 
C5 0.0122(10) 0.0270(12) 0.0158(11) 0.0018(8) 0.0038(9) -0.0009(8) 
C6 0.0121(10) 0.0154(9) 0.0149(10) 0.0000(8) 0.0017(8) 0.0010(8) 
C7 0.0110(9) 0.0142(10) 0.0177(10) 0.0011(8) -0.0001(8) -0.0043(8) 
C8 0.0167(10) 0.0175(10) 0.0142(11) -0.0031(8) 0.0030(9) -0.0042(8) 
C9 0.0118(9) 0.0130(9) 0.0170(10) 0.0011(8) 0.0035(8) -0.0003(8) 
C10 0.0120(9) 0.0258(12) 0.0218(11) 0.0055(9) 0.0044(8) 0.0008(8) 
C11 0.0149(10) 0.0209(11) 0.0230(11) 0.0031(9) 0.0032(9) -0.0061(8) 
C12 0.0203(11) 0.0151(10) 0.0251(11) 0.0004(9) 0.0025(9) -0.0055(9) 
C13 0.0180(10) 0.0201(10) 0.0182(11) 0.0039(9) 0.0030(8) -0.0010(8) 
C14 0.0237(11) 0.0170(10) 0.0267(12) -0.0031(9) 0.0075(10) 0.0004(9) 
C15 0.0122(9) 0.0128(10) 0.0179(10) -0.0015(8) 0.0032(8) -0.0009(7) 
C16 0.0206(11) 0.0140(11) 0.0227(12) -0.0018(8) 0.0069(9) 0.0010(8) 
C17 0.0249(11) 0.0157(11) 0.0255(11) 0.0013(9) 0.0104(10) -0.0036(8) 
C18 0.0142(10) 0.0187(11) 0.0306(13) -0.0036(9) -0.0003(9) -0.0025(8) 
O1 0.0168(7) 0.0278(8) 0.0140(7) -0.0038(6) 0.0019(6) -0.0082(6) 
O2 0.0113(7) 0.0145(7) 0.0212(8) 0.0025(6) -0.0016(6) -0.0036(6) 
S1 0.0160(3) 0.0158(3) 0.0264(3) -0.00082(19) 0.0105(2) 0.00005(18) 
S2 0.0143(2) 0.0139(2) 0.0197(3) 0.00326(19) 0.0014(2) -0.00069(18) 
Si1 0.0110(3) 0.0110(3) 0.0138(3) 0.0003(2) 0.0020(2) -0.00067(18) 




  Table A 3-2-2-5. Bond Distances in Compound 3.28, Å 
C1-O1  1.422(2) C1-C2  1.512(3) C1-C6  1.555(3) 
C1-C9  1.565(3) C2-C3  1.321(3) C3-C4  1.503(3) 
C4-C5  1.524(3) C5-C6  1.528(3) C6-C7  1.555(3) 
C7-O2  1.427(2) C7-C8  1.530(3) C8-C9  1.530(3) 
C9-S1  1.818(2) C9-S2  1.834(2) C10-C11  1.519(3) 
C10-S1  1.810(2) C11-C12  1.520(3) C12-S2  1.811(2) 
C13-Si1  1.866(2) C14-Si1  1.865(2) C15-C18  1.533(3) 
C15-C17  1.533(3) C15-C16  1.541(3) C15-Si1  1.882(2) 
O2-Si1  1.6496(15)     
 
Table 6. Bond Angles in Compound 1374, ° 
O1-C1-C2 109.50(17) O1-C1-C6 112.74(17) C2-C1-C6 112.30(17) 
O1-C1-C9 108.46(16) C2-C1-C9 110.03(17) C6-C1-C9 103.61(16) 
C3-C2-C1 125.4(2) C2-C3-C4 123.5(2) C3-C4-C5 110.66(19) 
C4-C5-C6 113.31(18) C5-C6-C1 113.45(17) C5-C6-C7 115.02(17) 
C1-C6-C7 105.72(16) O2-C7-C8 110.84(17) O2-C7-C6 113.92(17) 
C8-C7-C6 105.82(16) C7-C8-C9 103.88(16) C8-C9-C1 101.56(16) 
C8-C9-S1 107.96(14) C1-C9-S1 117.46(14) C8-C9-S2 105.11(14) 
C1-C9-S2 112.62(14) S1-C9-S2 110.85(11) C11-C10-S1 112.71(16) 
C10-C11-C12 112.60(19) C11-C12-S2 114.06(16) C18-C15-C17 109.20(18) 
C18-C15-C16 108.94(17) C17-C15-C16 109.06(17) C18-C15-Si1 109.36(14) 
C17-C15-Si1 110.33(14) C16-C15-Si1 109.92(14) C7-O2-Si1 121.66(13) 
C10-S1-C9 102.16(10) C12-S2-C9 104.45(10) O2-Si1-C14 109.91(10) 
O2-Si1-C13 109.13(9) C14-Si1-C13 109.77(10) O2-Si1-C15 105.56(8) 
C14-Si1-C15 110.48(10) C13-Si1-C15 111.89(10)   
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